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1.1 Introduction 
Cattle can get infested with several mite species that occur worldwide: 
Demodex bovis, Sarcoptes scabiei, Chorioptes bovis and Psoroptes ovis (Taylor et al., 
2007). Demodex bovis is located in the hair follicles and sebaceous glands and 
although the mite can live as a commensal on the skin, it can also cause small 
cutaneous nodules, causing hide damage (Taylor et al., 2007). Infections with 
Sarcoptes scabiei (S. scabiei), a mite that burrows into the epidermis, cause hair loss 
and thickened skin but have become rare in cattle in Belgium. Chorioptes bovis (C. 
bovis) mange is a relatively benign condition that is often located at the legs, tail base 
and udder and that mainly affects dairy cattle, such as Holstein Friesians (HF) 
(Mitchell et al., 2012; Taylor et al., 2007). Psoroptes ovis (P. ovis) infestations are the 
most aggressive mite infections, leading to severe pruritus, crusts, excoriation and 
secondary bacterial infections. The disease is highly contagious, affects mostly beef 
cattle breeds and causes important economic losses mainly due to weight loss and 
impaired leather quality (Cole and Guillot, 1987; Fisher and Wright, 1981; Pouplard 
and Detry, 1981; Rehbein et al., 2003; Taylor et al., 2007). The Belgian Blue (BB) 
beef breed seems to be highly susceptible to this infection and often has more severe 
and sometimes even generalized lesions (Bates, 1998; Losson et al., 1999; Pouplard et 
al., 1990). Although this mite species is ubiquitous in sheep, in cattle the geographical 
spread is more restricted (Losson et al., 1999), with a focus in Belgium where the 
disease is endemic (Minihan et al., 2002). Outbreaks of psoroptic mange in countries 
where P. ovis was previously eradicated often occur after importation of BB cattle 
(Jones et al., 2014; Millar et al., 2011; Minihan et al., 2002; Mitchell et al., 2012). 
 
The classification of Psoroptes spp. mites has long been a subject of debate. 
The earliest information dates from 1838, when Hering determined 9 species based on 
the infested host (Pegler et al., 2005). In 1861 Furstenberg hypothesized that all 
Psoroptes-mites belonged to the same species, P. communis, but that different 
varieties existed according to the host (Bates, 1999). Megnin and Raillet changed the 
species name in 1877 and 1893 respectively and in 1922 Hirst split the genus into P. 
communis and P. natalensis (Bates, 1999). From 1958 onwards the Sweatman 
taxonomy has been used, in which 5 species are differentiated: P. cuniculi, P. 
cervinus, P. equi, P. ovis and P. natalensis. This classification is based on the 
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morphology of the outer opisthosomal setae (OOS) of male mites and the location on 
and species of the host (Bates, 1999; Pegler et al., 2005; Sanders et al., 2000). 
However, recent research demonstrated a large inter- and intraspecies variation in the 
OOS length, making this parameter unreliable for species differentiation. Moreover, 
P. ovis and P. cuniculi crossbreds were able to produce viable offspring, genetic 
studies revealed little to no difference between mite species and complete antigenic 
cross-reactivity was demonstrated between mites from different hosts. Hence, it was 
concluded that these supposedly separated species are in fact one species (Sanders et 
al., 2000). In conclusion, the classification of P. ovis can be based on several 
differentiation techniques, of which the practicality is still under discussion. In the 
present thesis the Sweatmann taxonomy is followed and P. ovis is used to indicate 
mites of cattle and sheep. These mites are suspected to be host adapted strains of the 
singular species P. ovis (Pegler et al., 2005). 
 
Causes of the increased susceptibility and the high prevalence of P. ovis 
infestations in BB cattle remain unclear (Bates, 1998; Losson et al., 1999; Pouplard et 
al., 1990), but as psoroptic mange is a multifactorial disease, environmental, 
epidemiologic and host immune parameters may influence the outcome of the disease 
on farm level and may partially explain the susceptibility of the BB breed. Therefore, 
in this introductory chapter, the available literature on P. ovis will be reviewed with 
the focus on life cycle, pathogenesis, epidemiology, diagnosis, treatment and the host 
immune reactions during infection.  
 
1.2 Life cycle and epidemiology 
The life cycle of P. ovis is direct and this obligate ectoparasite spends its entire 
life on the host (Figure 1). Gravid females produce large 250 µm long, oval eggs 
(Taylor et al., 2007). A hexapod larva hatches from this egg and undergoes 3 
moulting stages: a protonymph develops first, which later moults into a tritonymph. 
During these moulting phases, the mites do not feed and are immobile. Nymphs 
already have 4 pairs of legs and sexual dimorphism can be noticed from these stages 
onwards. The tritonymph finally moults into an adult P. ovis, which has several 
characteristic features: the body is oval, the mouthparts (chelicerae) are pointed and 3 
out of 4 pairs of legs support 3 segmented pretarsi (pediculi) ending in funnel-like 
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suckers, the pulvilli (Figure 10) (Taylor et al., 2007). These mites do not have 
external tracheal openings (stigmata), which means gas exchange occurs directly 
through the cuticle (Bates, 2012). Adult males are smaller than females, have 
copulatory suckers and the fourth pair of legs is very short (Sanders et al., 2000; 
Taylor et al., 2007). They will mate with female tritonymphs and detach after the 
female has moulted into an adult. Insemination takes place just before the male 
detaches. After this, the female starts to produce about 2 to 3 eggs per day depending 
on the environmental temperature, and as the life span of a female is around 16 to 42 
days, she will have laid 40 to 90 eggs in total (Bates, 1998 and 2012; Pouplard et al., 
1990; Taylor et al., 2007; van den Broek and Huntley, 2003). The transition from one 
stage to another takes approximately 2 days (12 to 36 hours), which means the total 
life cycle from egg to adult takes about 10 up to 19 days (Bates, 2012; Gibbs et al., 
1986; van den Broek and Huntley, 2003; Wall et al., 1999). Because of the large 
numbers of eggs produced by the females and the relatively short life cycle duration, 
the mite population will increase exponentially and double every 6 days (Wall et al., 
1999). The mites feed superficially by scraping the epidermis with their chelicerae, 
which will release proteins and serous exudate. By using a pre-oral trough, the mites 
can transport these nutrients to their pump-like pharynx. Sheep derived mites appear 
to feed mainly on lipid emulsions, which consist of skin cells and bacteria, but cattle 
derived mites also feed on blood serum and red blood cells (Bates, 1998, 2012; 
Kirkwood, 1985; Wright and Deloach, 1981). The digestion of nutrients in the mite 
gut mainly occurs through secretion of enzymes, such as cysteine proteinases, serine 
proteinases and metalloproteinases. In addition, luminal bacteria including Serratia 
marcescens and Comamonas spp. may be a direct or indirect food source, have an 
additional symbiotic digestive function and/or may be crucial for mite survival 
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The life cycle of Chorioptes bovis is identical to that of P. ovis but the 
duration is about 3 weeks. Females only lay 1 egg per day and live for 2 to 3 weeks. 
The mites are smaller than P. ovis and have short, unsegmented pediculi ending in a 
large cup-shaped pulvillus (Figure 2). With their rounded mouthparts, the mites 
mainly feed on cell debris. They are located at the hind legs, tail base, groin and udder 
and cause less severe symptoms compared to P. ovis with formation of small, dry 
scales or crusts (Bates, 2012; Taylor et al., 2007). 
 
Figure 2. Chorioptes bovis with typical short pediculus and large pulvillus (black 






Another obligate ectoparasite is Sarcoptes scabiei, the burrowing mite. 
Females live for 2 months and burrow deep in the skin to deposit their eggs (1 to 3 per 
day). In 3 to 4 days, the eggs hatch and the larvae either develop in the burrow, in hair 
follicles or on the skin surface. The larva moults to a protonymph, which develops 
into a tritonymph and finally an adult, with each moulting stage taking about 2 days. 
Adults mate on the skin after which the female tries to find a suitable place to make 
her permanent burrow. The whole cycle takes between 2 to 3 weeks. The mites have a 
round body and short legs, the pediculi are long and unsegmented and the pulvillus is 
small (Figure 3). The mites prefer less well haired areas and are often found at the tail 
base, the neck and the head. They cause severe pruritus and alopecia, lichenification 
and crust formation may occur (Bates, 2012; Taylor et al., 2007). 
 





Mange is a winter disease, although in severe cases it can be seen all year 
round (Bates, 1998). Once introduced in a herd or farm, this highly contagious 
infection will rapidly spread through direct and indirect transmission. Direct or close 
contact between animals is the main transmission route of P. ovis infections (Mitchell 
et al., 2012) and this statement indicates the importance of subclinical carriers. 
Carriers are clinically healthy but infested, although the mites seem to be in 
hibernation (Jones et al., 2014; Mitchell et al., 2012; Pouplard et al., 1990). In sheep, 
‘latent phase’ mites have been found around the ears, the perineum, the infra-orbital 
and interdigital fossae and the inguinal pouches (Bates, 2012; Kirkwood, 1985) and in 
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cattle at the base of the horns and the top of the head (Bussiéras, 1987). Introducing 
untreated, seemingly healthy carriers into a herd is therefore a major risk factor for 
introduction of the disease, as these animals can transmit the infection to uninfested 
herd members (Carty and Nisbet, 2011; Millar et al., 2011; Mitchell et al., 2012; 
Phythian et al., 2013; Pouplard et al., 1990). Even though P. ovis mites remain on the 
host throughout their entire life cycle, they are capable of surviving in the 
environment. Indirect transmission through contaminated housing infrastructure, 
bedding, tools, work wear and transportation machinery should therefore not be 
underestimated (Bates, 1998). Several studies on off-host survival time for P. ovis 
have been conducted and the longest period for sheep derived mites was 48 days 
(Smith et al., 1999). As mites do not feed during this period, their viability will 
decline and consequently, their infectivity (capability of inducing an active infection 
in a new host) is about 2 weeks, depending on the environmental conditions. Low 
temperatures, high humidity and low exposure to direct sunlight are ideal for P. ovis 
survival and infectivity off the host (Bates, 1998 and 2012; van den Broek and 
Huntley, 2003). The influence of climatic conditions on the off host survival time of 
mange mites indicates that climate change could potentially have an effect on the 
disease. However, as an increasing global temperature will decrease off host survival 
and duration of the housing period, during which the highest transmission of mites 
occurs, climate change will most likely have a negative effect on mange mite 
abundance and spread. However, more research on the complex interactions between 
climate change and parasite population dynamics is necessary (Morgan and Wall, 
2009). 
For psoroptic mange, there is no specific predisposition for animals of a 
certain age or sex: the disease occurs as often in females as in males and all ages can 
get infested (Bates, 2012; Mitchell et al., 2012; O’Brien, 1999). It should be stressed 
however that there is a clear breed susceptibility: while dairy cattle seem to be 
resistant and rather affected by chorioptic mange, beef breeds tend to frequently get 
infested with P. ovis and suffer from more severe lesions (Bates, 1998; Losson et al., 
1999; Pouplard et al., 1990). Similarly, large differences in the progress and extent of 
P. ovis infections between sheep breeds have been documented, with fine wooled 
breeds presenting more severe and rapidly spreading lesions with high numbers of 
adult mites, compared to coarse wooled breeds (Bates, 2012; Fourie et al., 2002; 
Smith et al., 2001). In cattle, the possibility to self-groom, associated with the 
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presence or absence of large horns, differences in skin thickness and/or conformation 
and behavioural varieties have been suggested as reasons for breed susceptibility 
differences to mange (Lonneux and Losson, 1996; Lonneux et al., 1998b and c). 
Based on experimental work on ticks, there are some additional hypotheses to explain 
why BB are more susceptible than other breeds, such as HF. Cattle breeds that are 
rather resistant towards tick infestations appear to have a smaller range of antigen 
recognition, which decreases the cellular inflammatory response, dampens the 
constant trigger of immune cell development and contains the advancement towards 
chronic inflammation (Piper et al., 2010). This coincides with earlier work done on 
psoroptic mange, in which the suggestion is made that HF display a faster decline in 
P. ovis antigen reactivity, leading to a less intense immune response and less severe 
clinical signs (Losson et al., 1999). Tick-resistant cattle breeds also appear to show a 
larger up-regulation of proteins that support collagen fibres, leading to a stronger skin 
barrier against tick infestation and potentially mite infections (Wang et al., 2007). 
Physiological differences in general, especially in skin structure and composition 
could influence the easiness by which mites can breach the skin. Lastly, breeds that 
have been exposed to ticks for hundreds of years have co-evolved into responding less 
to the biologically active compounds of tick-saliva and as such, diminish the ability of 
the tick to modulate the skin in order to facilitate blood feeding (Piper et al., 2010). 
Because the BB breed is a relatively ‘new’ cattle breed (Huyghe et al., 2014), P. ovis 
might induce a much stronger cellular reaction compared to other cattle breeds and 
result in the severe clinical signs typical for these animals. Even within one breed, 
differences in susceptibility on group or individual level can be observed. Problem 
farms where all animals suffer from persistent and severe mange have been described 
for sheep (Phythian et al., 2013) and have been suggested to exist in cattle practice. 
Environmental influences, the presence of resistant mite strains, concurrent infectious 
diseases with a potential immunosuppressive effect (e.g. bovine viral diarrhoea, 
infectious bovine rhinotracheitis, bovine malignant catarrhal fever…) or distinctive 
management strategies, such as specific feed composition, treatment (of mange and 
other diseases) and hygiene protocols, could explain the different clinical outcome on 
farm level (Minihan et al., 2002; Phythian et al., 2013; Wall, 2012). In sheep, 
differences in susceptibility between individual animals might be linked to the ability 
of the host to mount an allergic response to the mite, as some immunologically 
unresponsive individuals seem to develop little to no clinical signs. Furthermore, a 
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divergent individual bacterial skin flora may also be responsible for more ‘resistant’ 
individuals in the field. Some bacteria can have inhibitory effects on parasites and 
mites have to adjust to the bacterial flora of a new host before they can start feeding 
and reproducing. Individuals carrying an ‘inhibitory’ bacterial flora might be more 
resistant to infestation (Bates, 2012). Whether these are also the causes of varying 
individual sensitivity in cattle remains uncertain, but the presence of separate P. ovis 
strains with unusual virulence could be partly responsible. Although not yet described 
in cattle, research on sheep in the US demonstrated the presence of several distinct, 
seemingly more pathogenic, P. ovis populations that spread faster, caused more 
severe lesions, survived longer on the host and had a higher survival rate after 
treatment (Bates, 1997; Roberts and Meleney, 1970). Finally, within the sensitive BB 
breed, the presence of highly susceptible genetic lines could also explain the variety 
in clinical signs within an affected herd (Jones et al., 2014; Minihan et al., 2002; 
Pruett et al., 1986; Stromberg and Fisher, 1986). 
 
1.3 Pathogenesis and clinical signs 
Psoroptic mange is a multifactorial disease: besides the presence of mites, 
nutrition, hygienic conditions, concomitant diseases, housing, climate, ventilation and 
other management factors, such as treatment protocol, may influence the presence or 
absence of a clinical mange infection (Mitchell et al., 2012; O’Brien, 1999; Pouplard 
et al., 1990). Under optimal conditions, the development of symptoms begins when 
the mites start feeding. Psoroptes ovis is a non-burrowing ectoparasite that lives 
superficially on the skin surface and by using its mouthparts, P. ovis actively scrapes 
and abrades the epidermis instead of piercing it (Bates, 2012; van den Broek and 
Huntley, 2003). This mechanical skin damage will cause leakage of proteins and 
serous exudate, which is one of the main nutrition sources for the mite (Bates, 1998; 
Kirkwood, 1985; Wright and Deloach, 1981). While the mites feed and reproduce, 
they release allergenic excretion and secretion (ES) products, such as faecal pellets, 
digestive fluids, enzymes and shed cuticle. As P. ovis mites damage the epidermis 
during feeding, the diffusion of these pro-inflammatory allergens into the skin is 
facilitated and they are thought to be the main initiators of clinical signs as they 
induce a hypersensitivity or allergic reaction in the host (Bates, 2012; Smith et al., 
2001; Stromberg and Fisher, 1986; van den Broek and Huntley, 2003; van den Broek 
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et al., 2004). When the mite population increases and the lesions spread, the released 
exudate dries out in the centre and forms a dry yellow crust or scab (Stromberg and 
Fisher, 1986; Taylor et al., 2007), while at the edges the infection remains ‘active’ 
indicated by moist, inflamed skin (van den Broek and Huntley, 2003). In sheep, 
reproducing mites are usually found at the edge of these crusts, while in cattle they 
are thought to reside on the entire lesion (Bates, 1998; Losson et al., 1999; Taylor et 
al., 2007; van den Broek and Huntley, 2003).  
Clinically, erythematous skin and multiple thick yellowish crusts can be seen 
(Figure 4), but in some cases milder clinical signs with more dandruff-like flakes are 
visible (Taylor et al., 2007; van den Broek and Huntley, 2003). While erythematous 
skin can be noticed from one hour post-infection (pi) onwards in sheep, in cattle it 
takes about 7 days for clinical signs to appear (Stoeckli et al., 2013; Stromberg and 
Fisher, 1986). Lesions are mainly seen at the tail base, back and withers, but the 
infestation spreads rapidly and can cover the entire body in severe cases (Bates, 1998; 
Millar et al., 2011; Pouplard et al., 1990; Stromberg and Guillot, 1987). Secondary 
bacterial infections often occur, causing abscesses or pyodermatitis. Moreover, the 
susceptibility to other infectious diseases, such as pulmonary infections may be 
increased (Bates, 1998; Stromberg and Guillot, 1987; Taylor et al., 2007; van den 
Broek and Huntley, 2003). Most importantly, the allergic reaction and the irritation 
from the mites induce an intense pruritus, leading to self-traumatising behaviour, such 
as licking, scratching and biting. Although affected hosts will get rid of some mites 
this way, mechanical skin abrasion is the most important consequence leading to hair 
loss, skin damage, seromas, hematomas and bleeding wounds (Bates, 1998; Pouplard 
et al., 1990; van den Broek et al., 2000). All these factors will intensify the local 
intradermal inflammation, which leads to increased serum extravasation, creating the 
perfect microclimate for mites to survive. This ideal environment will in turn translate 
in an exponential growth of the mite population and the clinical lesions (Lonneux and 
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Figure 4. Dorsal view of a BB cow infested with P. ovis (left) and close-up of the 
clinical lesions (right). Typical clinical signs are alopecia, erythematous skin and 




Histopathologically, epithelial hyperkeratosis, dermal oedema, sebaceous gland 
hypertrophy, increased dermal thickness and marked perivascular dermatitis are 
observed with fast infiltration of eosinophils, neutrophils and lymphocytes to the site 
of infection. Mast cell hyperplasia and degranulation are also obvious, with further 
attraction and activation of eosinophils and the release of vasoactive substances as 
consequences. The latter will increase dermal oedema and vascular permeability, 
which in return will intensify the extravasation of serous exudate. Occasionally, 
epithelial microabscesses, pustules and ulcerations are noticed (Minihan et al., 2002; 
Stromberg and Fisher, 1986; Stromberg and Guillot, 1989; Taylor et al., 2007; van 
den Broek et al., 2000 and 2004).  
Systemic changes can be anaemia, neutropenia, lymphopenia, eosinophilia and 
increased plasma protein concentrations (Losson et al., 1988; Stromberg et al., 1986; 
Stromberg and Guillot, 1989; van den Broek et al., 2000; van den Broek and Huntley, 
2003).  
 
In parallel with the expansion of the mite population, the host develops the P. ovis 
specific immunoglobulins (Ig) IgE, IgM and IgG, which negatively affect mite 
survival as they are excreted in the serous exudate and ingested by the mites (Bates, 
2012; Pruett et al., 1986; van den Broek et al., 2000 and 2003b). On the other hand, 
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IgE antibodies might be partly responsible for the cutaneous pathology as they induce 
an IgE-mediated type 1 hypersensitivity reaction (van den Broek et al., 2000). None 
the less, if this humoral response is sufficient, combined with the lack of new feeding 
sites for the mites, the further development of the mite population will stabilize, 
decrease and eventually be eliminated (Stromberg and Fisher, 1986). Compared to the 
response during primo-infection, the rapid increase in anti-P. ovis antibodies, 
especially IgE, during consecutive mange infections or after vaccination can even 
lead to a marked clinical resistance in sheep (Bates, 2000; Smith et al., 2001 and 
2002; van den Broek et al., 2000).  
Several distinct phases in the longitudinal progression of the disease have indeed 
been identified in sheep. At first, a subclinical or lag phase is observed, during which 
the mites adjust to the new host and low mite numbers and very small, almost 
undetectable lesions are present. Under field conditions, the lag phase might take up 
to 240 days before the rapid growth phase sets in. This phase, during which mite 
numbers, lesions and mite specific antibodies increase dramatically, is followed by a 
peak or plateau phase. The increase in mite numbers and lesion development slows 
down and eventually the decline phase is initiated. At this point, feeding sites for the 
mites have become scarce and the immune response of the host takes over, which is 
translated in a decreased mite population and less active clinical signs. Eventually, the 
regression phase begins, during which the clinical signs heal and all mites are 
eliminated (Bates, 2012). Natural recovery from the infection is therefore not unusual, 
but will depend on the host’s previous exposure to P. ovis, the virulence of the mites 
and the host species and breed (Bates, 2012). An example of the latter is that 
compared to BB animals, self-cure in HF cattle is much more frequent (Bates, 1998). 
On the other hand, infested animals often get into the cryptic or ‘carrier’ stage of 
mange, in which they are clinically healthy but carry hibernating mites that can re-
introduce the disease later on (Bates, 2012; van den Broek and Huntley, 2003). 
Finally, patients may also develop chronic mange, meaning they are unable to control 
the disease, which often leads to high mite numbers, dry crusts or flakes with 
excoriation, lichenification and hyperkeratinisation of the skin (Bates, 1998; Pruett et 
al., 1986; Taylor et al., 2007). 
 
Psoroptic mange is a threat to the beef cattle industry as it causes animal welfare 
issues and important economic losses (Minihan et al., 2002; Pouplard and Detry, 
  22 
1981; Pouplard et al., 1990). Skin damage induced by increased self-grooming 
behaviour will negatively influence hide quality (Figure 5) and in dairy cattle milk 
production might be impaired. Moreover, affected animals are restless and pruritic 
and therefore preoccupied with scratching and licking and distracted from feeding. 
Together with substantial protein loss through the damaged epithelial barrier, the 
lower feed intake may translate in weight loss or impaired weight gain in growing 
animals (Cole and Guillot, 1987; Fisher and Wright, 1981; Pouplard and Detry, 1981; 
Rehbein et al., 2003; Taylor et al., 2007; van den Broek and Huntley, 2003). 
According to Lonneux et al. (1998a), potential weight gain is decreased up to 30 
grams per day for every percentage of infested skin surface. This growth retardation 
can often not be recuperated by compensatory growth after treatment and can extend 
the fattening period (Lonneux et al., 1998a; Rehbein et al., 2003; Taylor et al., 2007). 
Due to large areas of alopecia, the maintenance energy requirements of affected 
animals will increase and as thermal insulation is impaired, animals can be more 
susceptible to respiratory problems (Cole and Guillot, 1987; Tobin, 1962). Finally, in 
severe cases and mostly in young animals, the infestation may lead to the death of the 
host, due to dehydration, bacterial septicaemia or other causes (muscle deterioration, 
weakness, anorexia…). Together with the substantial treatment and prevention costs, 
these occasional mortalities can result in significant economic losses (Losson et al., 
1988; Millar et al., 2011; Mitchell et al., 2012; Pouplard and Detry, 1981; Taylor et 
al., 2007; Wall, 2012).  
 
Figure 5. Severely affected 11-month-old BB calf. The calf suffered from a 
generalized psoroptic infection, was anorectic, too small for its age and had skin 




 1.4 Immune response against mites 
Little is known about the specific immune reactions that are induced during a P. 
ovis infection and it is still unclear whether these contribute to or counter the 
development of lesions. Previous research has suggested the former, as treatment of 
sheep with the anti-inflammatory drugs cyclosporin A and dexamethasone reduced 
lesion development (Bellworthy et al., 1997; Huntley et al., 2005). In the following 
chapter the immune response elicited by the host against P. ovis is described. In 
general, a pro-inflammatory and pro-allergic innate immune reaction develops within 
hours after the first contact with the mite. This pro-inflammatory response advances 
into a predominantly Th2-driven innate immune reaction with production of IgE and 
IgG antibodies. A comparison with immunologic data described for S. scabiei, the 
causative pathogen of scabies in dogs, pigs and humans, is also provided. 
 
1.4.1 Introduction 
The skin of healthy individuals is continuously challenged by pathogens and if 
these breach the skin barrier, most of them are eliminated quickly by the first line of 
defence, the innate immune system. At first, mainly soluble, preformed components, 
such as antimicrobial peptides or proteins from the complement system directly 
interact with the intruding pathogen. In a next phase, innate immune cells, such as 
macrophages, antigen-presenting cells (APC) and innate lymphoid cells (ILC) come 
in contact with non-self antigens. ILC are not T-cells but produce similar cytokine 
patterns and also include natural killer (NK)-cells. These innate T-cell counterparts 
have been demonstrated to be important in protecting the host against various 
infectious pathogens and play a role in wound healing (Hwang and McKenzie, 2013; 
Murphy, 2012). Specific pathogen-associated molecular patterns (PAMP) on the 
pathogen are recognized by innate immune cells using pattern recognition receptors 
(PRR) of which Toll-like receptors (TLR) are a subgroup. Hereupon, different 
signalling pathways and transcription factors are activated. This activation may lead 
to an attack on the intruding pathogen or to a general state of inflammation, but in 
both cases pro-inflammatory cytokines and chemotactic molecules are released 
(Murphy, 2012).  
If an infectious agent is able to survive this first attack, the adaptive immune 
response is activated, which generates memory cells, inducing long-term and 
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pathogen-specific protection (Murphy, 2012). The adaptive immune reaction is 
characterized by 2 distinct phases: the cell-mediated and humoral immune response.  
First, naïve T-cells in the lymphoid organs recognize non-self antigens that are 
presented by circulating APCs. In response, these lymphocytes will differentiate, 
proliferate and become effector T-cells that activate macrophages and aid B-cells in 
producing antigen-specific antibodies. T-cells can specialize in different subsets, 
characterized by a specific cluster of differentiation (CD): cytotoxic CD8+ T-cells or 
CD4+ helper T (Th)-cells. Murine Th-cells are able to produce distinct cytokine 
profiles, marking them as Th1, Th2, Th17 or regulatory (Treg) cells. Whether bovine 
Th-cells subsets produce similar polarized cytokine patterns is still under discussion 
(Brown et al., 1998). Besides this cellular immune response, there is also a humoral 
component, in which naïve B-cells are activated by APCs and the co-stimulatory 
signal from Th-cells. Activated B-cells, called plasma cells, produce antigen-specific 
antibodies that will neutralize the intruding pathogen or opsonize it for targeting by 
phagocytes. Th1-cells are thought to influence B-cells to produce IgG antibodies, 
while Th2-cells increase the allergic response by pushing plasma cells towards an IgE 
profile (Murphy, 2012). In Figure 6, a summary of the immune responses during 
infection is presented. 
 
Figure 6. The different response stages during infection. When the local innate 
immune response fails to eliminate the infection, the adaptive immune response is 
induced by antigen-presentation between dendritic cells and naïve T-cells (© 2012 
from Janeway's Immunobiology, Eighth Edition by Murphy. Reproduced by 





1.4.2 Innate immunity against Psoroptes ovis in sheep and cattle 
The host immune response during the first hours of a P. ovis infection has been 
closely studied by Burgess et al. (2010) using transcriptomic analysis of skin biopsies 
from sheep. It should be stressed that as clinical signs in cattle are only noticeable 
after about one week, the immune responses in this species might also develop more 
slowly as compared to sheep (Stromberg and Fisher, 1986).  
During the first contact between P. ovis and a suitable host, the mite deposits ES 
antigens on the host’s skin, with keratinocytes being the first contact point. These 
antigens, including ‘Pso o 1’ and ‘Pso o 3’ (homologues of the house dust mite 
allergen groups ‘Der p 1’ and ‘Der p 3’) have a direct effect on epidermal cells 
because of their proteolytic activity. Moreover, they are able to cleave intercellular 
tight junctions and as such breach the epidermal barrier. Pathogens can either get 
directly attacked by the complement system or their PAMPs may be recognized by 
PRRs, such as TLRs (Nakamura et al., 2006; Stoeckli et al., 2013; van den Broek and 
Huntley, 2003; Wan et al., 1999 and 2001). Several complement factors are down-
regulated in ovine skin within 3 hours pi (Burgess et al., 2010). Furthermore, the 
house dust mite allergen ‘Der p 3’ is known to cleave C3 and C5, 2 important parts of 
the complement system and this leads to the production of C3a and C5a (Maruo et al., 
1997). These pro-allergic peptides attract dendritic cells (DCs), eosinophils, 
neutrophils and mast cells and trigger their degranulation and as such already push the 
adaptive response towards a Th2 profile from early on (Arlian et al., 1994b; Muller-
Eberhard, 1988).  
Besides being confronted with the complement system, pathogenic antigens can 
be recognized by TLRs on innate immune cells. Not only mite antigens, such as ‘Pso 
o 2’, the homologue of ‘Der f 2’, but also small amounts of bacterial 
lipopolysaccharide (LPS) are present on the skin of affected sheep and both molecules 
are recognized by TLR-4 together with the up-regulated, co-stimulatory molecule 
CD14 (Burgess et al., 2010 and 2011). LPS might also be derived from the mites 
themselves as these often carry commensal bacteria. Through up-regulation of the 
adaptor protein myeloid differentiation (MYD) primary response gene 88, TLR-4 
activates the transcription factors nuclear factor kappa-light-chain-enhancer of 
activated B cells (NFκB) and activator protein 1 (AP-1) pathways. As a result, a pro-
inflammatory Th2 driven adaptive immune response may follow, as has been 
described in helminth infections before (Burgess et al., 2010, 2011 and 2012; 
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Kerepesi et al., 2007). Beside the up-regulation of cyclooxygenase 2 (COX-2), an 
important inflammation mediator, some of the increased cutaneous pro-inflammatory 
cytokines that are released after NFκB pathway activation are tumor necrosis factor α 
(TNF-α), interleukin (IL)-6, IL-1 and IL-8 (Burgess et al., 2010 and 2011). IL-6 not 
only stimulates acute phase protein synthesis, it also induces T-cell activation, 
production of Th2 cytokines and proliferation of keratinocytes, which may lead to the 
typical hyperkeratotic scabs (Arlian et al., 2003). Together with IL-6, suppressor of 
cytokine signalling 3 (SOCS-3) is activated, which has been linked to atopic 
dermatitis in humans as it regulates the onset of Th2-cells through the suppression of 
interferon (IFN)-γ production by keratinocytes (Seki et al., 2003). The up-regulation 
of IL-4, IL-10 and IL-13 combined with the lack of Th1 cytokines IFN-γ and IL-18 in 
infested sheep skin around 6 hours post infection (pi) confirms the hypothesis that P. 
ovis most likely induces a Th2-driven immune response (Burgess et al., 2010). The 
pro-inflammatory cytokine IL-1 is released by keratinocytes in response to skin 
damage and has been described as being important in human skin diseases (Debets et 
al., 1995), mainly because it induces a number of pro-inflammatory chemokines. One 
of the earliest up-regulated chemokines is chemokine C-C motif ligand 26 (CCL-26), 
a specific eosinophil chemotactic molecule that could explain the early influx of 
eosinophils in affected tissue (Burgess et al., 2011). IL-8 is another chemokine and 
together with TNF-α and complement factors C3a and C5a it mainly attracts 
neutrophils and eosinophils to the site of infection. In vitro cultured ovine 
keratinocytes transcribed high amounts of IL-8 mRNA within one hour after 
challenge with mite ES products (Erger and Casale, 1995; Watkins et al., 2009). 
Other chemokines, such as CCL-2 and C-X-C ligand 2 (CXCL-2) are also up-
regulated within 3 hours pi and mainly attract monocytes and neutrophils (Burgess et 
al., 2010). Around 24 hours pi, these chemokines and cytokines, combined with the 
complement activation products increase the expression of cell-adhesion molecules, 
such as selectins, integrins and intercellular adhesion (ICAM) molecules on 
endothelial cells, potentially leading to a greater extravasation of lymphocytes and 
phagocytes, such as neutrophils, eosinophils and basophils to the site of tissue damage 
(Burgess et al., 2010 and 2012).  
 
During P. ovis infections in sheep, a fast influx of eosinophils, neutrophils, 
macrophages and lymphocytes in the infested skin is obvious within hours, which 
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correlates with a systemic lymphopenia. In vitro work demonstrated that specific mite 
derived factors that are part of mite ES material are responsible for a direct 
chemokinetic migration of ovine eosinophils (Wildblood and Jones, 2007) and the 
production of the pro-inflammatory chemokine IL-8 by ovine keratinocytes (Watkins 
et al., 2009). This indicates that the mite might be directly responsible for the 
attraction of eosinophils and other immune cells in infested tissue in vivo and that the 
effects of these immune cells are partly beneficial for mite survival (Wildblood and 
Jones, 2007). Within days, an influx of mast cells is detected as well. Vascular 
permeability increases too, with oedema as a consequence (Murphy, 2012; Stromberg 
and Fisher, 1986; Stromberg et al., 1986; Stromberg and Guillot, 1989; van den Broek 
et al., 2000; van den Broek and Huntley, 2003; van den Broek et al., 2004). The 
degranulation of mast cells and eosinophils may contribute to the damage of 
keratinocytes and the disruption of the epidermal barrier in general. Furthermore, the 
cytokines that are released during this process may guide the adaptive response in a 
certain direction. As mentioned above, one of those cytokines is IL-4:  its release 
from mast cells and eosinophils is stimulated by specific mite allergens, such as ‘Pso 
o 1’ (van den Broek et al., 2004) and it can direct the adaptive immune reaction 
towards a Th2-driven response. Other cytokines, such as IL-1, IL-8 and TNF-α will 
enhance the antigen presenting function of APC, furthermore linking the innate with 
the adaptive immune response (Sugita et al., 2007). In sheep it was demonstrated that 
the early innate response at the level of the skin is augmented by the adaptive immune 
response, which results in a further influx of eosinophils, mast cells and other immune 
cells over time (van den Broek et al., 2004). This was confirmed in circulating 
peripheral blood mononuclear cells (PBMC) in sheep that showed a peak up-
regulation at 6 weeks pi of IL-4R and C-C chemokine receptor 3 (CCR-3), the 
receptor of CCL-26, which attracts eosinophils. Furthermore, pro-inflammatory 
molecules and peptides responsible for the extravasation of immune cells to the site of 
infection were still up-regulated after 3 to 6 weeks pi (Burgess et al., 2012).  
 
In order to counter the disruption of the epidermal barrier, mirrored by the down-
regulation of several keratin and collagen genes in the skin of affected sheep, tissue 
repair mechanisms and keratinocyte differentiation genes are up-regulated within 24 
hours pi. Important genes in this respect are members of the epidermal differentiation 
complex (EDC), such as small proline rich proteins (SPRR) and S100 calcium 
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binding proteins (Burgess et al., 2010; Stoekcli et al., 2013). EDC genes are 
responsible for maintaining the integrity of the epidermal barrier by coding for 
structural and regulatory proteins that are important for epidermal cornification and 
maturation of keratinocytes. The up-regulation of these proteins, most likely 
controlled by IL-1 and IL-13 (Zimmerman et al., 2005), has been linked to allergy, 
psoriasis and atopic dermatitis in humans (Broome et al., 2003; Sugiura et al., 2005). 
S100 proteins have been shown to up-regulate IL-8 production and expression of 
ICAM-1, as well as promoting genes from the NFκB pathway (Viemann et al., 2005; 
Vogl et al., 2007). While these EDC genes are up-regulated, a clear down-regulation 
of some others (filaggrin, involucrin and loricrin) is observed within the same time 
frame, potentially caused by the up-regulation of transcription factor protein C-ets 1 
(ETS-1) (Burgess et al., 2011; Stoeckli et al., 2013). Loricrin, involucrin and filaggrin 
can be down-regulated by the presence of IL-4 and IL-13, which are abundant in 
infested sheep skin (Burgess et al., 2010; Howell et al., 2007; Kim et al., 2008). 
Furthermore, the S. scabiei homologue of the house dust mite serine protease ‘Der p 
3’, has proven to actively digest filaggrin (Beckham et al., 2009), with more skin 
barrier damage as a result. In addition, heritable loss of function mutations of filaggrin 
can cause several skin diseases in humans and could cause individual differences in 
susceptibility to mange in other species, such as cattle (Irvine, 2007; Stoeckli et al., 
2013). As described in humans with atopic dermatitis (Kim et al., 2008; Sugiura et 
al., 2005), suppression of EDC genes in general can accelerate the epidermal 
disruption causing excessive transdermal water loss but also an increased exposure to 
mite allergens. The latter can lead to continuous triggering of the immune response 
and more pronounced clinical signs (Burgess et al., 2010; Stoeckli et al., 2013). In 
circulating PBMCs, down-regulated levels of genes responsible for the skin barrier 
function maintenance were observed up till 3 weeks pi (Burgess et al., 2012). 
 
1.4.3 Adaptive immunity against Psoroptes ovis in sheep and cattle 
When the innate immune response, which is not completely pathogen-specific 
and not protective in the long run, is insufficient to eliminate the pathogen, the 
adaptive immune response steps in. Increased in vitro peripheral blood T-lymphocyte 
reactivity towards mitogens and P. ovis antigen is documented in mange infested 
cattle, irrespective of the breed, and is linked to the extent of dermatitis and severity 
of the lesions (Lonneux et al., 1998a; Losson et al., 1988; Stromberg et al., 1986). 
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Research in sheep demonstrates higher PBMC proliferative activity in susceptible 
compared to more resistant breeds (Wildblood et al., 2005). Several studies have 
described this increased lymphocyte reactivity: after primo-infection, P. ovis antigen-
specific lymphocyte activity significantly increased between 7 to 40 days and returned 
to control values after 42 to 110 days, depending on the study. These observations 
indicate the presence of memory T-cells (Lonneux et al., 1998b; Losson et al., 1988; 
Pruett et al., 1986). During subsequent challenge infections, contradictory 
observations were made as in one study the lymphocyte responsiveness increased 
sooner and was more pronounced but declined after about 7 weeks (Pruett et al., 
1986); while in another study the cell responsiveness occurred later, was less 
prominent and returned to control values already after about 4 weeks (Losson et al., 
1988). Nonetheless, if the mites are not cleared before the decline of lymphocyte 
reactivity, this could lead to a chronic and long-term stress reaction to the mites, with 
hyperplastic lymph nodes and adrenal glands as a consequence (Blutke et al., 2015; 
Pruett et al., 1986).  
In the skin of infested sheep, a significant influx of CD4+ Th-cells and 
CD45RA+ B- or naïve T-cells can be measured 4 days after primo-infection. By day 8 
pi, T-cell receptor γδ (TCRγδ) T-cells and CD1+ DCs also increase (van den Broek et 
al., 2005). Next to CD4+, also substantially more CD8+, CD25+ and CD2+ 
circulating T-cells are detected in susceptible sheep breeds, while TCRγδ T-cells and 
CD14+ cells (macrophages and DCs) are mainly seen in resistant breeds (Wildblood 
et al., 2005). Because of the eosinophil and mast cell infiltration in the skin of 
infested animals, CD4+ Th-cells are thought to produce an allergic Th2 cytokine 
pattern (van den Broek and Huntley, 2003; van den Broek et al., 2005), which would 
correspond with the IgE-driven type 1 hypersensitivity reaction that is seen clinically 
(Figure 7). The presence of IL-4 that can be released by eosinophils and mast cells 
during the innate phase of infection contributes to this hypothesis, as it is known to 
direct naïve T-cells towards a Th2-cell polarisation (Murphy, 2012; van den Broek et 
al., 2004). Up-regulation of IL-10 and IL-13 that suppresses macrophage function and 
stimulates B-cell differentiation and antibody production, further leads to a Th2 
biased response (Figure 8) (Burgess et al., 2010; Murphy, 2012). Similarly, TCRγδ T-
cells are capable of producing Th2-related cytokines, as described during helminth 
infections (Ferrick et al., 1995). The fact that these cells also express keratinocyte 
growth factor indicates a role in tissue repair and the attraction of more lymphocytes 
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to the site of epidermal damage (Boismenu et al., 1996; Jameson et al., 2002). The 
cutaneous B-cells may be responsible for local antibody production, but together with 
DCs they can also function as APC to increase T-cell activation (van den Broek et al., 
2005). While the number of TCRγδ T-cells seem to decline after 21 days, CD4+ Th-
cells, B-cells (CD45RA+) and DCs numbers remain high till 49 days pi (van den 
Broek et al., 2005).  
In order to modulate and counteract the (pro)-inflammatory effects of a Th2-
driven hypersensitivity response, as soon as one day pi, Treg cell surface markers and 
transcription factors are up-regulated in the skin of infested sheep (Burgess et al., 
2010 and 2011). These cells, consisting of several subpopulations, suppress effector 
T-cell function, release regulatory cytokines, such as IL-10 and transforming growth 
factor (TGF)-β and can also have a direct cytotoxic effect on mast cells and 
eosinophils (Figure 8) (Askenasy et al., 2008; Akdis, 2009). One of the Treg 
subpopulations are the forkhead box P3 (Foxp3)+ Treg-cells and by 2 weeks pi, 
significant numbers of these cells are detected in the skin of infested sheep (McNeilly 
et al., 2010). These cells are typically CD4+ and CD25+ and, as mentioned above, 
higher numbers of these regulatory cells have been demonstrated in infested animals 
belonging to a susceptible sheep breed (Wildblood et al., 2005). IL-10 producing Tr1 
Treg-cells are another Treg-cell subpopulation and are believed to play a crucial role 
in controlling hypersensitivity reactions in humans (Hawrylowicz and O’Garra, 
2005). However, the presence of these cells in bovine or ovine skin during P. ovis 













Figure 7. Allergic reaction caused by Der p 1, an inhaled allergen. Pso o 1, the 
Der p 1 homologue of P. ovis could elicit a similar reaction in the skin of infested 
animals (© 2012 from Janeway's Immunobiology, Eighth Edition by Murphy. 




Parallel to the onset of this cell-mediated immune response, the humoral immune 
response is initiated: P. ovis specific IgG antibodies are detectable in cattle as soon as 
one week pi (Lonneux et al., 1996 and 1998b; Losson et al., 1999) and in sheep from 
2 weeks onwards (Bates, 1997; Nunn et al., 2011; Ochs et al., 2001; van den Broek et 
al., 2003b). While no IgA antibody production is seen, IgM antibodies significantly 
increase 7 weeks pi in sheep (van den Broek et al., 2003b). An increase in IgE 
antibodies in infested cattle is suspected to appear fairly late as only from 28 days pi 
the passive cutaneous anaphylaxis (PCA) test became positive, indicating the 
presence of IgE antibodies (Losson et al., 1999). This is confirmed in sheep, in which 
IgE levels only start to rise after 6 to 7 weeks pi (van den Broek et al., 2000). This 
late detection of IgE in cattle and sheep is in contrast with the assumption that this 
antibody plays a vital role from early on, as it is a component of the type 1 
hypersensitivity reaction causing leakage of serum to the mite and causing the typical 
symptoms (Pruett et al., 1986). However, IgE will mainly bind to mast cells in the 
skin, causing degranulation and inflammation, which means the functionality of IgE 
in the skin might precede the detection of IgE in the blood. This observation might 
explain the late detection of IgE in sheep and cattle using a serum enzyme-linked 
immunosorbent assay (ELISA) (Losson et al., 1999; van den Broek et al., 2000). 
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Figure 8. Subsets of CD4+ effector Th-cells. Th1-cells activate macrophages that 
are infested or have ingested pathogens, mainly through the release of IFN-γ. Th2-
cells promote allergy and the immune response against parasites through B-cell 
activation and antibody (mainly IgE) production. Th17-like cytokines promote acute 
inflammation by attracting neutrophils and they support barrier integrity, including 
the skin. Treg-cells suppress T-cell activity (© 2012 from Janeway's Immunobiology, 
Eighth Edition by Murphy. Reproduced and adapted by permission of Garland 




After challenge infection, a rapid but moderate increase in IgG and high levels of 
IgE are documented in sheep from one week after re-infestation (van den Broek et al., 
2000 and 2003b), while no significant IgG production is seen in challenged cattle 
(Fisher, 1983b). However, the presence of IgE in re-infested cattle is suspected, as 
lesions occur very rapidly in a similar manner as observed in sheep (Stromberg and 
Fisher, 1986). Hence, for sheep and cattle it is hypothesized that a rapid increase in 
IgE during challenge infection is partly responsible for the rapid appearance of 
clinical signs but could also have a protective effect. The rapidly induced immediate 
type 1 hypersensitivity could facilitate the leakage of serum containing P. ovis-
specific antibodies and complement factors to the mites, thus leading to the clearance 
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of the ectoparasite and the stagnation and eventual disappearance of clinical signs 
(Pruett et al., 1998; Stromberg and Fisher, 1986; van den Broek et al., 2000). Mites 
will take up antibodies while feeding (Pettit et al., 2000) and the direct interaction 
between these antibodies and gut-associated proteins in the mite can impair digestion 
and lead to the death of the parasite. In addition, specific allergens in the mite’s faecal 
pellets may be neutralized by these antibodies and as such counteract the induction of 
an allergic response in the host (Nisbet and Huntley, 2006). The presence of an IgE-
driven type 1 immediate hypersensitivity can be confirmed with an intradermal skin 
test. Psoroptes ovis crude protein antigen is injected in the skin and will bind with 
mast cell-bound IgE. As a result, mast cells will degranulate and an immediate skin 
swelling can be observed after 15 minutes. Only in infested susceptible cattle (BB) a 
delayed skin response is seen after 48 to 72 hours (Losson et al., 1988 and 1999) even 
though the underlying mechanism of this difference with the more resistant HF 
remains unclear. Infested sheep also display an immediate and delayed response after 
intradermal challenge, atypically characterized by the influx of eosinophils instead of 
mononuclear cells and neutrophils. This delayed influx of eosinophils is particularly 
noticeable in susceptible breeds (van den Broek et al., 2003a; van den Broek and 
Huntley, 2003). The delayed skin reaction in infested BB and sheep could be 
identified as a Th2 mediated delayed eosinophilic hypersensitivity response, which 
has been described during other parasitic infections as well (Meeusen, 1999) and 
which could be a marker for breed susceptibility in both species (van den Broek et al., 
2003a).  
 
1.4.4 Immunity during Sarcoptes scabiei infections 
As in depth literature on the immunologic reactions against P. ovis is limited 
(Burgess et al., 2010, 2011 and 2012; Stoeckli et al., 2013), a comparison with the 
immune reactions during an infection with another mange mite, S. scabiei, is made in 
this chapter. Humans, cattle, pigs, dogs, camelids and several wildlife species (fox, 
wild boar…) are natural hosts for S. scabiei and for research purposes rabbits and 
mice often serve as alternative hosts (Taylor et al., 2007). In humans, 2 clinical 
manifestations of scabies occur: common or ordinary scabies and crusted or 
Norwegian scabies. The latter mostly occurs in in developing countries or in socially 
disadvantaged communities of Indigenous populations where immune-compromised 
individuals are at higher risk. Immunosuppression can be linked to concurrent disease, 
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such as human immunodeficiency virus, leprosy or diabetes or to other health related 
factors, including alcohol abuse, malnutrition or overcrowding in low quality housing 
conditions. Crusted scabies is characterized by very high mite numbers and severe 
hyperkeratotic crusts, while people with ordinary scabies have less symptoms and 
lower mite burdens (La Vincente et al., 2009; Roberts et al., 2005; Walton et al., 
2004a and 2010). Similarly, different clinical appearances of P. ovis mange are seen 
in infested BB animals, making the underlying immune mechanisms of various 
scabies forms interesting to investigate in cattle as well. As the immune responses 
against S. scabiei are largely similar to those against P. ovis, only the clear differences 
will be reviewed in this chapter. 
 
1.4.4.1 Innate immunity against Sarcoptes scabiei 
The biggest difference between both mite species is that P. ovis lives 
superficially, while S. scabiei is a burrowing mite, which makes burrows in the 
epidermis of the host to deposit its eggs (Taylor et al., 2007). Therefore, the 
epidermal barrier is immediately disrupted and mite ES products, including several 
house dust mite homologues (Arlian et al., 1988), get in contact with the host immune 
cells, of which keratinocytes, skin DCs (Langerhans cells) and fibroblasts are the first 
(Arlian et al., 2003). Mite allergens first encounter the innate complement system but 
specific scabies mite inactivated (serine) protease paralogs (SMIPPs) are known to 
inhibit this system in humans in order to evade the immune system (Bergstrom et al., 
2009; Fisher et al., 2009; Holt et al., 2003). These SMIPPs belong to the ‘Sar s 3’ 
antigens, S. scabiei specific homologues of the house dust mite ‘Der p 3’, and include 
scabies mite serpins (SMSs), serine proteases inhibitors of which 2 already proved to 
interfere with the human complement activation (Holt et al., 2003; Mika et al., 2012). 
By direct binding to several complement proteins (C1, C3, C4…) and through 
additive effects at the C9 level in the lectin pathway, the overall effect of these SMSs 
is the protection of the mite from complement-mediated gut damage (Mika et al., 
2012).  
PAMP recognition by TLR on innate immune cells, such as DCs, also takes place 
and depending on the pathway that is activated, specific chemokines and cytokines 
are produced. Vascular endothelial growth factor (VEGF), responsible for increased 
vascular permeability and granulocyte-colony-stimulating factor (G-CSF), activator 
of neutrophil and DC formation are significantly up-regulated in keratinocytes and 
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fibroblasts after in vitro stimulation with S. scabiei extract, a phenomenon which is 
not seen during P. ovis infections (Arlian et al., 2003). Whilst in the skin of P. ovis 
infested sheep, IL-6, IL-1, TNF-α, IL-8, IL-4, IL-13 and IL-10 are up-regulated, 
conflicting results are observed in humans after in vitro stimulation with S. scabiei 
extracts. Whereas IL-1 and IL-6 are up-regulated in dermal fibroblasts, keratinocytes 
and circulating PBMCs (Arlian et al., 1996b, 2003 and 2004b; Walton et al., 2008), 
IL-6 is down-regulated after stimulation of DCs and dermal endothelial cells (Arlian 
et al., 2004b; Elder et al., 2009). In parallel with the response during P. ovis, TNF-α 
production is also increased after S. scabiei stimulation of circulating PBMCs (Arlian 
et al., 2004b). The production of IL-8 is up-regulated in dermal fibroblasts and 
PBMCs but no secretion is observed by keratinocytes, DCs and endothelial cells 
(Arlian et al., 2003 and 2004b; Elder et al., 2009). In addition, cell adhesion 
molecules selectin and vascular cell adhesion molecule 1 (VCAM-1) are suppressed 
in skin from humans with scabies, while they are up-regulated in P. ovis infested 
ovine skin (Elder et al., 2006 and 2009). As these molecules, together with IL-8, are 
mainly responsible for the attraction and extravasation of immune cells to the site of 
infection, this can be an indication that S. scabiei tries to avoid the induction of 
inflammatory reactions, in that way delaying the display of clinical signs. The latter is 
also reflected in an up-regulation of anti-inflammatory TGF-β in the skin of humans 
and pigs with crusted scabies, an increased IL-10 production in circulating human 
PBMCs and the suppression of IL-6 production in human dermal endothelial cells 
(Arlian et al., 2006; Mounsey et al., 2015; Walton et al., 2008 and 2010). Moreover, 
in the absence of IL-6, TGF-β can potentially induce the development of Treg-cells 
(McGeachy and Cua, 2008).  
Despite several immune evasion strategies of the mite, chemotactic cytokines will 
attract a similar cell infiltrate as seen during P. ovis infections to the site of infection, 
with the composition of the cellular infiltrate depending on the host species (Arlian et 
al., 1994b and 1997; Morsy and Gaafar, 1989; Mounsey et al., 2015; Reunala et al, 
1984; Stemmer et al., 1996). Large numbers of eosinophils are particularly seen in 
humans affected by Norwegian scabies (Walton et al., 2008).  
 
1.4.4.2 Adaptive immunity against Sarcoptes scabiei 
Circulating PBMCs from humans with scabies show a strong proliferation after in 
vitro stimulation with recombinant S. scabiei antigens and the effector cells that can 
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be found are mainly the same as during P. ovis infections (Walton et al., 2010). In 
infested pigs, circulating CD4+ Th-cells and TCRγδ-cells proliferate from one week 
pi onwards (Liu et al., 2014) and in infested humans, Treg-cells can also be found, 
although the function of these cells might be impaired (Arlian et al., 2006; Walton et 
al., 2008). The cell infiltrate in the skin of human patients with ordinary scabies 
predominantly consists of CD4+ T-cells, while in persons with Norwegian scabies 
and psoriasis mostly CD8+ T-cells are present in the skin, with almost no CD4+ T-
cells (Bovenschen et al., 2005; Cabrera et al., 1993; Mounsey et al., 2015; Reunala et 
al., 1984; Stemmer et al., 1996; Walton et al., 2008; Wooten et al., 1986). These 
findings correspond with data from pigs with crusted scabies, where CD8+, TCRγδ+ 
and IL-17 producing cells were the main cellular infiltrate in the skin (Liu et al., 
2014). Few to no B-cells are detected in humans with Norwegian scabies and this is in 
contrast to infested pigs, rabbits and humans with ordinary scabies (Arlian et al., 
1994b and 1997; Morsy and Gaafar, 1989; Reunala et al., 1984; Walton et al., 2008).  
The cytokine profile that these immune cells produce has an influence on the 
clinical manifestation of the disease. Resistant dogs and rabbits display a more 
pronounced Th1 cell-mediated immune profile, while susceptible animals elicit a 
Th2-driven humoral reaction (Arlian et al., 1994a and b, 1995 and 1996a). Similarly, 
in vitro re-stimulated PBMCs from pigs and humans with common scabies produce 
IFN-γ (Liu et al., 2014), linked to a cellular Th1 response, while the cytokine profile 
in PBMCs from patients suffering from crusted scabies correlates with a humoral Th2 
response with high levels of IL-5 and IL-13 (Walton et al., 2004a and 2010). In 
porcine skin, higher levels of IL-4 and IL-13 are also present when animals suffer 
from the crusted form of the disease (Mounsey et al., 2015). While these cytokine 
profiles are expected to originate from CD4+ T-cells, CD8+ T-cells, which are 
abundantly present in the skin of humans with Norwegian scabies, are able to do the 
same (Kelso and Groves, 1997). In addition, whereas lymph node cells from mice 
immunized with Sarcoptes extract, produce IFN-γ, lymph node cells mainly release 
IL-4 during in vivo primo-infection with S. scabiei. This observation indicates the 
living mite may induce molecules that inhibit IFN-γ production in favour of a Th2 
response. However, when challenge infections were performed, these cells produced 
IFN-γ instead of IL-4, which suggests that protective immunity is linked with a Th1 
cytokine profile (Lalli et al., 2004). Finally, it is assumed that Th17 cytokines, such as 
IL-23 and especially IL-17, play an important role in the induction of crusted scabies 
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and other skin diseases, such as psoriasis.  Pro-inflammatory IL-17 (Figure 9) can 
originate from mast cells, CD4+ Th2-cells and TCRγδ T-cells and the latter are 
present in high numbers in the skin of patients with Norwegian but not common scab 
(Liu et al., 2014; Mounsey et al., 2015; Stepanova et al., 2012; Wang et al., 2010). In 
general, a mixed Th2/Th17 cytokine profile might be typical for the development of 
severe clinical signs during crusted or hypersensitive scab infections (Mounsey et al., 
2015; Liu et al., 2014). 
 
There are contrasts between studies on antibody production with 
immunoglobulins increasing or decreasing during S. scabiei infection. The onset of 
antibody production after infection also seemed to differ according to the study 
(Walton, 2010). In general, increased levels of IgG, IgM and IgE are obvious from 
about 6 weeks pi in infested humans and pigs and this correlates well with the influx 
of B-cells. A correlation between antibody levels, including IgA and the extent of the 
lesions is also assumed, as during P. ovis infections (Morsy and Gaafar, 1989; Morsy 
et al., 1993; Rampton et al., 2013; Walton et al., 2008 and 2010). IgE levels are 
especially high in human patients with crusted scabies. Nevertheless, the latter does 
not seem to lead to protection, which is in contrast to observations made in goats with 
sarcoptic mange (Arlian et al., 2004a; Mounsey et al., 2013; Tarigan and Huntley, 
2005; Walton et al., 2008 and 2010). As in sheep and cattle, IgE might be partially 
responsible for the development of clinical signs: after challenge infection, lower 
circulating antibody titres are seen in resistant rabbits compared to susceptible ones. 
Lower antibody titres are also linked with fewer plasma cells in the dermal infiltrate 
and it could confirm the hypothesis that in resistant animals a predominant cell-
mediated Th1 and less of a humoral Th2 response is elicited (Arlian et al., 1994a and 
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Figure 9. Dendritic cells produce cytokines that regulate the balance between Th17- 
and Treg-cell differentiation (© 2012 from Janeway's Immunobiology, Eighth Edition 




1.5 Diagnosis of psoroptic mange in cattle 
Diagnosing psoroptic mange is relatively easy and it is a crucial step towards 
controlling the infestation. The typical clinical signs can be an indication that animals 
are infested: the presence of yellowish crusts and erythematous skin at the withers, 
back and tail base, secondary complications such as hematomas or abscesses, 
scratching, licking and restlessness due to pruritus, weight loss and a rapid spread of 
these symptoms towards other herd mates can suggest the presence of P. ovis mites on 
a farm (Bates, 1998; Pouplard et al., 1990; Stromberg and Guillot, 1987). A 
differentiation from other ectoparasitic diseases, such as lice, S. scabiei or atypical C. 
bovis infections, mechanical skin damage (e.g. sacrum lesions from being mounted in 
oestrus) and other infectious diseases, such as bovine malignant catarrhal fever is 
however necessary as these can induce a comparable clinical image (Bates, 1997; 
Taylor et al., 2007).  
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Psoroptic mange can be confirmed through the microscopic examination of skin 
scrapings, which are taken with a scalpel blade, superficially, at the edge of several 
lesions and examined as soon as possible (Lonneux and Losson, 1998; Pouplard et al., 
1990; Taylor et al., 2007). Following facultative short exposure to a heat source to 
activate the ectoparasites, direct examination using a stereomicroscope (x25) for 
detection of live mites is essential (Lonneux and Losson, 1998; Pouplard and Detry, 
1981; Pouplard et al., 1990). Microscopic examination (Figure 10) will reveal the 
sharp mouthparts and the segmented pediculi and small pulvili, typical for P. ovis 
(Mitchell et al., 2012; Soulsby, 1982). When direct examination is negative, indirect 
examination is performed after digesting the sample in 10% potassium hydroxide 
(KOH) overnight (Hollanders and Castryck, 1989; Lonneux and Losson, 1998; 
Mitchell et al., 2012; Pouplard and Detry, 1981). This procedure will kill the mites 
and makes discrimination between live and dead mites impossible (Walton and Curie, 
2007). The mites in the KOH suspension are enriched by centrifugation-flotation and 
microscopic examination of the concentrate is performed to identify the species 
(Hollanders and Castryck, 1989; Pouplard and Detry, 1981). Psoroptes ovis can be 
differentiated from other mange mites through microscopic investigation of the 
pediculi: C. bovis has very short, unsegmented pediculi that carry a large pulvillus 
(Figure 2) whereas the pediculi of S. scabiei are long but unsegmented (Figure 3) 
(Taylor et al., 2007). 
 
Examination of skin scrapings is a conventional way of diagnosing P. ovis 
infections and will directly confirm the presence of the mites, but there are some 
drawbacks: it requires expertise in ectoparasite identification, it can be time-
consuming and it lacks sensitivity as subclinical or early infections are easily missed 
(Lonneux et al., 1997a; Wells et al., 2012). Finding mites in skin scrapings from 
subclinically infested carrier sheep by microscopic examination has been shown to 
have a probability of only 18% (Bates, 2009) and in pigs infested with S. scabiei as 
low as 10% (Smets and Vercruysse, 2000). Therefore, the development of improved, 
cost effective and precise diagnostic methods with higher sensitivity should be 
encouraged.  
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Figure 10. Close-up of the 3-jointed pretarsus or pediculus (black arrow) and 
pulvillus (white arrow) of P. ovis (x400). 
 
One of those methods is the enzyme linked immunosorbent assay or ELISA, 
which is used to detect circulating anti-P. ovis antibodies in the blood of the infested 
host (Wells et al., 2012). After confirming the presence of these specific antibodies in 
sheep and cattle (Fisher, 1972; Fisher and Wilson, 1977), an ELISA to detect them 
was developed in 1983 using crude P. ovis antigen (Fisher, 1983a and b). Nearly 
complete cross-reactivity between P. ovis and P. cuniculi could be demonstrated in 
1991 (Boyce and Brown, 1991), which led to increased sensitivity of the bovine 
ELISA in 1996 by using P. cuniculi instead of P. ovis antigen. This measure 
decreased background values, as there was no contaminating bovine material present 
(Lonneux et al., 1996). The ELISA revealed that antibodies in infested animals 
usually appear around the onset of the clinical signs (Fisher, 1983b), which can be as 
soon as one week after infection in cattle (Losson et al., 1999). In sheep, small 
pathologic changes in the skin already occur within 24 hours pi, but ELISA often 
becomes positive after about 2 to 3 weeks when more obvious clinical signs are 
present (Bates, 1997; Nunn et al., 2011; Ochs et al., 2001). Antibody titres in both 
host species correlate with mite numbers and the degree of dermatitis (Figure 11) 
(Pruett et al., 1986; Lonneux et al., 1998a). Although still under discussion in sheep, 
as mentioned above, in cattle, clinical signs are usually obvious at the same time or 




technique. Moreover, mostly crude proteins are used but identification of the key 
antigens that induce antibodies and production of recombinant versions of those 
antigens may further improve the sensitivity, specificity, reproducibility and cost. 
Indeed, an ELISA using the recombinant antigen ‘Pso o 2’, a house dust mite 
homologue, has proven to be an excellent tool to diagnose psoroptic mange in sheep. 
Antibodies can be detected as soon as 2 weeks pi and even seem to be able to identify 
subclinical carrier animals (Burgess et al., 2012; Nunn et al., 2011). A similar highly 
sensitive ELISA is an IgE ELISA using the specific recombinant mite allergen ‘Sar s 
14.3’ to diagnose S. scabiei affected humans (Jayaraj et al., 2011). Other downsides 
of this diagnostic tool are the potential cross-reactivity with C. bovis (Jacober et al., 
2006) and the fact that an ELISA is usually performed only once in the field. Hence, 
it is impossible to distinguish circulating antibodies during active infection from 
residual antibodies from a previous infestation (Wells et al., 2012). Although anti-P. 
ovis antibodies start declining from 7 to 14 days after treatment, in parallel with the 
disappearance of the mites, they may persist in the blood up till 6 months after 
effective treatment in sheep and up till 7 months in cattle, causing a bias for the 
interpretation of the ELISA results (Bates, 2009; Burgess et al., 2012; Lonneux et al., 
1997a).  
Figure 11. Correlation between the extent of dermatitis (clinical index, %) and 
the antibody titre (logarithmic scale) in cattle. Data from trial 1 (circles) and trial 2 
(squares) on day 56 post-infection show a positive correlation between the degree of 
dermatitis and the antibody titres measured by sandwich ELISA (from Lonneux et al., 
1996 with permission of Elsevier). 
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Other diagnostic tools could therefore be of help. A pen-side lateral flow assay 
that is currently being developed for psoroptic mange provides not only improved 
diagnostic accuracy in the field, but also reduced costs, leading to an easy, precise and 
complete assessment of P. ovis infections on farm level. This efficient microfluidic 
technique resembles a modified sandwich ELISA, as capillary membrane bound mite 
specific antibodies are used to detect mite antigens in the field. A similar test is 
available to detect lice infections in New Zealand by using wool fibres (Bates, 2009; 
Wells et al., 2012). Additional diagnostic tools that not only indicate (previous) 
contact with the pathogen, but also give an indication of the phase of infection 
(subclinical, active, chronic or healing) are often based on host-parasite interactions 
but are currently not used to diagnose psoroptic mange in the field (Wells et al., 
2012). Examples of such immunodiagnostic techniques are the identification of key 
signalling transcription factors or blood biomarkers, such as specific acute phase 
proteins (haptoglobin, serum amyloid A, complement 4 binding protein-β chain) 
indicating active or early infections (Wells et al., 2012 and 2013a and b). The latter 
has already been used in diagnosing psoroptic mange in sheep (Wells et al., 2013a 
and b) and sarcoptic mange in Alpine ibex (Rahman et al., 2010). Molecular methods, 
such as polymerase chain reactions (PCR) are already used to experimentally detect 
Demodex canis DNA in canine hair plucks and skin biopsies (Ravera et al., 2011).  
 
1.6 Treatment and prevention of psoroptic mange 
1.6.1 Treatment of psoroptic mange  
Treating psoroptic mange is not an easy task and several aspects should be taken 
into consideration to achieve complete eradication (O’Brien, 1999). As cattle may be 
affected by several mange mite species and/or other infectious diseases that may 
induce similar clinical signs, a diagnosis to confirm the presence of P. ovis should be 
performed first and an appropriate acaricide should be chosen accordingly (O’Brien, 
1999; Taylor et al., 2007). It should be emphasized that 100% efficacy for any 
acaricide is desirable because only a couple of surviving mites can cause new 
symptoms and a rapid spread of the disease in a herd (Bates et al., 1995).  
Leaving out products such as sulphur and mercury, the first commonly used drugs 
to treat psoroptic mange were organochlorines (lindane) in the 1940’s, 
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organophospates (diazinon, coumaphos, propetamphos and phoxim) since the 50’s 
and synthetic pyretroids (flumethrin, deltamethrin and cypermethrin) from the 70’s 
onwards, all of them used for plunge dipping (sheep) or as pour-on’s (Losson, 1997; 
O’Brien, 1999; Taylor et al., 2007; van den Broek and Huntley, 2003). A double 
topical administration of amitraz or flumethrin with an interval of 10 days has proven 
to be completely effective and is currently still used to treat psoroptic mange in cattle 
(Guillot et al., 1982/1983; Harrison and Palmer, 1981; Losson and Lonneux, 1992). 
Successful topical treatment is encouraged when most of the crusts are removed 
before treatment and the animals are thoroughly wetted (Lonneux and Losson, 1996; 
Plant, 2006). Although phoxim is still used for treating mange in pigs, it is not 
registered for cattle in Belgium. Most of these products lack a persistent effect, may 
induce considerable side effects and are toxic for the environment, so nowadays they 
are pushed aside by the group of macrocyclic lactones (ML) in the treatment of 
psoroptic mange.  This group consists of the avermectins (ivermectin, eprinomectin 
and doramectin) and the milbemycins (moxidectin) and they are available in 
injectable, pour-on and oral formulations. MLs interact with the glutamate-gated 
chloride channels (GluCls) in arthropods and nematodes and as such increase nerve 
cell membrane permeability to chloride ions, inducing paralysis and often death of the 
parasite. Γ-aminobutyric acid (GABA)-gated chloride channels may be targeted by 
MLs as well (Vercruysse and Rew, 2002). These drugs are safe as GluCls typically 
only occur in invertebrates. Furthermore, these products offer a broad-spectrum 
activity against endo- and ectoparasites, they are easy to use and numerous cheaper 
generic formulations have been developed over the years (Losson, 1997; O’Brien, 
1999; Pouplard and Detry, 1981; Sallovitz et al., 2002). Ivermectin was the first ML 
to prove it’s beneficial effect in the treatment of psoroptic mange and both doramectin 
and moxidectin followed quickly.  
In cattle, all of these drugs gave similar results: one injection at a dose of 0.2 
milligram (mg)/ kilogram (kg) body weight (BW) led to the elimination of the 
infection after 14 to 28 days (Barth, 1980; Clymer et al., 1997; Guillot and Meleney, 
1982; Logan et al., 1993; Lonneux et al., 1997b; Lonneux and Losson, 1992; 
Pouplard and Detry, 1981; Wright and Guillot, 1984). Although animals were not 
parasitologically examined between day 0 and day 7 after treatment, one study 
demonstrated a 100% efficacy of ivermectin after 7 days (Lonneux et al., 1997b). 
This means that directly after and up till 7 to 14 days post-ML-treatment, live and 
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infective mites may still be present on treated individuals. Therefore, treated animals 
should be isolated from the rest of the herd for at least one week (O’Brien, 1999).  
In sheep, single ML injections gave more variable results compared to cattle, but 
it should be stressed that treatment of sheep is often more challenging in general. The 
presence of wool or fleece may impede the application of topical drugs and as P. ovis 
mites on sheep do not ingest serum, systemically applied products can have an 
inferior effect, leading to the need for multiple treatments (Kirkwood, 1985; Ortega-
Mora et al., 1998). Indeed, single ivermectin injections were not always 100% 
sufficient (Bates and Groves, 1991), but by treating the animals 2 or 3 times with an 
interval of one week or with an intraruminal controlled-release formulation, complete 
efficacy was reached (Benz et al., 1989; Forbes et al., 1999; Sargison et al., 1995; 
Soll et al., 1992). For doramectin, a 93% efficacy was observed after injecting 0.2 
mg/kg BW and only the 0.3 mg/kg BW dose gave a 100% efficacy after 7 days (Bates 
et al., 1995). For moxidectin, although mite counts and lesions were significantly 
reduced, both a single and double injection failed to completely control the infection; 
the maximum efficacy was 97% and >90% respectively after 56 days (Ortega-Mora et 
al., 1998).  
 
Beside the selection of a suitable acaricide, some other factors should be taken 
into consideration in the treatment of psoroptic mange in cattle. The life cycle and 
epidemiology of P. ovis give an indication of some of these essential steps: as the 
duration of the cycle is fairly short (about 10 days) and the disease is highly 
contagious, it spreads fast. Moreover, subclinical carriers are often present. These 
factors indicate the necessity to treat all in-contact animals at the same time (Jones et 
al., 2014; Mitchell et al., 2012; Taylor et al., 2007).  
Secondly, the thick yellow crusts enclose large amounts of mite eggs, they protect 
the mites from dehydrating and prevent good contact with topical acaricides, therefore 
it is advised to shear the animals and remove the largest crusts before treatment. 
Injectable formulations are distributed to the infection site through the blood and the 
acaricidal activity will be achieved at the level of the skin. By shearing the animals 
before treatment, all mites that are located further away from the skin, i.e. on the hairs 
or in crusts, are removed, which will benefit the treatment efficacy (Jones et al., 2014; 
Lonneux and Losson, 1996; Plant, 2006). 
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In addition, none of the available products has a complete ovicidal effect 
(Lekimme et al., 2006a; Lonneux and Losson, 1996) therefore, products with no 
persistent efficacy, such as amitraz and flumethrin should be administered at least 
twice. The second treatment is applied after the eggs have hatched but before these 
immature stages become sexually active (and produce eggs of their own), which 
makes an interval of 7 to 10 days ideal (Lekimme et al., 2006a; Lonneux and Losson, 
1996; Taylor et al., 2007). One injection of MLs, which should have a prolonged 
efficacy due to their lipophilic nature, used to be sufficient to control a P. ovis 
infection (Barth, 1980; Clymer et al., 1997; Guillot and Meleney, 1982; Logan et al., 
1993; Lonneux et al., 1997b; Lonneux and Losson, 1992; Pouplard and Detry, 1981; 
Wright and Guillot, 1984), but since a couple of decades this seems to be inefficient 
(Benz et al., 1989; Clymer et al., 1997; Lonneux and Losson, 1996; Pouplard and 
Detry, 1981; Vercruysse and Rew, 2002; Vercruysse et al., 2008). Therefore, at least 
2 treatments are recommended for any product, especially for the treatment of BB 
cattle (Jones et al., 2014; Lonneux et al., 1997b; Minihan et al., 2002; Mitchell et al., 
2012; O’Brien, 1999; Vercruysse et al., 2008; Wall, 2012). To avoid having to treat 
twice, the application of long acting (LA) formulations could be beneficial, in which a 
highly concentrated ML is administered and released slowly over time. Such products 
have shown their persistent efficacy in several gastro-intestinal endoparasite 
infections (Rehbein et al., 2015; Sargison et al., 2012; Yazwinski et al., 2006), but the 
efficacy against psoroptic mange remains unclear. While a single injection of 
ivermectin LA (3.15%) as a prophylactic treatment in cattle was 100% efficacious 
from 56 days before, till 35 days after challenge infection (Bridi et al., 2001), infested 
animals that were therapeutically treated only became parasitologically negative after 
2 to 4 weeks (Blutke et al., 2015; Hamel et al., 2015; Rehbein et al., 2002). A single 
injection of moxidectin LA (10%) gave various results: although one study 
demonstrated that BB animals remained mange free for 77 days (Losson et al., 2008), 
a recent study showed that in the field this procedure was not sufficient to control the 
infection (Mitchell et al., 2012). The use of the LA formulation of moxidectin (2%) 
against sarcoptic mange in sheep showed that animals were protected against 
infection up till 60 days, but in infested animals complete clinical cure was only 
reached 40 days after single injection. It must be stressed that no mite counts were 
performed in this study and efficacy was based purely on the evaluation of the clinical 
symptoms (Astiz et al., 2011). Finally, a single extended-release injection of 
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eprinomectin in cattle with sarcoptic mange eliminated all mites by 1 to 4 weeks after 
treatment (Visser et al., 2013). These observations indicate that animals treated with 
MLs, including LA formulations, are still infective for some days post-treatment. 
Finally, the mite’s feeding behaviour will influence the optimal administration 
route of acaricides: as cattle specific P. ovis feeds on cell debris, lipids but also serum, 
systemically applied (injectable) MLs at 0.2 mg/kg BW have the largest beneficial 
effect (Lonneux and Losson, 1996; Mitchell et al., 2012; Taylor et al., 2007). Orally 
administered MLs have an inferior effect and should not be used to treat mange 
(Vercruysse and Rew, 2002). Although successful results have been described in the 
past (Lonneux and Losson, 1992; Losson and Lonneux, 1996), pour-on MLs (at 0.5 
mg/kg BW) are not recommended as these have proven to be less efficacious against 
P. ovis compared to injectable formulations (Benz et al., 1989; Lonneux et al., 1997b; 
Millar et al., 2011; Mitchell et al., 2012; Vercruysse and Rew, 2002). After pour-on 
application, large differences in plasma concentrations and percutaneous absorption 
have been documented depending on the cattle breed (Sallovitz et al., 2002) and 
pharmacokinetics of pour-on formulations may vary depending on the product of 
choice. In parallel with findings on subcutaneously administered doramectin and 
ivermectin, it was demonstrated that the area under the plasma concentration-time 
curve and the mean residence/persistency time of doramectin were higher than those 
of ivermectin and that the inter-individual variation in plasma concentration was less 
(Gayrard et al., 1999). A potential explanation for this individual variability comes 
from previous research that demonstrated that substantial amounts of a pour-on 
formulation are taken up orally through licking or grooming behaviour and as such 
have a substantial anti-parasitic effect. However, the degree of this individual oral 
uptake and the exposure levels of the drug in the blood are highly variable (Bousquet-
Mélou et al., 2011). In conclusion, pour-on application of MLs may lead to highly 
variable exposure doses in the host and as such, some individuals may be over-
exposed, while others are under-exposed. Not only can this lead to therapy failure on 
individual and herd level, it can also stimulate the development of acaricide resistance 
in the mites (Bousquet-Mélou et al., 2011). In exceptional cases pour-on formulations 
may be justified, for instance when treating animals becomes difficult when they are 
on pasture or when they become unmanageable after multiple injections. For the 
treatment of adult dairy cattle on the other hand, the only available products are 
eprinomectin and moxidectin pour-on at 0.5 mg/kg BW. Moxidectin should be 
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preferred, as eprinomectin officially has no claim for P. ovis (Barth et al., 1997; 
Mitchel et al., 2012; Taylor et al., 2007).  
 
1.6.2 Treatment failure 
Although treatment failure is often reported in the field, few detailed scientific 
studies on the possible reasons for insufficient treatment efficacy are available. 
Potential causes of treatment failure in general could be failing to identify the mite 
species, misapplication of the acaricide (inappropriate formulation or incorrect 
interval between treatments, only treating clinically affected animals, not shearing 
prior to treatment) or individual variances in the pharmacokinetic of the applied drug 
(Plant, 2006; Wall, 2012). In BB for instance, higher plasma and skin levels of 
ivermectin could be documented after a single subcutaneous injection compared to 
HF animals. Potential explanations could be inherent differences in skin physiology, 
body or carcass composition and nutritional status (Sallovitz et al., 2002; Vercruysse 
et al., 2008). Lastly, therapy failure could be caused by the presence of resistant mites 
(Plant, 2006; Wall, 2012). For S. scabiei, several in vitro tests have been developed 
and resistance has already been identified in humans (Brimer et al., 1993; Currie et 
al., 2004; Mounsey et al., 2009; Nong et al., 2014). The frequent but often incorrect 
use of MLs causes high selection pressure and potential resistance in the mites 
(Lekimme et al., 2010; van den Broek and Huntley, 2003). There are indications of P. 
ovis resistance in the field, as 3 ivermectin treatments failed to eliminate the 
infestation in a group of affected BB animals (Lekimme et al., 2010; Losson, 1997). It 
should be stressed that in this study a 14 days interval was used between treatments, 
when 7 to 10 days are advised. Furthermore, a generic formulation of ivermectin was 
used and considerable differences in kinetic behaviour and therapeutic efficacy 
between generics and the original formulation have been demonstrated (Figure 12) 
(Genchi et al., 2008; Lifschitz et al., 2004). Finally, in vitro confirmation of apparent 
in vivo resistance is impossible as no in vitro tests for assessment of acaricide 
resistance in P. ovis are available yet. To avoid the development of acaricide 
resistance, animals should not be under-dosed, LA products should be used with care 




  48 
 
Figure 12. Mean concentration of ivermectin reference formulation (triangles) and 
ivermectin generic formulation (circles) in cattle (from Genchi et al., 2008 with 




1.6.3 Prevention of psoroptic mange 
Beside therapeutic treatment, general management aspects should be taken into 
account to control and/or prevent P. ovis infections at farm level. Introduction of new 
untreated herd members, which may be subclinical carriers, is one of the main sources 
of infection on a farm and quarantine measurements should therefore always be 
implemented after purchase of new animals (Carty and Nisbet, 2011; Millar et al., 
2011; Mitchell et al., 2012; Phythian et al., 2013; Pouplard et al., 1990; Taylor et al., 
2007). Contact between treated and untreated animals should be avoided and it is 
advised to leave cleaned pens, where infested animals were previously housed, 
unoccupied for 14 to 21 days, as this will dry out and kill any remaining mites (Bates, 
1998 and 2012; Losson, 2003; O’Brien, 1999; van den Broek and Huntley, 2003). Off 
the host, P. ovis mites remain infective up till 2 weeks. Therefore, general hygiene 
protocols, such as frequently changing the bedding and cleaning tools should be 
implemented in order to minimize re-infection from the environment (Lonneux and 
Losson, 1996; Mitchell et al., 2012; O’Brien, 1999; Pouplard and Detry, 1981). 
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Furthermore, attention should be given to optimizing the feed composition, amount 
and quality and on controlling concomitant infectious diseases in order to guarantee 
an optimal herd immunity (Minihan et al., 2002; O’Brien, 1999; Phythian et al., 2014; 
Pouplard and Detry, 1981). 
 
1.6.4 Alternative treatment methods 
In the long run, upcoming resistance and residues in meat, milk and the 
environment will only further increase the need for alternative treatment methods 
(Pruett, 1999b; Smith et al., 2001). Preliminary research in the field of microclimate 
manipulation and biological control agents has not delivered useful treatment tools yet 
(O’Brien, 1999; Smith et al., 2001; van den Broek and Huntley, 2003). However, 
some fungi, such as Beauveria bassiana, have proven to have an effect on P. ovis as 
mites were killed, egg hatchability was decreased and the life span of emerging larvae 
was reduced after exposure to fungal conidia (Lekimme et al., 2006b and 2008). In 
addition, antibiotic treatment with the aim of eliminating the symbiotic bacteria 
Comamonas spp. in the mite gut, led to decreased P. ovis survival (Hall et al., 2015). 
Furthermore, some natural substances, such as petroleum ether extract, lavender, tea 
tree and neem oil have been tested and seem to have some acaricidic efficacy (Nong 
et al., 2014; Perrucci et al., 1994; Walton et al., 2000; Walton et al., 2004b). Future 
research is necessary to further explore the possibilities and practicality of these 
alternative control strategies. 
Another alternative option in treating mange could be the selection of resistant 
cattle, which might reduce or even disregard the need for chemical treatments as a 
whole, but this is still far out of reach at this moment (Bates, 2012; O’Brien, 1999; 
Pruett, 1999b; Smith et al., 2001).  
Another interesting alternative treatment method is vaccination. As previously 
affected cattle and sheep seem to develop a fast increase in P. ovis specific antibody 
titres and show less severe lesions during challenge infections, the development of a 
protective immunity or resistance, potentially able to get boosted by vaccination, is 
suspected (Bates, 2000; Pruett et al., 1986; Stromberg and Fisher, 1986). Moreover, 
mites digest immunoglobulins that are released in the serous exudate during feeding, 
bringing them in contact with the host’s defence mechanism (Smith et al., 2002). As 
the immunopathogenesis of the disease is not fully clarified yet, it remains difficult to 
select specific antigens that could potentially function as vaccine candidates (van den 
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Broek and Huntley, 2003). Immunization of rabbits with a whole mite extract of P. 
cuniculi induced partial protection (Uhlír, 1992). Similarly, vaccination of sheep with 
fractions from crude P. ovis extracts increased specific antibody titres and reduced 
mite numbers, lesion areas and pathology in general (Smith et al., 2002; Jayawardena 
et al., 2000; Stella et al., 1997) and remarkably all these antigens seemed to be water-
soluble (Smith et al., 2001). Several purification and filtration procedures were able to 
concentrate one of those fractions to 2 proteins of 20 to 22 kilodalton (kDa) with more 
pronounced protective effects as a consequence. However, these allergens could not 
be exactly identified (Smith et al., 2002; Smith and Petit, 2004). In the search for 
more specific and potentially recombinant allergens, several possible vaccine 
candidates have been put forward, some of them linked to the feeding and digestion 
behaviour of the mites (McNair et al., 2010). Most of them are homologues of house 
dust mite allergens. A partially purified soluble extract of P. ovis was used to 
immunize cattle by Pruett et al. (1998). Although the results were not statistically 
significant, 8 out of 14 animals were free of lesions around 2 months after challenge 
infection. The increased grooming activity in response to a pruritic immediate allergic 
reaction that was elicited in the vaccinated animals was believed to play a role in 
protection (Pruett et al., 1998). This partially pure fraction was further purified in 
1999 and a 16 kDa antigen, homologous with the ‘Der f group 2’ allergens from 
Dermatophagoides farinae, could be identified as ‘Pso o 2’ (Pruett, 1999a). A 
Dermatophagoides pteronyssinus ‘Der p group 1’ homologue has been identified in 
P. ovis by Lee et al. in 2002, called ‘Pso o 1’. This allergen appeared to be a cysteine 
proteinase and provoked an immediate skin reaction and dramatic rise in specific IgG 
antibodies in sheep that were previously exposed to mites. Nevertheless, the reaction 
was less pronounced compared to the whole-mite extract and vaccination studies were 
not performed (van den Broek et al., 2003a). The fact that in humans, inhibition of 
‘Der p 1’ activity interrupted the development of the allergic Th2 reaction and 
reduced the development of severe symptoms, indicates an important role for this 
allergen (John et al., 2000). ‘Der p 10’ (tropomyosin), ‘Der p 11’ (paramyosin) and 
‘Der p 14’ (vitellogenin/apoliopohorin) were the next immunodominant allergen 
homologues that were identified in P. ovis (Huntley et al., 2004). Even though these 
homologues had variable results in vaccination trials against other parasites, further 
investigation is needed to assess the effect against P. ovis (Nisbet et al., 2006). 
Vaccination is not yet applied as a control measure to prevent psoroptic mange and 
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although it looks as if vaccination will never be able to fully protect individuals from 
getting infested through induction of sterile immunity, it certainly has potential to 
reduce parasite counts and clinical disease (Pruett, 1999b). Moreover, mathematical 
modelling demonstrated that in the field a 100 % efficacy in all animals might not be 
necessary for conventional vaccines to have a beneficial effect on disease severity and 
spread of infection (Barnes et al., 1995). For example, the recombinant Bm86 vaccine 
against Boophilus microplus significantly reduces larval abundance instead of 
protecting individual cattle. Nevertheless, the use led to a decrease in acaricidic 
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Objectives 
 Psoroptes ovis is a ubiquitous ectoparasite that causes mange in livestock. Clinically, 
an allergic dermatitis with wet crusts, alopecia and excoriation is observed at the withers, back 
and tail base. Differences in susceptibility to psoroptic mange are obvious within and between 
cattle breeds. While Holstein Friesian (HF) animals are more resistant to the disease, Belgian 
Blue (BB) cattle seem to be hypersensitive with severe and often generalized lesions as a 
consequence. Within this cattle breed a variety in sensitivity is also noticeable on group and 
individual level, but the mechanisms behind this observation remain unclear. Physical 
differences, such as a distinctive skin conformation or the presence or absence of horns and 
behavioural varieties have been suggested as possible influencing factors. In sheep, the wool 
composition, bacterial skin flora and the influence of farm management have been identified 
as potentially important and in this species the ability to mount an allergic immune response 
during infection also appeared to have an effect on the clinical outcome. Whether these 
factors are also important in cattle remains uncertain. 
 
The overall aim of this research project was therefore to identify potential causes 
of the susceptibility differences within the BB cattle breed and between the BB and 
HF breed. Two potentially influential factors, the environment and the host itself, led 
to 2 specific research questions. 
1. Do farm related management factors, including treatment protocol, 
influence the differences in susceptibility to mange that are observed 
between individual BB farms?  
A risk analysis was performed to identify potential risk factors for mange on 
farm level (Chapter 2) and 2 treatment protocols were evaluated on 9 mange 
problem farms in order to assess the influence of an (in)correct treatment 
schedule on the persistence of psoroptic mange on a farm (Chapter 3). 
2. Do individual immunologic host factors explain the susceptibility of the 
BB breed to psoroptic mange, especially when compared to the HF 
breed? 
The in vivo cutaneous and in vitro cellular immune responses in uninfested 
and infested BB were evaluated and compared to those in HF animals 
(Chapter 4). 
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CHAPTER 2 
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E. Claerebout. (2012) Risk factors for Psoroptes ovis mange on Belgian Blue farms in 
Northern Belgium. Veterinary Parasitology 190, 216-221. 
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2.1 Introduction 
The mite Psoroptes ovis (P. ovis) is a common ectoparasite of cattle. It causes 
a severe exudative dermatitis, characterized by thick scabby lesions and an intense 
pruritus (Stromberg and Guillot, 1989). As these pathological changes have a 
significant effect on the animal’s metabolism and its growth, mange can lead to 
important economic losses, especially in the beef industry (Cole and Guillot, 1987; 
Lonneux et al., 1998; Rehbein et al., 2003).  
The geographical distribution of the parasite in cattle is limited to certain 
areas, such as continental Europe and some parts of the USA (Guillot, 1984; Clymer 
et al., 1997; Losson et al., 1999; Minihan et al., 2002; Lekimme et al., 2010). 
Remarkably, psoroptic mange is only a major issue in some beef breeds, such as the 
Belgian Blue (BB) breed, whereas in dairy cattle (e.g. Holstein Friesian (HF)) clinical 
symptoms are rare (Lonneux et al., 1998; Losson et al., 1999; Rehbein et al., 2003; 
VLA Disease Surveillance Report, 2010). Besides the differences between breeds, 
mange problems can vary substantially between farms and even between individual 
barns on a farm, suggesting that management factors, such as acaricide treatments, 
feed, housing and barn climate may be important. This hypothesis has also been 
suggested in sheep. A study performed on sheep farms in Great Britain demonstrated 
that several farms within high-risk areas for mange had never experienced problems 
with mange. This indicates that an appropriate management can overcome the higher 
risk of disease (Rose et al., 2009). Despite the importance of cattle mange in several 
countries, no unambiguous data on the prevalence of the disease are available. 
In Belgium, psoroptic mange is common, but recent information about the 
prevalence is lacking as well. The BB breed represents the biggest part of the Belgian 
beef production and this breed is highly susceptible to psoroptic mange. In contrast to 
HF, the disease in BB often takes on a chronic, generalized form and repeated 
treatments may give disappointing results (Minihan et al., 2002; Losson, 2003; VLA 
Disease Surveillance Report, 2010; Lekimme et al., 2010). Moreover, outbreaks of 
psoroptic mange in other countries are often initiated by the import of a BB animal 
(Minihan et al., 2002; Mitchell, 2010; VLA Disease Surveillance Report, 2010). In 
accordance with the hypothesis of Rose et al. (2009), mange problems often appear to 
vary significantly between cattle farms in the field, but the potential effect of specific 
farm practices on the outcome of the disease in cattle has never been described. 
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Therefore, the objectives of this chapter were two-fold: (1) to estimate the 
prevalence and clinical importance of psoroptic mange in beef herds in Northern 
Belgium (Flanders) and (2) to identify potential risk factors for mange on farm level. 
 
2.2 Materials and methods 
2.2.1 Cross-sectional questionnaire survey 
A questionnaire was developed and tested in a pilot study on 4 farms to 
evaluate the validity of the approach and the comprehensibility. The questionnaire 
contained questions about the severity of mange on the farm and the farm 
management, with emphasis on acaricide treatments.  
After fine-tuning, the questionnaire was sent to 1,800 farms in Flanders. The 
farms were selected from Sanitel, which is the Belgian central database for the 
identification and registration of animals 
(http://www.favv.be/dierlijkeproductie/dieren/sanitel/). The only inclusion criterion 
was the presence of at least 20 Belgian Blue animals over 24 months of age. 
Consequently, both beef farms and mixed beef and dairy farms were included in the 
study. A random number generator in Excel was used to select the farms. 
 
2.2.2 Farm visits 
Ten percent of the farms with a completed questionnaire were visited to 
validate the questionnaire and to retrieve additional information on specific 
management parameters. Based on the questionnaire results, the farms were divided 
into 2 groups: farms with significant mange problems that were difficult to control or 
uncontrollable and farms without mange problems or with mange problems that were 
easy to control during the previous winter. Within these 2 groups, the farms were 
selected by a random sampling method (random number generator in Excel), stratified 
by province and weighed according to the response rate in each province. In total 66 
farms were visited, i.e. 36 farms with severe mange problems and 30 farms with little 
or no mange problems. During the farm visit, the farmer was interviewed, using the 
same questions as in the questionnaire survey (Annex 1). Feed labels were collected 
to get detailed information about the different feed components. All barns were 
inspected to evaluate the floor type, ventilation system, barn orientation, number of 
places at the feeding rack, straw management and animal stocking rate where ≥1 m2 
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per 100 kilograms of body weight is acceptable (Annex 2). A general hygiene score (0 
– 4) was given to each barn based on a hygiene score for dairy cattle (Hulsen, 2004). 
Light intensity (lux) and relative humidity (%) in the barn and temperature (°C) in and 
outside the barn were determined using a Testo 540 light intensity meter and a Testo 
610 humidity and temperature meter. For cattle, the optimal light intensity is 150 lux 
or more, the temperature comfort zone is between 5°C and 15°C and relative humidity 
should not be higher than 80% (reference values in Nantier, 2006).  
The number of animals with skin lesions compatible with mange was counted 
per barn and a scratching index (ScI) was calculated to estimate the intensity of the 
mange problem. The scratching index was obtained by observing 10 animals per barn 
for 5 minutes. Each licking or scratching action was counted and the total number of 
actions was then divided by the number of observed animals. Skin scrapings were 
taken from 5 animals with signs of mange to determine the mite species present. The 
scrapings were examined through direct and indirect microscopic examination (after 
10% KOH digestion followed by sedimentation-flotation with sucrose) (Damriyasa et 
al., 2004). A clinical index (CI, % affected body surface) was calculated for the same 
animals by marking and photographing the affected body areas. The photos were 
analysed using the software program ImageJ in order to obtain a CI for each animal. 
An arithmetic mean CI was determined per barn.  
Serum samples were taken from the jugular vein of 6 clinically healthy 
animals between 9 and 12 months of age. In these samples, copper (Cu) and iron (Fe) 
concentrations were determined with a Gallery™ automated photometric analyser 
(Thermofisher) and zinc (Zn) and selenium (Se) levels were quantified by graphite 
furnace atomic absorption spectrophotometry (GF-AAS) (Oster and Prellwitz, 1982).,  
 
2.2.3 Statistical analysis 
The concordance between answers in the questionnaire and results from the 
farm visits was determined using a Kappa test. Kappa-values higher than 0.75 
indicate an excellent agreement. Values between 0.4 and 0.75 demonstrate a good 
agreement and values between 0 and 0.4 suggest a marginal agreement (Rosner, 
2000).  
Only data from herds for which a fully completed questionnaire was available 
were used in the risk analyses. The questionnaire and farm visit data were analysed by 
a logistic regression model to evaluate the associations between herd management 
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factors (independent variables, Annex 1 and 2) and the presence of mange (dependent 
variable) (SPSS Statistics 19). There were 4 possible dependent variables available 
(see (*) in Annex 1 and 2) and the dependent variable used in this analysis was ‘no 
mange problem’ (absence of mange or mange easy to control) versus ‘severe to 
uncontrollable mange problem’. Initially a univariate binary logistic regression was 
performed to identify potential risk factors. In the univariate analysis a significance 
level P <0.2 was used to reduce the risk of unintentionally overlooking putative risk 
factors. Significant parameters were subsequently tested for correlations through Chi 
Square tests (χ²), as all variables were categorical. When a significant association was 
detected between 2 parameters (level of significance P <0.05) only one of the 2 
parameters was selected for further evaluation. The remaining parameters were 
ultimately combined in a backward stepwise multivariate analysis (P <0.05). Presence 
of confounders in the final multivariate model was tested by comparing the regression 
coefficients of the remaining variables when one variable was excluded. 
The farm visit data were collected from multiple barns per farm. To account 
for clustering of observations within farms, a random effect for herd was included in 
the logistic model of the farm visits (MLwiN v2.19). Statistical significances for fixed 
parameters were based on Wald tests (P <0.05). However, as no significant effects 




2.3.1 Questionnaire validation 
Information was obtained from 680 of the 1,800 selected herds (38%). The 
mean response rate per question was 36% with a range from 31 to 38%. A fully 
completed questionnaire was obtained from more than half of these farms (n = 351, 
52%). In total 238 barns on 66 farms were visited. The results of the Kappa test 
demonstrated a good concordance (0.4 – 0.75 or >0.75) between the questionnaire 
results and the responses obtained during the farm visits.  
 
2.3.2 Prevalence of mange 
Mange was present on 74% (95%CI (70.7 – 77.3)) of all farms. Although on 
most of these farms less than 20% of the animals were infested, approximately half of 
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the farmers perceived the mange problem on their farm as difficult to control or 
uncontrollable (Questionnaire (Q): 44% – Farm visits (FV): 53%). On most farms, the 
susceptible breed was the BB breed (Q: 83% - FV: 98%). The skin scrapings 
confirmed that P. ovis was present in 58% of the sampled barns, with or without other 
ectoparasites, such as C. bovis or lice. Despite the high prevalence of psoroptic 
mange, only in a small proportion of the barns (14%) the scratching index was high 
(>1) and in most of the sampled animals (80%) the affected body surface was less 
than 10%. Details are listed in Annex 1 and 2.   
 
2.3.3 Applied management procedures 
Most farmers provided concentrate to the animals (FV: 73% – Q: 88%) and 
approximately half of them provided additional mineral supplements (FV: 41% – Q: 
52%). Nevertheless, low serum Cu and Se levels were found in 60% and 46% of the 
sampled animals, respectively. 
Most animals were housed on a full floor with straw bedding (88%). Straw 
was replaced at least weekly on most farms (73%) and hygiene scores of the animals 
were generally good (72%). At the time of the farm visits, temperature in most barns 
was within or below the comfort zone for cattle (73%) and relative humidity was 
below 80% on 86% of the barns, but 53% of the barns were too dark (<150 lux). 
Animals were housed in groups on 73% of the farms, and here stocking rates were 
usually acceptable (55%), but physical contact between groups of animals was 
possible (84%).  
On most farms, the cattle received an acaricide treatment at housing (Q: 69% 
– FV: 99%). Most of the animals were shorn prior to treatment (Q: 88% – FV: 91%) 
and were treated with macrocyclic lactones (Q: 36% – FV: 51%, mostly as a pour-on 
formulation) or amitraz (FV: 36% – Q: 44%). In most cases all animals were treated 
(Q: 79% – FV: 93%), but less than half of the farmers treated the animals twice or 
more with an interval of ≤ 10 days (FV: 24% – Q: 46%). On the majority of the farms 
(Q: 49% – FV: 97%), additional mange treatments were given during the housing 
period. These additional treatments were similar to the treatments at housing, except 
that almost half of the farmers (FV: 29% – Q: 49%) only treated clinically affected 
animals and that shearing prior to treatment was applied less frequently (FV: 20% – 
Q: 69%). 
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Further details of the descriptive statistics are presented in Annex 1 and 2. 
Annex 1 shows the descriptive statistics of the parameters that were addressed in both 
the questionnaire and the farm visits. Annex 2 illustrates the descriptive statistics of 
the additional parameters that could only be measured during the farm visits.  
 
2.3.4 Risk analyses 
2.3.4.1 Cross-sectional questionnaire survey  
The univariate analysis (results not shown) revealed a high number of 
potential risk factors, such as the period of the year (autumn/winter vs. spring/summer 
vs. year round), additional mineral supplements in the feed and almost all parameters 
concerning acaricide treatments. All these parameters were positively associated with 
the presence of mange. Because the χ² tests revealed that all treatment related 
parameters were significantly correlated with each other (results not shown), only one 
treatment parameter ‘mange treatments’ was used in the multivariate analysis together 
with ‘period of the year’ and ‘supplements’. The results of the multivariate analysis 
(Table 1) indicated that mange problems occurred more often with an increasing 
number of acaricide treatments. In most cases mange problems were perceived the 
whole year round. When this was not the case, mange was more present in 
autumn/winter in comparison with spring/summer.  
 
Table 1. Significant parameters in the multivariate binary logistic regression of the 
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Odds  
Ratio 
95% CI p-value 
Period 
   Spring-summer  
   Autumn-winter 
   Year round 
 
Mange treatments 
   None 
   Only HT 
   Only AT 







































2.3.4.2 Farm visits 
The univariate analysis (results not shown) indicated a fairly high number of 
significant parameters. Mange appeared to be a problem all year round on most farms. 
The disease was also more prevalent in beef farms in comparison to mixed beef-dairy 
farms, when mineral supplements were fed to the animals and when a higher 
temperature in the barn was measured. On the other hand, problems with mange 
occurred less frequently when a sufficient number of places at the feeding rack was 
provided and when the animals had a good hygiene score. In addition, significant 
effects were found for the animals purchase policy, the availability of (supplemented) 
concentrate, the separation between (groups of) animals, the frequency of straw 
bedding replacement, the ventilation system and the relative humidity. In contrast to 
the questionnaire analysis, the overall treatment parameter ‘mange treatments’ was 
not significant and could therefore not be used in the multivariate analysis. 
Because many parameters were correlated according to the χ² tests (results not 
shown) the number of parameters to include in the multivariate analysis was reduced. 
Concerning the barn climate, the ventilation system was chosen together with the 
animal hygiene score, which was preferred over the frequency of bedding 
replacement. Both of these parameters, together with the other significant parameters 
from the univariate analysis (see above) were included in the multivariate logistic 
regression.  
This multivariate analysis revealed that mange was found less in cleaner cattle 
(higher hygiene score) and that on most farms mange was present during the whole 
year. Significant effects were also identified for the purchase policy and the feeding 
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Table 2. Significant parameters in the multivariate binary logistic regression of the 



















A questionnaire survey and subsequent farm visits were performed in this 
chapter to estimate the prevalence and clinical importance of psoroptic mange in BB 
cattle in Flanders and to identify putative risk factors. There was a good concordance 
between the response obtained by the questionnaire and the farm visits, except for 
some questions about mange treatments. The discrepancy can be explained by the fact 
that the treatment schedule was thoroughly discussed during the farm visits, whilst 
farmers often gave vague and incomplete answers to the same questions asked in the 
questionnaire. These were also the only open questions, which makes interpretation of 
the answers more difficult. Still, it can be concluded that the questionnaire and farm 
visit answers were sufficiently correlated to consider the survey analyses results as 
trustworthy. 
Results of the skin scrapings demonstrated that P. ovis is the most common 
ectoparasite on Flemish beef or mixed dairy-beef farms. The perceived herd 
prevalence of mange in Flanders was 74% (95%CI (70.7 – 77.3)), which confirms the 
Variable 
   (Levels) 
Odds 
Ratio 
95% CI p-value 
Purchase policy 
   0 
   1-5 
   5-15 
   >15 
 
Period 
   Year round 
   Autumn-winter 
   Spring-summer 
 
Hygiene score 
   Unclean 
   Clean  
 
Concentrate 
   No  
   Yes 




























































ubiquity of this disease in northern Belgium. Concerning the affected proportion of 
the herd, there was a difference between the farmers’ perception and our observations 
during the farm visits. Although most farmers recognised the presence of mange on 
their farm, the majority (86%) estimated that less than 20% of their animals were 
infested. In contrast, the farm visits results demonstrated that on 61% of the farms 
more than 20% of the animals were found visibly affected, suggesting that a number 
of farmers underestimated the mange problem in their herd. Although a high 
percentage of herds and animals are infested with P. ovis, the scratching index in most 
barns was lower than one and the majority of the animals had a CI below 10%, which 
indicates that most infections had a relatively mild character.  
Surprisingly, the risk analyses demonstrated a significant positive association 
between all variables related to acaricide treatment and the presence of mange. 
Probably this suggests that farmers that are aware of mange problems on their farm 
treat more frequently and more intensively. This study indicated that, taking into 
consideration all treatment parameters, less than half of the farmers applied an 
optimal treatment strategy at housing. When additional treatments were applied in 
winter, compliance with advised treatment strategies was even poorer. In other animal 
species, such as goats and camelids, it has also been reported that farmers often apply 
an incorrect treatment scheme (Lusat et al., 2009). Farmers and veterinarians should 
be informed about the importance of a correct diagnosis of psoroptic mange, 
including identification of the mite species, followed by a correct acaricide treatment 
and follow-up of the treatment efficacy.  
The questionnaire and farms visit results in this chapter demonstrated that 
mange was a problem all year round on most farms. On farms where this was not the 
case, the questionnaire results demonstrated that mange was significantly more 
present in autumn/winter than in spring and summer. This seasonality was also 
observed in goats in the UK, but not in alpaca’s (Lusat et al., 2009). Possible reasons 
for a higher incidence of mange during the housing season may be close contact 
between the animals and favourable environmental conditions (cold, humid) for the 
off-host survival of mites (Smith et al., 1999). Although higher indoor temperatures 
were positively related to mange in the univariate analysis of the farm visit data, this 
factor was not retained in the multivariate analysis. Results of humidity were 
inconclusive.  
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The hygiene score of the animals had a negative association with the 
occurrence of mange. A possible explanation is that faeces and urine that remain on 
the animal can affect the skin barrier, making an animal more susceptible for 
developing clinical symptoms. This parameter was also strongly associated with the 
straw management on the farm (χ² = 16.040, P-value = 0.003). The risk of having 
mange was the lowest on farms in which the boxes were cleaned daily. In pigs, the 
negative effect of straw bedding (vs. strawless) on mange was also demonstrated 
(Damriyasa et al., 2004). Although direct contact between animals is most likely the 
main source of infection (Hourrigan, 1979; Minihan et al., 2002; Losson, 2003), this 
finding suggests that transmission of mites from the infested environment to the 
animals might be an important factor in the epidemiology of mange and should not be 
neglected. 
Purchasing animals also appeared to be a risk factor for mange. Lusat et al. 
(2009) reported that the import of new animals and a large herd size were positively 
associated with mange in goats and camelids. In buffaloes, it was also demonstrated 
that the presence of other animals and importation are related with mange problems 
(El-Khodery et al., 2010). However, according to the farm visit analyses, purchasing 
1 to 5 animals had a significant negative association with mange. It should be stressed 
that this category was mainly represented by farmers who bought only one bull, 
which was housed separately on the farm and often also treated against mange before 
being introduced in the herd. The risk of having mange after purchasing one bull is 
therefore much smaller than after the purchase of multiple animals that are 
immediately housed together with the rest of the herd. In general, purchased animals 
should be treated and kept in quarantine for 2 to 3 weeks, to avoid the introduction of 
the infection in the herd (Lusat et al., 2009).  
Although many farmers provided concentrate and/or mineral supplements to 
their animals, the majority of the sampled animals showed a deficiency in Cu and Se. 
Low Se levels appear to be a pervasive problem in the BB breed (Guyot et al., 2009). 
Cu has an important role in the immune system and Cu deficiency may affect the 
progress of a mange infection (Guyot et al., 2009). The cause of the low Cu levels 
remains unclear. However, no conclusive results were obtained about possible 
associations between feeding of minerals or (supplemented) concentrate and the risk 
for mange.  
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In conclusion, mange is highly prevalent in BB cattle in Flanders (74%), 
although the clinical appearance of the disease is rarely severe. Because the disease 
induces important economic losses and intense pruritus, it can be considered as an 
important threat and animal welfare issue for the Belgian beef industry. The 13% of 
farms that did not experience any mange problems in BB cattle demonstrate that not 
only the susceptibility of the breed is important in the aetiology of mange, but also 
farm management parameters. This chapter revealed that differences in hygienic 
measures and purchase of animals can explain some of the variation in mange 
problems across farms. It was also demonstrated that infections with mites from the 
environment should not be neglected. Together with a correct treatment scheme, these 
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2.6 Annex 1 
Descriptive statistics of the questionnaire (Q) and farm visit (FV) results, with the 
proportion of herds and the corresponding kappa-values.  
*possible dependent variable 
  
Variable 













   Beef 




The farm was a pure beef farm 
















   BB 
   BB without problems 
   No BB 
 
 
BB is the breed with the most mange problems 
BB on the farm without mange problems 










1 (1; 1) 
Purchase policy 
   0 
   1-5 
   6-15 




   0% 
   1-20% 
   >20% 
 
Perception problem* 
   No problem 
   Easy controllable 
   Difficult to control 
   Uncontrollable 
 
Period 
   Spring-summer 
   Fall-winter 
   All year round 
 
Spread 
   Localised 




   No 
   Yes, always 
   Yes, fattening 
 
Supplements 
   No 
   Yes, always 




   None 
   Only HT 
   Only AT 
   HT and AT 





























Animals do not get concentrate in the feed 
Animals always get concentrate in the feed 
Animals only get concentrate in the feed in the fattening period 
 
 
Animals do not get extra mineral supplements 
Animals always get extra mineral supplements 




No mange treatments 
Only treatment at housing 
Only additional treatments during winter 

































































































































0.129 (-0.001; 0.26) 
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2.7 Annex 2 
Descriptive statistics of the farm related parameters investigated in all 238 visited 
barns (during 66 farm visits).  
Variable 





   0 
   0-1 
   1-2 
   2-3 
 
Clinical index* 
   0-1% 
   1-10% 
   10-25% 




   No 
   Psoroptes 
   Psoroptes + other 
   Other 
 
Zn 
   Low 
   Medium 
   High 
 
Fe 
   Low 
   Medium 
   High 
 
Cu  
   Low 
   Medium 
   High 
 
Se 
   Low 
   Medium 




   Full floor 
   Slatted floor 
   Combination 
 
Animal stocking rate 
   Tethered 
   Box correct 
   Box incorrect 
 
Animal separation 
    None  
    Fence 
    Solid wall 
   
Feeding places 
   Insufficient 




   Open barn 
   Closed barn 
   Slanting intake 
   Other (e.g. spaceboarding) 
 














No ectoparasites present in the barn 
Only Psoroptes spp. mites present in the barn 
Psoroptes spp. and other ectoparasites present in the barn 
Other ectoparasites present in the barn (Chorioptes spp. or lice) 
 



























Animals are tethered (no stocking rate) 
Box with correct stocking rate (≥1m2/100kg) 
Box with high stocking rate (<1m2/100kg) 
 
 
Animals are in 1 box (no separation) 
Animals are separated by a fence (animal contact possible) 
Animals are separated by a solid wall (animal contact impossible) 
 
Number of places at the feeding rack 
No place at the feeding rack for some animals 
All animals have a place at the feeding rack 
 
 






























































































   Below comfort zone 
   In comfort zone 
   Above comfort zone 
 
Temperature difference 
   0-1°C 
   1-2°C 
   2-4°C 
   4-8°C 
 
Relative humidity 
   <70% 
   70-80% 
   >80% 
 
Light 
   Insufficient 




    None (tethered or slatted floor) 
   <1x/week 
   Once a week 
   Minimum 2x/week 
   Daily 
 
Hygiene score 
   Unclean 




   No 
   Yes 
   Yes (supplemented) 




Barn temperature below comfort zone (<5°C) 
Barn temperature within comfort zone (5-15°C) 
Barn temperature above comfort zone (>15°C) 
 












Insufficient light intensity in the barn (<150 lux) 
Sufficient light intensity in the barn (>150 lux) 
 
 








Hygiene score  <2 




Animals do not get concentrate in the feed 
Animals get concentrate in the feed 













































Evaluation of two intensive treatment schedules against Psoroptes 











Based on: C. Sarre, T. Geurden, J. Vercruysse, N. De Wilde, S. Casaert, E. Claerebout. (2015) 
Evaluation of two intensive treatment schedules against Psoroptes ovis mange in Belgian 
Blue cattle on nine Flemish farms. Vlaams Diergeneeskundig tijdschrift 84 (6).
  90 
 91 
3.1 Introduction 
Mange is a common parasitic skin disease in Belgian cattle and is potentially 
caused by 4 mite species: Demodex bovis, Sarcoptes scabiei, Chorioptes bovis (C. 
bovis) and Psoroptes ovis (P. ovis). Demodex bovis lives in the hair follicles as a 
commensal but can occasionally cause small cutaneous nodules. Infections with 
Sarcoptes scabiei have become rarities in Flemish cattle, while C. bovis mainly 
affects dairy cattle and causes relatively benign symptoms. The most common species 
in BB beef cattle is P. ovis and this mite causes fairly aggressive clinical signs. 
Moreover, the BB breed seems to be highly susceptible to this infection (Losson et 
al., 1999). Clinically, an allergic dermatitis is observed, characterized by papules, 
moist crusts, alopecia and lichenification, especially at the withers, back and tail base. 
Generalized lesions can occur and often get bacterially infected. Because of an intense 
pruritus, animals intensely scratch themselves with complications, such as abscesses 
and hematomas as a consequence (Aiello, 1998; Taylor et al., 2007). Beside an 
impaired animal welfare, the infestation also leads to production losses due to reduced 
weight gain, compromised hide quality and increased treatment costs for the farmer 
(Cole and Guillot, 1987; Lonneux et al., 1998; Rehbein et al., 2003; Stromberg and 
Guillot, 1989). Psoroptic mange is best treated with an injectable macrocyclic lactone 
(ML) or topical administration of amitraz, during which all in-contact animals are 
treated simultaneously and 2 treatments are applied with an interval of 7 to 10 days 
(Lonneux et al., 1997; O’Brien, 1999; Personne et al., 2006; Taylor et al., 2007; 
Vercruysse and Rew, 2002). One treatment can be sufficient if the long acting (LA) 
formulation of moxidectin (10%) is used (Losson et al., 2008). Shearing the animals 
and removing most of the thick crusts prior to treatment is beneficial for a successful 
treatment (Plant, 2006). 
A 74% farm prevalence of psoroptic mange was demonstrated in a study on 
Flemish beef farms (Chapter 2). Although many farms are affected, large differences 
in the severity of the disease are noticeable between individual farms and 
management factors, such as hygiene (frequency of changing the bedding) and 
purchase policy may play an important role (Chapter 2). Besides these risk factors, it 
was also demonstrated that 75% of the questioned farmers implemented an incorrect 
treatment schedule, during which no diagnosis was made before treatment, an 
inappropriate product formulation was used, only the clinically affected animals were 
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treated instead of the whole herd, the animals were only treated once or the interval 
between 2 treatments was too long (Chapter 2). This could also be the reason of 
persistent mange problems on certain farms.  
The objective of this chapter was to assess whether infestations with P. ovis 
could be controlled on 9 beef farms suffering from chronic mange problems, using 
one of 2 intensive treatment schedules combined with an optimized farm 
management. 
 
3.2 Materials and methods 
Nine farms with BB animals were followed during one complete housing 
period (winter 2012-2013, 2013-2014 or 2014-2015) (Table 1). The farms were 
selected because the farmer or veterinarian stated that mange had been present on the 
farm for years and that the disease was hard or even impossible to control. 
 
Table 1. Location and number of investigated cattle per farm. 
 
Farm Province n cattle* 
1 Vlaams-Brabant 50 
2 Limburg 40 
3 Oost-Vlaanderen 300 
4 Oost-Vlaanderen 250 
5 West-Vlaanderen 200 
6 West-Vlaanderen 350 
7 Oost-Vlaanderen 90 
8 West-Vlaanderen 15 
9 Oost-Vlaanderen 15 
*number of investigated cattle 
 
During a first farm visit, skin samples were collected from minimum 5% of 
the total number of cattle on the farm, spread over all stables, in order to estimate the 
severity of the problem and to identify the mite species present in each stable (P. ovis, 
C. bovis or mixed infection). For each animal, a surface of 3 cm x 2 cm at each 
clinical lesion was sampled using a scalpel blade. Using a stereomicroscope (25x 
magnification), these skin samples were screened directly for the presence of live (and 
mobile) mites, after which 10 living mites from each sample were isolated and 
clarified in lactophenol to identify the species microscopically. Negative samples 
were incubated at 37° for 12 hours in 10% KOH (v/v) for indirect examination. After 
centrifugation (5 minutes at 3000 g), the present mites were enriched by flotation with 
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a sucrose solution (specific density 1.27) after which they were microscopically 
identified (100x magnification). Only farms where P. ovis or a mixed infection with 
both P. ovis and C. bovis was present were followed. 
On all farms it was advised to implement specific management measures, such 
as shearing the animals (at least the back) prior to the first treatment, frequently 
changing the bedding and treating and isolating purchased cattle for 2 to 3 weeks 
(Lusat et al., 2009). 
Subsequently, one out of 2 treatment protocols was started, in which the 
animals underwent several treatment rounds (Figure 1). On farms 1 to 7 the first 
protocol was implemented, starting with the application of a first treatment round on 
all animals. A treatment round against P. ovis mange consists out of 2 treatments of 
the whole herd with an injectable ML of choice at the prescribed dose with an interval 
of 7 to 10 days. Ideally, animals should be weighed to calculate the ML dose but in 
this study the dose for the herd was calculated based on the estimated weight of the 
heaviest animal (farms 1 – 7). On farms 8 and 9, individual weights were estimated by 
measuring heart girth (Nantier, 2006). One week after this first treatment round, 
samples were collected from the visibly affected animals. Only direct examination 
was performed on these samples as only active infections, characterized by the 
presence of live mites, needed to be detected after treatment.  When a minimum of 
one sample was positive, another treatment round was administered to all animals. If 
during the next sampling, one week after treatment, positive animals were still 
present, only the affected animals were treated in the consecutive treatment rounds 
due to practical and economic considerations. In the second treatment protocol (farms 
8 and 9), the first treatment round consisted of a single injection with the LA 
formulation of moxidectin (Cydectin 10% LA; Zoetis). Additional treatments were 
only administered to the affected animals and the regular injectable formulation of 
moxidectin (Cydectin 1%; Zoetis) was used in each treatment round (2 x with a 7 to 
10 days interval). This schedule was applied until all animals were parasitologically 
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Figure 1. Schematic overview of the applied treatment protocols (*follow-up and 





In the first protocol, the treatment efficacy was evaluated by the presence of 
visible, active clinical lesions (erythema, crusts and/or flaky and wet skin) combined 
with the presence of live P. ovis mites, expressed as the percentage of positive 
sampled animals. In the second protocol, several complementary criteria were added: 
a scratching index (ScI) was determined by counting the actions linked to pruritus 
(licking, scratching, rubbing) during 10 minutes and dividing this total by the number 
of observed animals. Moreover, a clinical index (CI) was calculated per animal by 
indicating the infested skin surface on a grid according to the method of Guillot 
(1981). Finally, for each animal, the number of mites in the skin sample was counted 
(mite count, MC). 
Before turn-out, new skin samples were taken on farms 1 to 7 from minimum 
50% of the animals under study. Asymptomatic animals were sampled at the 
predilection sites for P. ovis and C. bovis mange. On these farms, another sampling 
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was performed one year later (at housing) on 5% of the total herd to evaluate the 
infestation level after being on pasture. 
 
3.3 Results 
Farm 2 was the only farm that did not completely implement the advice 
concerning management, as the animals were not sheared before treatment. 
Besides moxidectin LA (farms 8 and 9), the most commonly used drugs were 
ivermectin and doramectin (farms 1 to 7) (Table 2). On 3 farms (farms 3, 4 and 7) 
some animals were (additionally) treated twice with amitraz (interval 7 to 10 days) 
when a mixed infection with C. bovis was present or when animals were in the 
fattening phase and products with a shorter residual activity were required. 
 
Table 2. Number of treatment rounds and used acaricide per farm. 
Farm n cattle* n Tx** Acaricide 
1 50 3 doramectin 
2 40 2 doramectin 
3 300 4 ivermectin & 
amitraz 
4 250 3 ivermectin & 
amitraz 
5 200 3 ivermectin & 
doramectin 
6 350 9 ivermectin 
7 90 4 ivermectin & 
amitraz 
8 15 4° moxidectin LA 
9 15 3° moxidectin LA 
*number of investigated cattle 
**number of treatment rounds to reach ‘mange free’ status 
°first treatment round is a single injection with moxidectin 10% LA and additional treatment rounds are 
double injections with moxidectin 1% with a 7 to 10 days interval 
 
All farms were declared ‘mange free’ after one housing period. Farms 1 to 7 
were ‘mange free’ when the whole herd was clinically healthy (Figure 2) and/or when 
all sampled animals were parasitologically negative during the last farm visit. For the 
animals on farms 8 and 9 this meant the MC were negative. To reach this ‘mange 
free’ status, on average 4 treatment rounds were necessary, with a minimum of 2 and 
a maximum of 9 treatment rounds (Table 2). The percentage of animals with living 
mites after each treatment round per farm is listed in Table 3. Table 4 presents the 
ScI, CI and MC of the positive animals on farm 8 and 9 after treatment. On farms 3, 5 
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and 7 no control samples could be taken as the last treatments (3, 1 and 1 animal(s) 
respectively) were given just before the herd went on pasture. Although it was 
therefore impossible to parasitologically confirm that these farms were ‘mange free’, 
the animals were clinically healed. The 7th and 8th injection on farm 6 were 
administered shortly after the 6th treatment without any interim sampling, because the 
farmer had noticed clinical signs in an adjacent group shortly after the treatment of 
the 2 last positive animals and decided to treat all animals, including these last ones.  
 









Table 3. Percentage (%) and number of animals with live mites compared to the total 
number of sampled animals after each treatment round per farm (n=number of 
treatment rounds). 
 
NS no sampling, only clinical evaluation 
*first treatment round is single injection with moxidectin 10% LA on farms 8 and 9       
 
Table 4. Arithmetic mean scratch index (ScI), clinical index (CI) and mite counts 
(MC) of all animals before and after treatment and the number of animals with live 
mites (n) after treatment on farms 8 and 9. 
 
   Farm 8   Farm 9 
n Tx* n ScI CI MC n ScI CI MC 




























0 0.7 3,2 
(0-6) 
0 
4 0 0.5 0,9 
(0-3.1) 
0 0 0.3 1,1 
(0-1.7) 
0 
*number of treatment rounds (treatment round 1: single injection with moxidectin 10% LA; 
treatment round 2-4: double injection with moxidectin 1% with a 7 to 10 days interval) In 
treatment round 1 all animals were treated while in treatment rounds 2-4 only animals with live 





Farm 1 Farm 2 Farm 3 Farm 4 Farm 5 Farm 6 Farm 7 Farm 8 Farm 9 












































4 - - 0% NS - - NS 0% NS 0% - 
5 - - - - - 28% (5/18) - - - 
6 - - - - - 35% (8/23) - - - 
7 - - - - - 8% (2/24) - - - 
8 - - - - - 18% (2/11) - - - 
9 - - - - - 0% (0/7) - - - 
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At housing, one year after the start of the follow-up, a control farm visit was 
performed on farms 1 to 7. On all these farms, after being on pasture, new symptoms 
of mange and live mites were observed on several animals.  However, the farmers 
indicated that the situation was less severe than in previous years: less animals were 
affected and milder lesions were observed compared to earlier years (smaller lesions 
and less lesions per animal). All farmers voluntarily applied the first treatment 
protocol again and stated that the mange problem was under control much faster (2 
treatment rounds were usually sufficient).  
 
3.4 Discussion 
In this chapter 2 intensive treatment schedules against psoroptic mange were 
tested on beef farms with chronic mange problems. Although the farm prevalence of 
mange on Flemish beef farms is very high (74%) according to a previous survey, 
‘problem farms’ such as the farms in the present study are a minority as only 2% of 
the survey participants indicated that the problem was uncontrollable (Chapter 2).  
In only a couple of months, the mange problem on all study farms could be 
controlled, with all animals being clinically healthy and/or parasitologically negative. 
In the short term, the application of an intense treatment strategy was therefore 
successful. It should be stressed that prior to treatment an etiological diagnosis was 
made, including identification of the mite species, which is essential for an efficient 
mange control (www.dgz.be/publicatie/fiche-aanpak-schurft). 
The number of treatments necessary to reach a ‘mange free’ situation appeared to 
be farm dependent and although this is not obvious from this study, larger farms often 
need more treatments to become completely mite negative. This has been described 
on sheep farms as well and could be explained by the fact that larger numbers of 
animals lead to closer contact between individuals and more displacements between 
stables, both enlarging the risk for dissemination of the infection (Falconi et al., 
2002). Moreover, since not all animals were sampled during each farm visit, cattle 
with small lesions or asymptomatic carriers could easily be missed, especially on 
larger farms. The results also show that the efficacy of a drug can differ from farm to 
farm. The presence of farm specific mite strains with a different pathogenicity and/or 
sensitivity could be a potential cause and this phenomenon has been previously 
described in sheep and cattle in the US (Roberts and Meleney, 1970). Even though it 
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was not clear from this study, implementing a suboptimal farm management 
(nutrition, housing,…) can also be responsible for the persistence of mange on herd 
level (Chapter 2), as management can influence the immunity or resistance of the 
animals and as such the response to treatment. Although one ML treatment used to be 
efficient to control psoroptic mange in the past (Aiello, 1998; Clymer et al., 1997; 
Lonneux et al., 1997; Pouplard and Detry, 1981), nowadays at least 2 treatments (one 
treatment round) are necessary to reach clinical improvement (Minihan et al., 2002; 
Vercruysse and Rew, 2002). The control or eradication of mange often even requires 
more than one treatment round of 2 ML injections on problem farms with severely 
affected animals, as in this study. It should be mentioned that the ML dose in this 
study was determined based on the estimated weight of the animals, thus underdosing 
is possible in some cases. This cannot only explain therapy failure and the need for 
more treatments on certain farms, but together with the intensive and often incorrect 
use of MLs, it can also induce the development of resistant mite strains. Up till now, 
an in vitro test to assess ML resistance in P. ovis is not available yet. Despite the 
clinical and parasitological improvement, additional treatments were also necessary 
on the farms using the LA formulation of moxidectin. A similar result was obtained in 
a study from 2012 in the UK, in which a single injection with Cydectin 10% LA was 
insufficient to control the infection (Mitchell et al., 2012). This is in contrast with a 
previous study, which demonstrated that in the presence of untreated mange positive 
animals, cattle remained mange free for a minimum of 77 days after a single injection 
with the same product (Losson et al., 2008). Nonetheless, an advantage of the LA 
formulation is that the first treatment round can be replaced by a single injection, 
which may lower the working load for the farmer. Moreover, the additional 
treatments on farms 8 and 9 were successful at herd level, despite being only 
administered to the mite positive animals. 
Finally, the question remains how the animals that were negative during winter 
could become positive during or after being on pasture. The most probable cause is 
the presence of subclinically infested carriers on the farm. These animals are 
clinically healthy, but on specific areas they harbour mites that are in a so-called 
‘latent phase’, meaning they do not induce clinical signs. In sheep, the infra-orbital 
and inter-digital fossae, the ears and perineum have been suggested as possible sites 
where ‘latent’ mites reside (Bates, 2012), but in cattle no such sites have been 
identified yet. Even when the whole herd would be sampled, these carriers could still 
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be missed, as ‘latent’ mites are often not present at the usual predilection sites. 
Another possible cause is re-infection from the environment. While it was previously 
assumed that the main infection source for psoroptic mange is direct contact between 
animals (Bates, 2012; Hourrigan, 1979; Minihan et al., 2002; Losson, 2003), stable 
hygiene was recently identified as a significant risk factor for psoroptic mange, which 
implies that re-infection from the environment is possible (Chapter 2). P. ovis mites 
can survive relatively long off the host, but they loose their infectivity after about 2 
weeks (Bates, 2012; Pegler and Wall, 2004; Smith et al., 1999). Therefore, it is 
unlikely that in this study the animals were re-infested on pasture. 
It can be concluded that the complete elimination of mange on a BB farm is a 
difficult task. At short notice, the application of an intensive treatment schedule, 
combined with an adapted management like shearing prior to treatment is very 
effective. Because of the possible existence of subclinical carriers or acaricide 
resistance and the implementation of a suboptimal farm management, the chances that 
the disease re-emerges in a herd are however high. An early etiological diagnosis is 
therefore crucial in order to start a correct treatment as soon as possible, to increase 
the chances for efficient control of the disease. 
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Psoroptes ovis (P. ovis), the causative agent of psoroptic mange, causes severe 
allergic dermatitis and intense pruritus in sheep and cattle. The disease is highly 
contagious and causes impaired animal welfare and major economic losses due to 
performance loss and substantial treatment costs in livestock production all over the 
world (Kirkwood, 1986; Lonneux et al., 1998; Pouplard et al., 1990). Compared to 
sheep, P. ovis in cattle has a more limited geographical distribution, with a hotspot in 
Belgium where a farm prevalence of 74% has been observed on Belgian Blue (BB) 
beef farms (Chapter 2). This cattle breed appears to be highly susceptible to the 
infection, whilst other beef breeds and dairy cattle, such as Holstein Friesian (HF), 
seem to be more resistant, although the reason for this difference has not been 
clarified yet (Losson et al., 1999). Host factors, such as genetic and immunologic 
variations, could be the cause of different breed susceptibility.  
Previous research suggested that immune-depression was not responsible for 
higher susceptibility of BB, since BB animals developed P. ovis specific antibodies 
after infection, which correlated with the mite population density and the progression 
of the lesions. Moreover, in vitro culture of peripheral blood mononuclear cells 
(PBMCs) showed an increased reactivity to mitogens (Lonneux et al., 1998; Losson 
et al., 1988, 1999; Pruett et al., 1986). In general, microscopic examination of the skin 
from infested ruminants reveals an increased dermal thickness and a superficial, 
perivascular dermatitis characterised by a rapid influx of lymphocytes (including 
TCRγδ T-cells in sheep), macrophages, mast cells, neutrophils and eosinophils 
(Stoeckli et al., 2013; Stromberg and Guillot, 1989; van den Broek and Huntley, 
2003; van den Broek et al., 2005). Previous work on sheep scab demonstrated an up-
regulation of genes encoding for pro-inflammatory and -allergic mediators 
(interleukin (IL)-1, IL-8, IL-6) and molecules involved in extravasation of immune 
cells (Burgess et al., 2010, 2011). Several infectious diseases, including scabies, have 
been linked to CD4+ helper T (Th)-cell differentiation into specific Th1, Th2, Th17 or 
Treg lineages (Babu et al., 2010) and the pro-inflammatory response in the skin of P. 
ovis infested sheep evolves towards a Th2 immune response within 24 hours after 
infection (Burgess et al., 2010, 2011, 2012), a pattern that has been described in S. 
scabiei infested mice and dogs as well (Lalli et al., 2004; Singh et al., 2014). In 
addition, the epidermal differentiation complex (EDC) genes filaggrin, involucrin and 
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loricrin are significantly down-regulated in infested sheep skin, indicating an 
impaired skin barrier function (Burgess et al., 2010; Stoeckli et al., 2013) and markers 
of skin barrier disruption can also be found in circulating PBMCs (Burgess et al., 
2012). Furthermore, the systemic immune response parallels the cutaneous Th2 
response as locally produced IL-4 and IL-13 stimulate PBMCs to up-regulate IL-4R 
transcription and CCR3, an eosinophil activator (Burgess et al., 2012). Remarkably, 
both BB and HF cattle showed an immediate hypersensitivity reaction one hour after 
intradermal injection of Psoroptes cuniculi antigen, but only in BB animals a delayed 
hypersensitivity reaction after 72 hours could be recorded (Losson et al., 1988, 1999). 
Inherent differences in skin physiology and body composition could be responsible 
for this altered skin reaction in BB, as it has been suggested that these physiologic 
factors can also influence the pharmacokinetics of acaricides (Sallovitz et al., 2002; 
Vercruysse et al., 2008).  
As described for ticks (Piper et al., 2009, 2010), susceptibility of cattle to mite 
infestations can also vary between individual animals. Increased susceptibility in 
sheep seems to correlate with higher numbers of eosinophils in the skin, larger lesions 
(van den Broek and Huntley, 2003) and potentially specific mutations in crucial EDC 
components (Burgess et al., 2010; Stoeckli et al., 2013). However, the existence of 
the latter needs further assessment. Humans suffering from severe sarcoptic scabies, 
better known as crusted or Norwegian scabies, show a predominant IgE-driven Th2 
response with high levels of IL-5 and IL-13, in contrast to patients with ordinary 
scabies, who mainly express the Th1 cytokines IL-2 and IFN-γ (Mounsey et al., 2015; 
Walton, 2010; Walton and Oprescu, 2013). In mice and rabbits, a skewed Th2/Th1 
response favouring the cell-mediated Th1 response is linked with lower antibody 
titres, also resulting in more resistant individuals (Arlian et al., 1995; Casais et al., 
2014; Lalli et al., 2004). Recent investigations demonstrate an important role for 
Th17 cytokines in humans suffering from chronic and/or allergic inflammatory 
diseases, such as crusted scabies and psoriasis (Liu et al., 2014). Moreover, in pigs 
with sarcoptic scabies, the development of severe symptoms is linked to higher levels 
of cutaneous IL-17, IL-23 but also Th2 cytokines IL-4 and IL-13 (Liu et al., 2014; 
Mounsey et al., 2015; Walton and Oprescu, 2013).  
In conclusion, several potential reasons for differences in susceptibility to 
mange between breeds and between individual animals have been suggested in 
various species, with predominant roles for Th2 and Th17 cytokines. Therefore, the 
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main objective of this chapter was to examine the in vivo cutaneous and in vitro 
cellular immune responses during natural P. ovis infestation in the highly susceptible 
BB cattle breed. In addition, these responses were compared with those in more 
resistant HF cattle.  
 
4.2 Materials and methods 
4.2.1 Animals and tissue collection 
Ethical approval to conduct this study was obtained from the Ethical 
Committee of the Faculty of Veterinary Medicine, Ghent University (ethical approval 
number EC 2013/130). In total 28 animals were sampled: 20 BB and 8 HF. All 
animals were females of approximately one year (BB) or 2 to 3 years (HF) old. The 
BB cattle were uninfested animals (n=8) or naturally infested animals with severe 
clinical signs of mange (n=12). The degree of infection was quantified by calculating 
the percentage of infested body surface (clinical index, CI) for each animal based on 
the method of Guillot (Guillot, 1981). Heavily infested animals had a CI of ≥10% 
(range 12-45%) and uninfested animals had a CI of 0%. The HF were also either 
uninfested (n=4) with 0% CI or naturally infested with P. ovis (n=4) with a CI of ≥1% 
(range 1-8%). Skin scrapings of all infested animals demonstrated a pure P. ovis 
infection. The absence of mites in the uninfested groups was confirmed by indirect 
examination (centrifugation-flotation after 10% KOH digestion) of skin scrapings.  
After confirmation of the presence or absence of P. ovis mites, 2 skin biopsies 
were taken per animal after shaving an area next to the tail base at the transition 
between healthy and infested skin, using a 4 millimeter (mm) diameter punch biopsy 
tool (Farla Medical). One biopsy was snap-frozen in liquid nitrogen and stored at -
70°C to allow ribonucleic acid (RNA) extraction. The second skin sample was stored 
in 4% formaldehyde and paraffin-embedded for histology and immunohistochemistry. 
In addition, blood was drawn from the vena jugularis using heparin-coated tubes and 
PBMCs were isolated using a Lymphoprep density gradient (Axis-Shield). The cells 
from the interphase were washed 3 times with Dulbecco’s phosphate-buffered saline 
(DPBS; Invitrogen), counted and processed or cultured as described further.  
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4.2.2 Psoroptes ovis antigen production 
P. ovis mites of a heavily infested BB animal were collected, washed with 
DPBS and stored at -70°C. For crude protein extract production, the mites were 
washed again with ice cold DPBS and crushed in liquid nitrogen in a pestle and 
mortar. This extract was centrifuged at 16,000 g for 30 minutes at 4°C and sterilised 
over a 0.45 micrometer (µm) filter (Millipore). Using the Bradford method (Sigma-
Aldrich), the concentration of the supernatant was determined at 10 
milligrams/millilitre (mg/ml) after which the extract was stored at -70°C (Bradford, 
1976). 
 
4.2.3 Histology, immunohistochemistry and cell counts 
Tissue sections of the paraffin-embedded biopsies were stained with 
haematoxylin-eosin (HE) for the detection of eosinophils, toluidin blue staining for 
mast cells and 2 immunohistochemical stainings (CD3 staining for T-cells and CD20 
staining for B-cells), based on Dreesen et al. (2012). In short, skin tissue sections of 4 
µm were mounted on APES-coated slides, blocked with H2O2 and stained with 
polyclonal rabbit anti-human CD3 (Dako) or rabbit anti-human CD20 (Sigma-
Aldrich, USA) antibodies. T- and B-cells were visualized by adding peroxidase 
labelled goat anti-rabbit antibodies (Dako), diaminobenzidin tetrahydrochloride 
(DAB; Dako) and by performing a counterstaining with haematoxylin. Eosinophils, 
mast cells, T-cells and B-cells were quantified by taking 2 random pictures per tissue 
slide at 400x magnification on a LEICA light microscope and counting the positive 
cells on 2 tissue slides per animal. Results were expressed as the number of cells per 
105 µm2 tissue surface. 
 
4.2.4 Quantitative real-time PCR 
The frozen skin samples that were crushed in liquid nitrogen, homogenized 
and phase separated in TRIzol (Invitrogen) were used for RNA purification according 
to Grit et al. (2014). In short, RNA was extracted from the aqueous phase using the 
RNeasy kit (Qiagen). On-column DNase digestion was included by using the RNase-
free DNase set (Qiagen) and RNA concentrations were measured with a Nano-Drop 
2000 spectrophotometer. In addition, PBMCs were re-stimulated with either DPBS or 
5 micrograms (µg)/ml P. ovis antigen and cultured for 5 days in a 24-well flat-
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bottomed plate (BD Biosciences), after which the harvested cell pellets were washed 
3 times with DPBS and stored at -70°C or directly used for on-column RNA 
purification as described above. Complementary DNA (cDNA) was generated from 
100 to 150 nanograms (ng) total RNA using the iScript cDNA synthesis kit (Bio-rad). 
As the RNA yield from the PBMCs of one uninfested HF was low, 60 ng RNA was 
used for the cDNA production of the PBMCs from all uninfested HF (n=4). The 
cDNA of all animals was diluted 1:10 in RNase free water and all qRT-PCR analyses 
were carried out as described by Dreesen et al. (2014) using the SYBR Green Master 
Mix (Applied Biosystems) on 2 microlitres (µl) of single-stranded cDNA per reaction 
volume. All reactions were carried out in duplicate. Primer sequences for all genes 
that were tested are listed in Table 1. Using GeNorm software (geNorm 3.5), 2 breed 
specific internal control genes were selected from 6 candidate housekeeping genes: 
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH), hypoxanthine 
phosphoribosyltransferase 1 (HPRT1), ribosomal protein P0 (RLP0), succinate 
dehydrogenase complex subunit A (SDHA), ribosomal protein 29 (RPS29) and 
histone deacetylase 10 (HDAC10). Analysis of the skin samples was performed with 
housekeeping genes SDHA and RPS29 for BB and HPRT1 and SDHA for HF. 
Additional genes were tested to evaluate skin related pathology (Table 1). New primer 
sets for three EDC genes; filaggrin (FIL), involucrin (IVL) and loricrin (LOR) were 
designed based on the following bovine reference gene sequences from the National 
Centre for Biotechnology Information (NCBI) database: [FIL: XM_010826841, 
XM_010826842, XM_010826843], [IVL: XM_005203832, XM_010802998, 
XM_005203836] and [LOR: NM_001113757, XM_010826802, XM_010802876]. 
The sequences were aligned in SeqMan Pro (DNASTAR Lasergene) and primers 
were designed with Primer3web version 4.0.0 (free available online) (Table 1). Mean 
fold changes in gene transcription levels were obtained by comparing infested with 
control animals. For the analysis of the PBMCs, housekeeping genes GAPDH and 
HPRT1 were used for normalization in the BB animals and RLP0 and SDHA for the 
HF. Relative quantities (Q values) were calculated using the delta Ct method to 
determine the fold differences in gene transcription levels of antigen re-stimulated 
cells of each animal compared to DPBS re-stimulated cells.  
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Table 1. Primer sequences (cattle) and abbreviations of the genes used in the qRT-
PCR assays, including GeneBank accession numbers 
 
Housekeeping genes Accession number Primer sequence 
GAPDH 
(glyceraldehyde-3-phosphate-dehydrogenase) 
NM_001034034.1 F: ACCCAGAAGACTGTGGATGG 
R: CAACAGACACGTTGGGAGTG 
HPRT1 
(hypoxanthine phosphoribosyltransferase 1) 
NM_001034035.1 F: CACTGGGAAGACAATGCAGA 
R: ACACTTCGAGGGGTCCTTTT 
RPS29 
(ribosomal protein 29) 
BC102702 F: GGAGCCATCCGAGAAAATTCG 
R: CAACTTAATGAAGCCGATGTCCTT 
RLP0 
(ribosomal protein P0) 
NM_001012682.1 F: CTTCATTGTGGGAGCAGACA 
R: GGCAACAGTTTCTCCAGAGC 
HDAC10 
(histone deacetylase 10) 
NM_001075460.1 F: CCGATGACGGGAGAAATCTA 
R: CTCAGGAACCCACCAGTTGT 
SDHA 
(succinate dehydrogenase complex subunit A) 
NM_174178.2 F: ACATGCAGAAGTCGATGCAG 
R: GGTCTCCACCAGGTCAGTGT 
qRT-PCR PBMC and skin Accession number Primer sequence 
IL-2 
(interleukin 2) 
NM_180997.1 F: TCCAAGCAAAAACCTGAACC 
R: CAGCGTTTACTGTTGCATCATC 
IL-4 NM_173921.2 F: GCGGACTTGACAGGAATCTC 
R: TCAGCGTACTTGTGCTCGTC 
IL-5 NM_173922.1 F: TGGTGGCAGAGACCTTGACA 
R: TTCCCATCACCTATCAGCAGAGT 
IL-6 NM_173923.2 F: TCCTTGCTGCTTTCACACTC 
R: CACCCCAGGCAGACTACTTC 
IL-10 NM_174088.1 F: TGTATCCACTTGCCAACCAG 
R: CAGCAGAGACTGGGTCAACA 
IL-13 NM_174089.1 F: GGTGGCCTCACCTCCCCAAG  
R: ATGACACTGCAGTTGGAGATGCTG 
IL-17 NM_001008412.1 F: GGACTCTCCACCGCAATGAG 
R: TGGCCTCCCAGATCACAGA 
IL-23A NM_001205688.1 F: CCCGTATCCAGTGTGAGGAT 
R: AGTATGGAGGCGTGAAGCTG 
FOXP3 
(forkhead box P3) 




NM_174086.1 F: TTCTTGAATGGCAGCTCTGA 
R: TTCTCTTCGGCTTTCTGAGG 
NCR1 
(natural cytotoxicity triggering receptor 1) 
NM_183365.1 F: CTGAGAGCGTGGGTGTATCA  
R: CTGAGAGCGTGGGTGTATCA 
   
 111 
TGF-β1 
(transforming growth factor β1) 
NM_001166068.1 F: CTGCTGTGTTCGTCAGCTCT 
R: TCCAGGCTCCAGATGTAAGG 
qRT-PCR skin Accession number Primer sequence 
AREG 
(amphiregulin) 
BC141281.1 F: TGGTCA 
R: GTCGATCACGGAGGACAGTT 
CCR3 
(chemokine receptor 3) 
NM_001194960.1 F: TGTGTCAACCCCGTGATCTA 
R: AGAGTTCCTGCTCCCCTGTT 
FCERA1 
(Fc IgE receptor alpha 1) 












* F: CAGTGGATCCGTCTGCCTGGGA 
R: CATGAGAGCGGTAAGCCCATCGAC 
* Primers designed based on bovine reference gene sequences from NCBI database 
 
4.2.5 Cell proliferation assays 
3H-thymidin uptake assay 
For the 3H-thymidin uptake assay, 500,000 cells per well were cultured in a 
96-well round-bottomed plate (Thermo Scientific) using 200 µl of complete Roswell 
Park Memorial Institute (RPMI) cell culture medium, which consisted of RPMI-1640 
(Invitrogen) supplemented with L-glutamine (Invitrogen), 10% foetal calf serum 
(Moregate), gentamycin (Invitrogen) and β-mercaptoethanol (Sigma-Aldrich). The 
cells were either re-stimulated with a negative control (DPBS), 5 µg/ml Concanavalin 
A (ConA, Sigma-Aldrich) as a positive control or P. ovis crude protein antigen at 5 
µg/ml, 10 µg/ml, 25 µg/ml or 50 µg/ml. All conditions were performed in triplicate. 
The cells were pulsed with 1 microcurie (µCi) 3H-thymidin (Perkin Elmer) after 4 
days of culture. After 18h of incubation, the cells were harvested and the incorporated 
radioactivity was measured using a β-scintillation counter (Perkin Elmer). Results are 
shown as stimulation indices (SI), which are the ratios of the counts per minute of P. 
ovis re-stimulated cells and the counts per minute of the negative control.  
 
PKH staining and flowcytometry 
To identify which cell populations from the whole PBMC fraction were 
proliferating after antigen re-stimulation, isolated PBMCs were labelled with Paul 
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Karl Horan dye (PKH) using the PKH26 red fluorescent cell linker mini kit (Sigma-
Aldrich) according to the manufacturer’s protocol. A small fraction of the stained 
cells was used to determine the PKH starting intensity by flowcytometry analysis. The 
rest of the labelled cells was cultured at 500,000 cells per well in a 96-well round-
bottomed plate (Thermo Scientific) in 200 µl complete RPMI cell culture medium and 
re-stimulated with DPBS or 5 µg/ml P. ovis. All conditions were performed in 
duplicate.  
After 5 days of culture, the cells were harvested and 2 cell stainings were 
performed in DPBS supplemented with 1% bovine serum albumin (BSA, Sigma-
Aldrich) and 0.1% Na-azide (Sigma-Aldrich) by using the following monoclonal 
primary antibodies: CD3 (mouse IgG1, clone MM1A, VMRD), TCRγδ (mouse 
IgG2b, clone GB21A, VMRD), CD4 (mouse IgG2a, clone CC8) and CD8 (mouse 
IgM, clone BAQ111A, VMRD) in the first staining. CD3, CD21 (mouse IgM, clone 
BAQ15A, VMRD) and Alexa Fluor 488-labeled CD335 (mouse IgG2b, clone AKS6) 
in the second staining. The CD335 antibody was kindly provided by Prof. A. Storset 
(School of Veterinary Medicine, Norway). Bound mAb were detected using the 
following secondary antibodies: rat anti-mouse IgG1-V450 (BD Biosciences), rat 
anti-mouse IgG1-APC (BD Biosciences), rat anti-mouse IgG2b-FITC (Southern 
Biotech), goat anti-mouse IgG2a-APC (Invitrogen) and rat anti-mouse IgM-APCCy7 
(Biolegend). The PKH intensity for each cell population was determined on a 
fluorescence-activated cell sorting (FACS)AriaIII (BD Biosciences). Viable cells 
were gated based on forward and side scatter and lack of propidium iodide (Molecular 
Probes) uptake. Doublets were eliminated from the analysis by gating on forward 
scatter-height and forward scatter-area. T-cells were identified as CD3+ cells, T-
helper cells as CD3+/CD4+ and cytotoxic T-cells as CD3+/CD8+. In the CD3- 
population, CD21+ cells were classified as B-cells, CD335+ cells as NK-cells and a 
third population of bovine CD3-/CD21-/CD335- cells was clearly defined but could 
not be identified so far. 
Data were analysed using FlowJo software (Tree Star) and quantified using 
ModFit LT software (Verity Software House). Proliferation indices (PI) were 
calculated for each separate cell population and compared between DPBS and P. ovis 
antigen re-stimulated cells. 
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4.2.6 Statistical analysis  
GraphPad Prism was used to perform all statistical analyses. For the 
comparison of the stimulation indices and Q values (qRT-PCR on skin biopsies) 
between infested and uninfested animals, a nonparametric Mann Whitney U test was 
performed. A one-sided test was used for the stimulation indices and a two-sided test 
for the Q values. Proliferation indices generated from the PKH staining and Q values 
of unstimulated vs. re-stimulated cells (qRT-PCR on PBMC) were compared using a 
nonparametric Wilcoxon signed-rank test: one-sided for the PKH data and two-sided 
for the Q values. P-values ≤ 0.05 were considered statistically significant.  
 
4.3 Results 
4.3.1 In vivo cutaneous immune response  
Results of the eosinophil, T- and B-cell and mast cell counts in the skin of 
infested and uninfested BB and HF animals are listed in Table 2. The number of 
eosinophils (46.7 per 105 µm2), T-cells (83.8 per 105 µm2) and B-cells (30.6 per 105 
µm2) was significantly higher in the infested BB than in the control animals (6.5 per 
105 µm2, 33.8 per 105 µm2 and 5.9 per 105 µm2 respectively), whereas the number of 
mast cells did not significantly differ. In HF animals, eosinophil, T-cell, B-cell and 
mast cell counts in the skin appeared to be higher in infested animals compared to the 
uninfested controls, although cell counts were not significantly different between the 
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Table 2. Histological cell counts in skin biopsies of control animals and Psoroptes 
ovis infested cattle. Panel A: Cell counts from Belgian Blue cattle. Panel B: Cell 
counts from Holstein Friesian cattle. Data are presented as mean number of cells per 






Eosinophils Mast cells 
Control (n=8) 33.8 ± 4 5.9 ± 1.1 6.5 ± 1.3 12.4 ± 1.2 






Eosinophils Mast cells 
Control (n=4) 34.5 ± 11.7 5.8 ± 0.8 6.4 ± 2.8 12.5 ± 1.2 
Infested (n=4) 46.6 ± 5.4 10.6 ± 4 35.1 ± 10 19 ± 4.6 
 
 
To identify whether specific cytokines characteristic for a Th1, Th2 or Th17 
immune response are produced during infection, qRT-PCR was performed on skin 
biopsies of uninfested and infested BB and HF animals (Figure 1). Only 11 infested 
BB animals were included as from one animal an insufficient amount of RNA was 
obtained. A mixed Th2/Th17 cytokine profile was observed in the skin of infested BB 
with an up-regulation of IL-6 (6.2 fold; P =0.043) and IL-17 (6.3 fold; P =0.006), as 
well as up-regulated transcription of IL-4 (3.2 fold; P =0.012), IL-5 (1.6 fold; P 
=0.149), IL-13 (2.5 fold; P =0.107) and IL-10 (4.3 fold; P =0.001). TGF-β and NRC1 
were also up-regulated in infested animals (1.4 and 2.5 fold and P-values of 0.006 and 
0.003 respectively). Topically transcribed IL-23 was down-regulated (0.7 fold; P 
=0.019) and a low IFN-γ (1.6 fold; P =0.159) response was observed.  
In general, these responses were comparable to those in HF cattle. The 
cytokine profile in the skin of HF demonstrated a predominant Th2-like response with 
up-regulated transcription of IL-4 (2.7 fold; P =0.686), IL-5 (1.9 fold; P =0.057), IL-
13 (6.6 fold; P =0.124) and IL-10 (4.4 fold; P =0.057). Virtually no change in IL-17 
transcription (1.2 fold; P =0.343) was observed, while IL-6 was up-regulated (9.2 
fold; P =0.057). No significant changes in IL-23 transcription were observed in the 
skin (0.6 fold; P =0.057). IFN-γ was up-regulated in 3 out of 4 infested animals, but 
could not be quantified as the transcription in the uninfested control animals was too 
low to detect.  
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Figure 1. Gene transcription profile in the skin of Psoroptes ovis infested Belgian 
Blue (Panel A) and Holstein Friesian cattle (Panel B). qRT-PCR data is presented as 
mean fold changes in infested animals (BB n=11; HF n=4) compared to uninfested 
controls (BB n=8; HF n=4; dashed horizontal line) with SEM as error bars. (*P< 0.05, 
(*)P=0.057) 
      
 
4.3.2 In vitro immune response after PBMC re-stimulation 
Proliferation of re-stimulated PBMCs was assessed using a 3H-thymidin 
uptake assay, in which cells from uninfested and infested BB and HF animals were re-
stimulated with either DPBS as negative control, ConA as positive control or several 
concentrations of P. ovis antigen (5 µg/ml, 10 µg/ml, 25 µg/ml or 50 µg/ml). Results 
demonstrated a significant and largely concentration-dependent PBMC proliferation 
in infested BB and HF compared to the uninfested animals (Figure 2; panels A and 
B). Using PKH staining on cells of infested BB and HF re-stimulated with 5 µg/ml 
antigen or DPBS, a significant antigen specific proliferation in all investigated cell 
populations (αβ T-cells, γδ T-cells, B-cells, NK-cells and CD3-/CD21-/CD335- cells) 
was observed, with the highest reaction seen in NK- and CD3-/CD21-/CD335- cells 
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Figure 2. 3H-thymidin uptake assay and PKH staining of circulating PBMCs from 
(un)infested Belgian Blue and Holstein Friesian cattle. Panel A: mean stimulation 
index (SI ± SEM) of PBMCs from uninfested (n=8) and infested (n=12) BB cattle re-
stimulated with medium, 4 different concentrations of P. ovis and ConA. Panel B: 
mean stimulation index (SI ± SEM) of PBMCs from uninfested (n=4) and infested 
(n=4) HF cattle re-stimulated with medium, 4 different concentrations of P. ovis and 
ConA. Panel C: mean proliferation index (PI ± SEM) of PKH labelled PBMCs re-
stimulated with 5 µg/ml P. ovis antigen compared to unstimulated PBMC (dashed 
horizontal line) of infested BB (n=12). Panel D: mean proliferation index (PI ± SEM) 
of PKH labelled PBMCs re-stimulated with 5 µg/ml P. ovis antigen compared to 




It was subsequently investigated whether circulating re-stimulated PBMCs of 
infested BB and HF animals after in vitro re-stimulation with P. ovis antigen 
produced similar cytokines as in the skin (Figure 3). As the RNA yield of one infested 
BB animal was insufficient to perform qRT-PCR, data of 11 instead of 12 BB animals 
is shown in Figure 3; Panel A. In parallel to the cutaneous immune response, re-
stimulation of PBMCs in infested BB induced a predominant Th2- and Th17-like 
response with up-regulated transcription of IL-4 (11 fold; P =0.019), IL-13 (58.6 fold; 










































































































































fold; P =0.032) and the natural cytotoxicity triggering receptor 1 (NCR1) (3.5 fold; P 
=0.003) transcription was observed, as well as of IFN-γ (36.8 fold; P =0.003), IL-5 
(3.5 fold; P =0.413), IL-10 (2.5 fold; P =0.102) and IL-6 (12.5 fold; P =0.831). TGF-
β, IL-2 and IL-23 were down-regulated (all 0.5 fold with P-values of 0.001, 0.005 and 
0.001 respectively).  
The cytokine profile of circulating re-stimulated PBMCs in infested HF 
animals (Figure 3; Panel B) revealed a mixed Th2/Th17-like response with 2.6, 11.5 
and 19.4 fold changes for IL-5, IL-13 and IL-6 respectively. IL-17 and IL-10 were 
consistently up-regulated in all samples (average fold changes of 69.1 and 8.5 
respectively), systemic IFN-γ was 2.4 fold up-regulated and IL-23, TGF-β and IL-2 
were slightly down-regulated, with 0.9, 0.8 and 0.5 fold changes respectively. 
However, the statistical significance for these data could not be interpreted due to the 
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Figure 3. qRT-PCR results of circulating PBMCs from infested Belgian Blue and 
Holstein Friesian cattle. Panel A: Gene transcription profile in PBMCs of infested BB 
(n=11). Panel B: Gene transcription profile in PBMCs of infested HF (n=4). qRT-
PCR results of PBMC re-stimulated with 5 µg/ml P. ovis antigen are presented as 
mean fold changes in re-stimulated compared to unstimulated cells (dashed horizontal 
line). (*P< 0.05) 
     
In order to evaluate whether these observations were mainly due to a cellular 
memory response or whether innate, primary reactions were also responsible, the 
same procedure was also followed for the uninfested BB (n=8) and HF (n=4) animals 
with the results listed in Figure 4. A 17.3 fold (P =0.039), 7.2 fold (P =0.031) and 
376.8 fold (P =0.039) up-regulation of respectively IL-13, IL-17 and IFN-γ was 
observed in BB animals (Figure 4; Panel A). Finally, qRT-PCR results from the re-
stimulated PBMCs of uninfested HF animals are listed in Figure 4; Panel B and show 
an up-regulation of IL-13 (14.2 fold) and IL-10 (25.5 fold). In contrast with the 
PBMCs from uninfested BB cattle, virtually no IL-17 response and a moderate IFN-γ 
up-regulation (1.9 and 5.3 fold) were observed in uninfested HF. For the results in HF 









































































Figure 4. qRT-PCR results of circulating PBMCs from uninfested Belgian Blue and 
Holstein Friesian cattle. Panel A: Gene transcription profile in PBMCs of uninfested 
BB (n=8). Panel B: Gene transcription profile in PBMC of uninfested HF (n=4). qRT-
PCR results of PBMCs re-stimulated with 5 µg/ml P. ovis antigen are presented as 
mean fold changes in re-stimulated compared to unstimulated cells (dashed horizontal 
line). (*P< 0.05) 
      
4.4 Discussion 
In this chapter the cutaneous in vivo immune response and in vitro cellular 
immune reaction in BB and HF cattle during natural P. ovis infestation were analysed 
in order to identify a potential cause of the high susceptibility of the BB breed to this 
parasitic infestation. A significant influx of immune cells in the skin of infested BB 
was observed, coinciding with a mixed Th2/Th17 cytokine profile. A largely similar 
cytokine pattern could be elicited when circulating PBMCs from infested BB were re-
stimulated with P. ovis antigen in vitro. Moreover, a significant and largely antigen 
concentration-dependent PBMC proliferation was observed in infested animals 
compared to uninfested controls, with proliferation of all cell investigated 
subpopulations (αβ T-cells, γδ T-cells, B-cells, natural killer (NK)-cells and CD3-
/CD21-/CD335- cells). This demonstrates the presence of antigen specific memory T-
cells, and it confirms previous assumptions that an impaired cellular immune response 
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in BB is not the cause of the high susceptibility of this breed (Losson et al., 1999). HF 
animals are known to display less severe symptoms during P. ovis infection in 
comparison to BB, which is reflected in the lower CI of the animals in this study and 
the less pronounced influx of immune cells in infested skin. Although the cytokine 
pattern observed in the skin was similar to that in BB, no cutaneous IL-17 production 
was observed in infested HF. Furthermore, circulating PBMCs from infested HF also 
produced a less pronounced Th2-like response. It should however be stressed that a 
different mite exposure in vivo could be responsible for these observations. 
Furthermore, the infestation stage of the animals was unclear and there was a small 
age difference between the animals, which could also partly explain the differences 
between both breeds.  
Th2 and Th17 cytokines have been described as being important in parasitic 
skin diseases. Production of Th2 cytokines is often observed in ectoparasite infections 
in cattle as it is in dogs, rabbits and mice with scabies (Arlian et al., 1995; Casais et 
al., 2014; Li et al., 2014; Singh et al., 2014). The cutaneous mixed Th2/Th17 profile 
that is observed in BB could potentially be associated with more severe symptoms, as 
described in pigs with aggravating symptoms of S. scabiei and in allergic diseases in 
humans (Mounsey et al., 2015; Li et al., 2014; Liu et al., 2015). Although this 
specific immune response could merely be a reaction to the presence of severe 
symptoms linked with high numbers of mites, the reversed hypothesis is also 
plausible. Indeed, Th2 cytokines produced in the skin will not only stimulate local 
immune cells to attack the mites, but will also cause collateral damage to the 
surrounding tissue, leading to the clinical symptoms. Despite the IL-23 down-
regulation, the additional pro-inflammatory Th17-like response in BB could intensify 
these effects leading to a more severe clinical phenotype. As mite counts were not 
performed in this study, it remains unsure whether this Th2/Th17-like response in 
infested BB animals is either not protective or is protective but ‘uncontrollable’. Little 
to no signs of a Treg reaction that could dampen this pro-inflammatory response, 
were noticed in both breeds, as only IL-10, which is also a Th2 cytokine, was up-
regulated without transcription of TGF-β. Furthermore, only a diminutive up-
regulation of Foxp3, a transcription factor that is generally expressed by Treg T-cells 
(McNeilly et al., 2010; Murphy, 2012) was noticed. Remarkably, little to no IFN-γ 
was transcribed in the skin of infested BB, while substantial up-regulation of this pro-
inflammatory cytokine was observed in re-stimulated PBMCs from infested and 
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uninfested BB. The latter indicates that IFN-γ could mainly be released by innate 
immune cells, such as macrophages, NKT- or NK-cells (Murphy, 2012). Low levels 
of this cytokine in the skin could be caused by the fact that the adaptive immune 
response already took over at this point of infection. Production of IFN-γ, a pro-
inflammatory cytokine that pushes naïve T-cells towards Th1-cells (Murphy, 2012), 
has been described in murine spleen and lymph node cells in vitro after challenge 
infection with S. scabiei (Lalli et al., 2004). In contrast with the uninfested BB, low 
IFN-γ and high IL-10 levels were observed in the re-stimulated PBMCs from 
uninfested HF animals. It remains unclear why IFN-γ and IL-10 transcription in HF 
does not resemble the pattern observed in BB and it should be further investigated 
whether this could be part of the cause of different breed susceptibility. 
The mixed cytokine profile seen in BB may have an effect on several immune 
cells downstream. Th2 cytokines are known to promote the immune response to 
parasites: IL-4 and IL-13 play a role in the induction of allergy as they stimulate B-
cell growth and IgE production, whilst IL-5 typically induces eosinophil 
differentiation and growth (Murphy, 2012). The pro-inflammatory effect of IL-17 
causes recruitment of neutrophils and further promotes the attraction of eosinophils in 
the skin (Iwakura and Ishigame, 2006; Li et al., 2014). Indeed, besides the 
recruitment of T- and B-cells, cell counts demonstrated a distinct influx of eosinophils 
in the skin of affected BB and a greater eosinophil skin infiltration has also been 
documented in sheep breeds susceptible to P. ovis and cattle breeds susceptible to tick 
infestations (Piper et al., 2010; van den Broek and Huntley, 2003). The presence of 
high levels of IL-17 in the skin has also been linked to delayed-type hypersensitivity 
in humans (Iwakura and Ishigame, 2006), which could explain the distinctive 
intradermal skin test response observed by Losson et al. (1988 and 1999). In this 
study, no suppression of the transcription of EDC genes could be observed (results 
not shown), unlike data available in sheep. As a down-regulation of these genes in 
sheep skin is seen within 24 hours after infection, it is possible that this was missed in 
this study (Burgess et al., 2010; Stoeckli et al., 2013). 
In summary, BB cattle display a mixed Th2/Th17 immune pathway during 
natural infection with P. ovis. We hypothesize that, in line with results from scabies 
affected humans and pigs, this might explain part of their susceptibility since no 
cutaneous Th17 profile could be detected in the more resistant HF breed. 
Furthermore, in contrast to the results from the HF, high transcription levels of IFN-γ 
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and low IL-10 transcription in the uninfested and infested BB could indicate a 
potential role for these cytokines in the innate immune reaction against the mite. 
These differences in IFN-γ and IL-10 transcription could therefore also be partly 
responsible for the observed difference in breed susceptibility to mange. Further 
research is needed to identify potential cell sources and biological functions for these 
up-regulated cytokines and to fully unravel the basis of this different breed 
susceptibility to P. ovis. 
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Belgian Blue (BB) cattle are highly susceptible to psoroptic mange, leading not 
only to impaired animal welfare but also important economic losses in the Belgian 
beef industry. The objective of this thesis was to identify factors that can explain (part 
of) the susceptibility of BB animals to Psoroptes ovis. Mange is a multifactorial 
problem in which different elements can affect the severity and outcome of the 
disease. Not only the mite itself is important in this respect but several environmental 
and host-associated factors can also play a role and were therefore examined in this 
thesis. This final chapter discusses the results and the potential practical applications 
from these studies and some suggestions for future research.  
 
5.1 Environmental and parasite factors  
5.1.1 Farm management  
Psoroptic mange is endemic in Belgium but prevalence data were not available 
until recently. We confirmed the importance of mange in Belgium by determining a 
(beef and mixed) herd prevalence of almost 75%, the predominant mite species being 
P. ovis (Chapter 2). Thirteen per cent of the questioned beef farms however indicated 
to have no problems with mange at all and the severity of the disease varied greatly 
between farms, which implies that besides the presence of the BB breed, other farm 
related factors could also be responsible for the variation in severity of mange across 
farms.  
This study demonstrated that poor animal hygiene and purchase of high numbers 
of new cattle are risk factors for mange. The hygiene score was correlated with the 
frequency of changing the bedding, which indicates the importance of (re)infection 
from the environment. Although mange infections mainly spread through direct 
contact between animals, mites can survive off the host and as such induce a rapid 
spread of the disease from the environment as well, even though they only stay 
infective off the host for about 2 weeks (Bates, 1998, 2012; van den Broek and 
Huntley, 2003). Improving general hygiene measurements, such as frequently 
cleaning the housing facilities and disinfecting boots and used tools, is therefore 
advised to avoid severe problems with mange. Purchasing new animals also forms a 
risk to (re)introduce the infestation as untreated cattle can carry and spread the disease 
without showing any clinical signs. This finding confirms previous suggestions in 
cattle and sheep (Berriatua et al., 1999; Carty and Nisbet, 2011; Millar et al., 2011; 
  130 
Mitchell et al., 2012; Phytian et al., 2013; Pouplard et al., 1990) and emphasizes the 
need to constrain the purchase of new cattle or at least implement a proper quarantine 
protocol including treatment and isolation (2 to 3 weeks) after import to avoid 
infection. The fact that farm management can influence the outcome of mange was no 
surprise, but we believe that identifying these 2 parameters as actual risk factors is 
important to improve practical guidelines for mange control in the field. However, 
additional field tests on a higher number of farms and experimental tests are necessary 
to confirm these results. A proposal for such an experimental study could be 
examining the importance of environmental infections by sampling uninfested cattle 
after introducing them in a pen where infested animals have been kept before. The 
time between removing the infested and introducing the uninfested animals could be 
adjusted in order to evaluate the survival and infectivity of P. ovis mites in the 
environment. 
 
5.1.2 Treatment protocols  
Although the risk factors discussed above may partially explain the variability 
between farms, in Chapter 2, ‘inadequate treatment protocol’ was identified as an 
additional factor influencing the severity of mange problems. Interestingly, even 
though a lot of mange treatments are carried out, less than half of the questioned 
farmers implemented a correct treatment scheme to control the mange problem on 
their farm. Important aspects of psoroptic mange treatment were identified in Chapter 
1, including frequency of treatment, interval between treatments and treating all in-
contact animals. Not applying one or more of these elements can lead to treatment 
failure. Beside not diagnosing the mite species prior to treatment, the most common 
mistakes are: only treating visibly affected animals, using pour-on formulations of the 
macrocyclic lactones (MLs) instead of injectable formulations, treating only once or 
leaving too much time between 2 treatments and not evaluating the efficacy of the 
treatment(s) (Chapter 2). Therefore, a sensitization campaign in cooperation with 
Veepeiler (Animal Health Care, Flanders) and Zoetis was launched to stimulate 
farmers to correctly diagnose and treat mange on their farm 
(www.dgz.be/publicatie/fiche-aanpak-schurft).  
Furthermore, to verify whether the infestation could be eliminated or controlled 
by implementing an intensive treatment schedule on farms with a history of chronic 
psoroptic mange problems, 2 treatment protocols were tested (Chapter 3). Although a 
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correct treatment schedule was applied for the first 4 treatments, due to practical 
reasons, both protocols were slightly modified by only treating the infested animals 
during additional treatments. While multiple treatments were often necessary, in all 
herds the infection could be controlled in a matter of months, which proved both 
intensive protocols to be effective at short notice. Although it is important to pay 
attention to as much aspects of an accurate treatment as possible, this study 
demonstrates that further investigation is needed to evaluate whether treating all in-
contact animals at once is necessary as good results were obtained by only re-treating 
affected cattle. In all cases, the infection reoccurred after summer grazing, most likely 
due to the presence of subclinical carriers, but the disease seemed to be less severe 
compared to other years and it was also more responsive to treatment. This result may 
encourage other farmers to put more effort in the treatment of mange on their farm 
and it demonstrates that an intensive follow-up leads to satisfying results. 
 
5.1.3 Mite strains  
Despite implementing the same treatment and a similar farm management, the 
number of treatments needed for eradication in the above mentioned study was clearly 
farm dependent, which suggests that additional factors affect the progress and 
treatment efficacy of psoroptic mange on farm level. This was also demonstrated by 
the fact that the only farm that did not follow the management advice (no animal 
shearing), was able to control mange with the fewest treatments, while on the farm 
where most treatments were administered, the management was optimal. One of these 
supplementary influencing factors could be related to the causative pathogen, the P. 
ovis mite. The presence of farm specific mite strains with differing pathogenicity has 
been described in sheep. High virulent mite strains could be ‘non-responsive’ even 
after multiple treatments (Bates, 1997; Roberts and Meleney, 1970). Furthermore, the 
findings in Chapter 2 demonstrate that acaricides are frequently used and that often-
incorrect treatments are carried out in the field, which could lead to the development 
of acaricide resistance in the mites. Psoroptes ovis resistance against ivermectin has 
already been suspected in cattle (Lekimme et al., 2010), but in contrast to S. scabiei 
(Brimer et al., 1993; Currie et al., 2004; Mounsey et al., 2009; Nong et al., 2014), in 
vitro tests to assess resistance in P. ovis are lacking. Therefore, protocols described by 
Brimer et al. (1993) and Nong et al. (2014), were adapted for P. ovis. Psoroptes ovis 
mites from 13 Belgian farms were exposed to several concentrations of ivermectin 
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and compared with susceptible control mites collected from Scottish sheep. 
Preliminary results showed a farm dependent variety in susceptibility and an 
increased lethal dose (LD50) on all but one Belgian farms compared to the susceptible 
control isolate (Maebe, 2015). These results are an indication of the possible existence 
of ivermectin resistance in Belgium.  
 
5.2 Host related factors  
5.2.1 Immune response 
Besides farm-related risk factors, host specific factors, such as the immune 
response, may also partly explain the difference in mange susceptibility that is 
observed between cattle breeds, e.g. susceptible BB versus more resistant Holstein 
Friesion (HF) (Bates, 1998; Losson et al., 1999; Pouplard et al., 1990). In Chapter 4, 
the cutaneous in vivo and in vitro cellular immune responses in uninfested BB animals 
were compared with those in infested BB cattle and more importantly these results 
were compared with those from uninfested and infested HF animals.  
Comparison of the cutaneous immune response revealed an interesting first 
difference between both cattle breeds. While in the skin of infested BB a mixed 
Th2/Th17-like cytokine profile was observed, there was virtually no IL-17 up-
regulation in the infested HF. As IL-17 production correlates with the severity of 
Sarcoptes scabies in pigs and allergic diseases in humans (Li et al., 2014; Liu et al., 
2014; Mounsey et al., 2015), it is possible that this pro-inflammatory cytokine in BB 
is responsible for more severe and often generalized clinical symptoms compared to 
HF. However, IL-17 transcription was observed in peripheral blood mononuclear 
cells (PBMCs) from HF after in vitro stimulation with P. ovis antigen. It cannot be 
excluded that, in contrast to the in vitro results, the antigen exposure or number of 
mites on HF cattle in vivo was too low to provoke an IL-17 response in the skin. 
Unfortunately, no mite counts were performed in this study, so this could not be 
confirmed. In addition, mange lesions are often secondary infected by bacteria and in 
general these will elicit a Th17 response in the host (Murphy, 2012). As the BB 
animals in this study had a higher clinical index compared to the HF, a higher 
bacterial exposure in the BB could explain the cutaneous Th17 response of infested 
BB. However, after in vitro stimulation of PBMCs with P. ovis antigen, a Th17 
response was observed in both breeds. This observation was independent of bacterial 
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exposure, because lipopolysaccharide (LPS) was included in the thymidine uptake 
assay as a positive control and results showed that this bacterial product had no 
stimulating effect on the PBMCs (results not shown). Therefore, bacterial 
contamination is most likely of limited importance in the transcription of Th17 
cytokines in the skin of infested BB. Up-regulated cutaneous IL-17 transcription in 
BB could be responsible for the greater influx of immune cells that was observed in 
the skin of affected BB compared to HF. The presence of high amounts of IL-17 in 
the skin of humans has been linked to delayed-type skin hypersensitivity (Iwakura 
and Ishigame, 2006). A delayed skin test reaction has been observed in infested BB as 
well, while it was absent in infested HF (Losson et al., 1988, 1999). The observation 
that only susceptible BB animals elicit a delayed skin reaction after antigen injection 
is in contrast with observations in S. scabiei infested rabbits, in which a delayed 
reaction, induced by a cell-mediated immune response is often linked with low 
antibody titres and resistance (Arlian et al., 1994 a and b, 1995).  
When the immune responses in circulating PBMCs from both BB and HF 
cattle were evaluated after in vitro re-stimulation with P. ovis crude antigen, an almost 
identical memory response was provoked in both breeds. In infested animals a 
significantly higher PBMC proliferation was observed compared to the controls and 
all investigated cell populations (αβ T-cells, γδ T-cells, B-cells, natural killer (NK)-
cells and CD3-/CD21-/CD335- cells) proliferated. Interestingly, when re-stimulated 
PBMCs from uninfested BB were compared to those from uninfested HF, 2 cytokines 
were not transcribed to the same degree: high fold changes of IFN-γ and low 
transcription levels of IL-10 were observed in PBMCs from uninfested BB animals, 
while this was reversed in uninfested HF cattle. As this observation was made both in 
uninfested and infested animals, it was concluded that the pronounced IFN-γ response 
in BB cattle and the high IL-10 transcription in HF animals most likely are part of the 
innate immune response and not produced by adaptive Th-cells. The function of this 
strong, probably innate, IFN-γ up-regulation in BB and IL-10 transcription in HF 
during infection remains unclear and needs further investigation.  
IFN-γ, Th2 and Th17 cytokines are generally thought to all have a pro-
inflammatory effect, but host immune regulatory mechanisms are thought to step in 
at some point during infection to dampen the inflammatory response. In this study 
(Chapter 4), no clear signs of regulatory T (Treg)-cells were noticed in the skin and 
PBMCs from the 2 cattle breeds and this was reflected in low transcription levels of 
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TGF-β and Foxp3. In human patients suffering from autoimmune diseases, mutations 
in Foxp3 have been linked to impaired Treg-cell function and high levels of IL-17 
(Passerini et al., 2011a), which corresponds with the pattern seen in cattle in this 
study. However, it is possible that in our study Treg-cells were missed, because it was 
uncertain in which stage of infection the naturally infested animals were or because 
Foxp3 might not be an appropriate cell marker for these cells in cattle. Although 
Foxp3 is a well-known cell-marker for human and murine Treg-cells, circulating 
bovine Foxp3+ T-cells have shown to fail induction of a regulatory effect ex vivo and 
Treg-cells in cattle were thought to belong to the TCRγδ T-cell fraction instead, 
which mainly resides in the skin (Hoek et al., 2009; Van Rhijn et al., 2007).  
 
Various cell sources can be responsible for the production of the important 
cytokines in this study. As IFN-γ transcription differed between BB and HF, the 
identification of the cell sources of this cytokine could lead to interesting findings. 
IFN-γ can originate from several innate immune cells, such as macrophages, NKT- 
and NK-cells (Murphy, 2012). In recent research it has been demonstrated that 
neutrophils can be a major IFN-γ source in mice, as these innate cells release IFN-γ 
during degranulation (Sturge et al., 2015).  
IL-10 transcription also varied between BB and HF and while IL-10 can be 
secreted by Th2-cells, it can also originate from mast cells, as has been described in 
humans suffering from allergic contact dermatitis (Grimbaldeston et al., 2007). The 
IL-10 up-regulation in the skin of infested BB could be associated with the moderate, 
although not statistically significant, increase in mast cells. IL-10 can also be released 
by Treg-cells but as TGF-β and Foxp3 were not up-regulated, the presence of these 
cells is questionable, as mentioned above. Although not yet identified in cattle, there 
are specific human Treg-cell subsets (Tr1 cells) that express low levels of Foxp3 and 
produce IL-10 but little TGF-β (Passerini et al., 2011b; Roncarolo et al., 2001). 
Finally, keratinocytes and innate immune cells, such as monocytes and macrophages 
can also release IL-10 (Moore et al., 1993). The fact that this cytokine is known to 
suppress IFN-γ production by NK-cells (Tripp et al., 1993), could also explain the 
cytokine pattern seen in uninfested and infested HF. 
Investigating the potential cell sources of IL-17 could also clarify the different 
expression of the cytokine in the skin of BB and HF: IL-17 can possibly originate 
from Th17 T-cells or several innate immune cells, such as neutrophils, CD8+ T-cells, 
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NK-like T-cells and TCRγδ T-cells (Stark et al., 2005). TCRγδ T-cell numbers are 
increased in P. ovis infested sheep skin (van den Broek et al., 2005) and in human 
psoriatic skin (Suzuki et al., 2014) and in the presence of IL-6 these cells can polarize 
into a specific TCRγδ17 T-cell subset, as described in cattle before (Peckham et al., 
2014). These bovine cells are known to produce high levels of IL-6 but not TGF-β 
and the lack of an IL-23 receptor may explain the non-responsiveness to IL-23 
(Peckham et al., 2014). Moreover, in human and mice, these cells are involved in the 
early pro-inflammatory response with production of IFN-γ, IL-4 and IL-17, 
stimulation of NK-cells with IFN-γ production and suppression of Treg development 
(Patil et al., 2015). This cytokine pattern is compatible with the cytokine profile in re-
stimulated PBMCs from infested BB.  
 
5.2.2 Genetics 
The immunologic differences between BB and HF that were observed in 
Chapter 4 could be inherent to the breed and therefore have a genetic basis. Even 
within the BB breed, individual variations in susceptibility to psoroptic mange have 
been observed and farmers often claim that susceptible dams and sires generate 
equally susceptible offspring. Similar family ties also seem to exist for more resistant 
animals, all leading to the assumption that the susceptibility to mange is (partly) 
heritable.  
In this context, our lab contributed to a federal project, called PSOROVIS, of 
which the ultimate goal was to identify genes that are potentially responsible for 
mange susceptibility and that could lead to the selection of mange resistant animals on 
the long run. Before a genome wide association study could be started, a protocol had 
to be optimized in order to phenotypically distinguish resistant from susceptible 
animals. A phenotyping formula was generated using a linear equation based on 
repeated weighed individual mite counts, clinical indices and lesion scores from 670 
animals. The individual animal scores were sorted as a continuous variable, with 
extremely sensitive and resistant animals at the ends and a large ‘grey zone’ in 
between (Coussé et al., 2014). After quality control, a single nucleotide 
polymorphism (SNP) chip analysis was performed on 656 animals and a selection of 
150 animals with extreme phenotypes was tested with a 50,000 SNP chip. Preliminary 
results demonstrated a haplotype at the end of bovine chromosome 11 that seemed to 
be associated with resistance/susceptibility (Coussé et al., 2015, unpublished results). 
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This haplotype consisted roughly of 1000 SNPs including the gene for ficolin, a 
protein that is important for complement activation. The detrimental influence of 
mange mites on components of the complement system has been demonstrated for P. 
ovis and S. scabiei (Bergstrom et al., 2009; Burgess et al., 2010; Fischer et al., 2009; 
Holt et al., 2003; Maruo et al., 1997) and a genetically fixed divergent complement 
activation could therefore have an influence on the mange susceptibility of an 
individual animal or an entire breed. 
 
5.3 Conclusion and future perspectives  
This thesis identified several factors that might contribute to the susceptibility 
of BB cattle to psoroptic mange. At first, the importance of mange on Flemish beef 
farms was confirmed by determining a (beef and mixed) herd prevalence of 74%. 
Besides demonstrating the negative influence of an incorrect treatment, this study also 
identified poor hygiene and purchase of high numbers of animals as risk factors for 
the occurrence of mange problems on farm level. In order to confirm the importance 
of these specific management factors and to potentially identify other risk factors, the 
execution of a similar study on more farms or experimental trials could be beneficial. 
One of those additional risk factors could be the feeding of (supplemented) 
concentrate, as animals in the fattening period often seem to be free of mange or 
appear to display less severe symptoms. As inconclusive results were obtained for this 
parameter in our risk analysis, research on a higher number of farms could lead to 
more significant results.  
Despite a similar farm management and treatment protocol, differences in 
acaricide efficacy could be observed between individual farms. This observation 
suggests the potential existence of more virulent or resistant mite strains. The 
development of an in vitro test to assess ivermectin resistance in P. ovis led to 
promising preliminary results (Maebe, 2015) and suggests that on some farms 
ivermectin resistant mites could be present. However, this test should be further 
optimized and since a threshold for acaricide resistance is currently unavailable, 
future research is necessary to determine such a cut-off value. In addition, the test 
should be validated on more farms and the in vitro results should be correlated with in 
vivo efficacy results. When acaricide resistance is suspected in specific mite 
populations, the next step will be to identify the molecular base of this resistance. As 
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MLs function through interaction with the GluCl and potentially the GABA-gated 
chloride channels of the parasite (Vercruysse and Rew, 2002), it would be interesting 
to compare the molecular structure and function of these features in resistant and 
susceptible mites. Besides GluCl-gated chloride channels, adenosinetriphosphate 
(ATP) binding cassette (ABC) transporters, such as P-glycoproteins, could be of 
interest as well, since these have been frequently mentioned as being important in ML 
resistance in helminths (Demeler et al., 2013; Ouellette, 2001; Prichard and Roulet, 
2007). As far as amitraz concerns, another frequently used acaricide in the treatment 
of mange, potential changes in the target of this drug, the octopamine receptor, are 
worth looking into (Chen et al., 2007). However, in this respect it should be 
mentioned that current research is limited to the expansion of a P. ovis cDNA library 
based on expressed sequence tag (EST) analysis (Burgess et al., 2011; Kenyon et al., 
2003; Lee et al., 1999) and the lack of a full genomic P. ovis DNA sequence might 
hamper future research on the molecular base of acaricide resistance.  
Besides environmental and mite-related factors, host-inherent aspects may also 
contribute to the mange susceptibility or resistance of a breed or individual animals. 
This study demonstrated a lack of IL-17 up-regulation in the skin of infested HF 
compared to BB, and PBMCs from BB but not HF seemed to elicit a substantial, 
presumably innate, IFN-γ response after re-stimulation with P. ovis antigen. In order 
to further investigate these breed dependent differences and to fill some of the gaps of 
this study, some future research suggestions are proposed in the following paragraph.  
A pitfall in this study was the mite exposure in the naturally infested animals from 
both breeds most likely not being identical and as this could influence the in vivo 
results from the skin biopsies, mite counts should be included in future studies when 
naturally infested animals are used. Another option is to perform experimental 
infections, during which equal mite loads are used in both breeds. This would allow a 
longitudinal follow-up of the immune responses from the moment the mites are 
administered on the skin, until a few weeks after experimental infection. During this 
period, skin biopsies and PBMCs could be processed as in our previous research. 
Alternatively, a microarray study (Burgess et al., 2010) or RNA-sequencing could be 
used to study the dynamics of the immune responses in BB and HF in more detail. At 
this stage, RNA-sequencing would be preferred as whole genome sequences of cattle 
and sheep (Daetwyler et al., 2014; Jiang et al., 2014) are available and the costs for 
this type of research are reduced. In order to further standardize the antigen load on 
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the skin, instead of mites, intradermal or topical application of P. ovis antigen could 
be considered. Such an intradermal skin test (IDT) was already optimized for BB 
animals (results not shown). Based on the test used by Losson et al. (1988, 1999) an 
optimal antigen concentration was determined, i.e. a concentration that did not elicit a 
reaction in uninfested animals. This optimized IDT was performed on 100 BB 
animals in an attempt to classify animals as resistant or susceptible based on their IDT 
reaction. Preliminary results of this test were inconclusive but the test could be used 
for other purposes in future research. After intradermal injection or topical application 
of the antigen, the immune response of both BB and HF animals could be evaluated 
by taking skin biopsies at regular time points and processing them as described above. 
Another drawback was that it was uncertain in which stage of infection the 
naturally infested animals were at the time of sampling and that only a ‘snapshot’ of 
the cutaneous immune response was evaluated. This could also be avoided by using 
experimental infections. The memory immune response mounted by in vitro re-
stimulated PBMCs was also only assessed at one time point, i.e. after 5 days in 
culture. In order to investigate the immune responses more closely over time and to 
see whether the cytokine profiles change over time after in vitro re-stimulation, 
proliferation and cytokine production of PBMCs could be evaluated at several 
evaluation points, for example after 24 hours, 3 days, 5 days and 7 days in culture.  
Thirdly, thorough investigation of the upstream mechanisms that lead to the 
immune responses that were identified during this study and of downstream 
mechanisms that may execute the effector response and/or regulate the inflammation, 
is needed in order to explain the differences between the 2 investigated cattle breeds 
and to completely understand the pathogenesis of psoroptic mange. Upstream 
investigation could focus on the interaction of antigen presenting cells (APC) with T-
cells, which gives an indication on which mite antigens are processed by APC and 
how the innate immune response models the adaptive immunity in a certain direction. 
The cellular sources of the observed cytokines in this study and the downstream 
(in)direct effects of these cytokines on the mites and potentially the host itself are also 
interesting pathways to investigate. More information on the IFN-γ cell sources could 
be obtained by including neutrophil counts in future research, as these cells have been 
mentioned as being important IFN-γ producers (Sturge et al., 2015). 
It would also be interesting to examine whether the differences that were observed 
in the immunologic study have a genetic basis. The breed specific up-regulated 
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cutaneous Th17 response or innate IFN-γ up-regulation could be heritable within the 
BB and therefore it would be beneficial to link the results from the PSOROVIS 
project to these findings. However, further research is necessary to confirm and refine 
the results of the genome wide association study, to potentially identify important 
genes and to see whether susceptibility to psoroptic mange is linked to structural 
proteins, such as ficolin or other proteins that might influence the immune response 
towards a Th17 profile or IFN-γ production. Even if the immune responses during 
infection could be described in detail over time, further research would still be 
necessary to demonstrate whether these counteract or contribute to the development 
of clinical signs. A corticosteroid test could be used to see whether the immune 
response is responsible for the lesions and whether dampening or interrupting this 
effector response by local and/or systemically applied corticosteroids would have an 
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Summary 
Psoroptes ovis mites cause psoroptic mange, a skin disease that affects sheep and 
cattle worldwide. Clinically an allergic dermatitis with yellow wet crusts, pruritic 
erythematous skin and alopecia can be observed and while symptoms typically occur at the 
withers, back and tail base, they can also spread covering the entire body (generalized form). 
The infection does not only lead to impaired animal welfare, but also to substantial economic 
losses, especially in beef cattle. The Belgian Blue (BB) beef breed is highly susceptible to 
psoroptic mange but the reason why these animals suffer more from the infection compared to 
dairy cattle remains unclear. Besides genetic, immunologic or physiologic differences 
inherent to the breed, environmental factors, such as farm management, may also be 
responsible for the susceptibility of these animals. 
 
In Chapter 1, the available literature on P. ovis is reviewed with the focus on 
pathogenesis, epidemiology, diagnosis, treatment and the host immune reactions during 
infection. This review demonstrates that, although psoroptic mange is a multifactorial disease, 
little information is available about the environmental parameters that may influence the 
outcome of the disease and that may explain the susceptibility differences between BB farms. 
Therefore, the first objective of this thesis was to identify specific farm management factors, 
including treatment protocol, that could act as risk factors for mange and that could explain 
the difference in severity of the disease between BB farms. Because mange problems can 
differ considerably, even within farms between individual animals, host related factors are 
also thought to contribute to the susceptibility of the BB breed in general. The second 
objective was therefore to study the immune responses during infection in BB animals and to 
compare these with those in the less susceptible Holstein Friesian (HF) cattle. 
 
Because mange problems vary significantly between farms, a cross-sectional 
questionnaire survey and subsequent farm visits were performed in Chapter 2 in order to 
identify potential risk factors for P. ovis infections on BB farms in Flanders (Belgium). The 
questionnaire was sent to 1,800 beef farms to evaluate the presence and severity of psoroptic 
mange in the herd and to assess farm management practices, including antiparasitic 
treatments. Subsequently, about 10% of the farms with a completed questionnaire were 
visited to validate the questionnaire and to retrieve supplementary information on additional 
management parameters, such as barn infrastructure and climate. Associations between 
parasitism and putative risk factors were assessed by logistic regression. Out of 1,800 
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contacted farms, 680 (38%) completed questionnaires were received. Data were collected 
from 238 barns during 66 farm visits. The questionnaire results demonstrated a high farm 
prevalence of mange (74%; 95% CI (70.7 – 77.3)) and half of the farmers declared that the 
problem was difficult to control. Nevertheless, in only 14% of the barns a high scratching 
index was recorded and in most of the sampled animals (80%) the affected body surface was 
less than 10%. This indicates that despite the high prevalence and the difficulty to control the 
infection, clinical signs were often quite moderate. Logistic regression analyses of the 
questionnaire and the farm visit data suggested that heavily infested farms treat more 
intensively against mange. On most farms, mange occurred the whole year round and more 
problems with mange were found on farms where a higher number of animals were purchased 
per year. In addition, the disease was more prevalent when the animals had a lower hygiene 
score. This score was strongly correlated with environmental hygiene, indicating that 
transmission of mites from the environment to the animals should not be underestimated. 
Conflicting results were obtained on the effect of supplementing minerals on the occurrence 
of mange. In this study, temperature, light intensity and relative humidity in the barns, 
ventilation systems, barn infrastructure, animal stocking rate and blood mineral levels were 
not indicated as risk factors for mange. In conclusion, maintaining a good animal hygiene and 
if possible, avoiding introduction of cattle may help in the control of psoroptic mange in 
Belgian Blue cattle.  
 
In the field, treatment failure is often allocated to acaricide resistance, but from the 
survey in Chapter 2, it became clear that most farmers use an incorrect treatment schedule in 
the control of the infection by treating affected animals only, using pour-on formulations 
instead of injectables or leaving more than 10 days between 2 treatments. The objective of 
Chapter 3 was therefore to evaluate whether an intensive treatment schedule could control 
the infection on farm level. Two intensive treatment schedules were evaluated on BB farms 
with a persistent mange problem. On farms 1 to 7, all animals were treated twice (7 to 10 days 
interval) with an injectable macrocyclic lactone (ML), while on the 2 remaining farms the 
initial treatment consisted of one injection with the long acting (LA) formulation of 
moxidectin (10%). Skin scrapings were taken one week after treatment and when living mites 
were found on at least one animal, all animals (farms 1-7) or only positive animals (farms 8 
and 9) were treated consecutively with an injectable ML. On all farms, treated animals were 
clinically healthy and P. ovis free at the end of winter, after 2 to 9 treatment rounds (2 
injections with 7-10 days interval or one LA injection). Although mange reappeared on the 
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first 7 farms after the subsequent grazing season, the disease was less severe and easier to 
control.  
 
Besides the farm related factors described in Chapter 2 and 3, host related immune 
responses could also be a cause of the natural predisposition of the BB beef breed to psoroptic 
mange. In Chapter 4, the in vivo cutaneous immune response and in vitro cellular immune 
response after antigen re-stimulation were examined in naturally infested BB. Cytokine 
transcription in the skin and in circulating re-stimulated PBMCs demonstrated a mixed pro-
inflammatory Th2/Th17 profile, with transcription of IL-4, IL-13, IL-6 and IL-17. Strong IL-
17 up-regulation in the skin of BB was associated with an influx of eosinophils and other 
immune cells, potentially leading towards more severe symptoms. Virtually no changes in 
cutaneous IFN-γ transcription were detected, while there was substantial IFN-γ up-regulation 
in re-stimulated PBMCs from infested and uninfested animals, potentially indicating a role of 
this pro-inflammatory cytokine in the innate immune response. In HF cattle, a largely similar 
immunologic response was observed. Differences between HF and BB were the lack of 
cutaneous IL-17 response in infested HF, the low transcription levels of IFN-γ and the clear 
up-regulation of IL-10 transcription in re-stimulated PBMCs from both infested and 
uninfested animals. Further research is needed to identify potential cell sources and biological 
functions for these cytokines and to fully unravel the basis of this different breed 
susceptibility to P. ovis. 
 
Finally, in Chapter 5, all results, some drawbacks of this thesis and potential future 
perspectives are debated. Besides confirming the importance of psoroptic mange in Belgium, 
this thesis could identify several factors (animal hygiene and import of new animals) that 
might partly explain the difference in mange problems between individual BB farms. As the 
number of examined farms was limited, similar research on additional farms and experimental 
studies are however necessary to confirm that management elements may influence the 
outcome of the disease on farm level. Another important factor was treatment protocol. 
Therapy failure is often observed under field conditions and although the presence of 
acaricide resistant mites should not be refuted, this thesis demonstrated that farmers often 
implement an incorrect treatment schedule, potentially explaining the lack of treatment 
efficacy. Therefore, a sensitization campaign in cooperation with Animal Health Care 
Flanders was launched, which focussed on correctly diagnosing and treating psoroptic mange 
(www.dgz.be/publicatie/fiche-aanpak-schurft). Additionally, the evaluation of 2 intensive 
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treatment schemes on 9 farms with mange problems showed that psoroptic mange could be 
controlled, although a high number of treatments were sometimes required. The results from 
this study can encourage other farmers to apply a correct treatment protocol as the favourable 
results may compensate for the intensive treatment protocol. However, despite similar 
management and treatment protocols, mange problems can still vary significantly between 
farms. This indicates that besides environmental factors, mite and host related aspects might 
also play a role in the high susceptibility to mange. Due to the frequent but often incorrect use 
of MLs, ivermectin resistance is already suspected in Belgian psoroptic mites. This was 
supported by preliminary results from an in vitro test demonstrating a decreased and highly 
variable susceptibility between mites originating from 13 Belgian farms compared to a 
susceptible control isolate. In the future, this in vitro test should be optimized, used on more 
farms and linked with in vivo efficacy data. In the long-term, the molecular mechanisms of 
ML resistance in the mites should be addressed, in order to develop molecular detection tests. 
Concerning host related influencing factors, this thesis confirmed that BB had a different 
immunologic response during P. ovis infection when compared to HF cattle. Future research 
should focus on confirming these results, revealing the upstream mechanisms and cell sources 
of important cytokines and their downstream effects and functions. In addition, some 
drawbacks of this work should be tackled in future studies: mite exposure should be 
standardized and quantified by performing mite counts and a longitudinal follow-up of the 
immune response after infection should be established by performing experimental infections 
and/or by including more evaluation points for the in vitro PBMC work. Finally, the genetic 
basis of the differing immune response should be identified, in view of genetic selection of 
mange-resistant animals.  
In conclusion, this thesis has revealed several potential causes of the high 
susceptibility of BB cattle towards psoroptic mange and practical guidelines could be 
generated to eliminate farm related risk factors. However, future research to specify and 
identify the BB specific immunity towards P. ovis is needed in order to construct practical 
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Samenvatting 
De ectoparasiet Psoroptes ovis veroorzaakt schurft, een huidziekte die wereldwijd 
zowel schapen als runderen kan aantasten. Klinisch wordt een allergische dermatitis met gele 
natte korsten, jeukende erythemateuze huid en alopecie opgemerkt. Hoewel symptomen 
typisch ter hoogte van de schoft, rug en staartbasis voorkomen, kunnen deze spreiden tot een 
gegeneraliseerde vorm waarbij het volledige lichaam aangetast is. De infectie heeft niet alleen 
een verminderd dierenwelzijn tot gevolg, maar ook belangrijke economische verliezen, 
voornamelijk in de vleesvee-industrie. Het Belgisch Witblauwe (BB) runderras is 
overgevoelig aan Psoroptes schurft, maar de reden waarom deze runderen erger lijden onder 
de infectie in vergelijking met melkvee blijft onduidelijk. De hypersensitiviteit van BB dieren 
kan veroorzaakt worden door genetische, immunologische en fysiologische verschillen die 
eigen zijn aan het ras, maar ook omgevingsfactoren zoals bedrijfsmanagement kunnen mede 
verantwoordelijk zijn voor verschillen tussen BB bedrijven onderling. 
 
In hoofdstuk 1 werd de beschikbare literatuur rond P. ovis samengevat. Onderzoek 
rond verschillende aspecten zoals epidemiologie, behandeling en immuniteitsopbouw toont 
aan dat Psoroptes schurft een multifactoriële ziekte is, maar dat er weinig gekend is over 
specifieke omgevingsfactoren die potentieel de overgevoeligheid van het BB ras mede kunnen 
verklaren. Daarom was de eerste doelstelling van deze thesis bedrijfs-afhankelijke 
managementfactoren, waaronder het behandelingsprotocol, te identificeren als mogelijke 
risicofactoren voor schurft. Deze factoren zouden het verschil in schurftproblematiek tussen 
individuele BB bedrijven kunnen verklaren, maar het probleem blijkt eveneens sterk te 
verschillen tussen individuele dieren binnen eenzelfde bedrijf. Dit impliceert dat specifieke 
gastheerfactoren vermoedelijk ook bijdragen aan de overgevoeligheid van het BB ras. De 
tweede doelstelling van deze thesis was daarom de immuunresponsen tijdens infectie bij BB 
dieren te evalueren en deze te vergelijken met die in meer resistente Holstein Friesian (HF) 
dieren. 
 
Doordat schurftproblemen sterk kunnen verschillen tussen individuele bedrijven 
onderling, werden in hoofdstuk 2 een enquête en bijhorende bedrijfsbezoeken uitgevoerd met 
als doel risicofactoren voor P. ovis infecties te identificeren op Vlaamse BB bedrijven. De 
enquête werd naar 1800 vleesveebedrijven gestuurd en bevatte vragen over de aanwezigheid 
en ernst van Psoroptes schurft in de kudde en over bedrijfsspecifieke managementfactoren, 
zoals antiparasitaire behandelingen. Vervolgens werd ongeveer 10% van de bedrijven met een 
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volledig ingevulde enquête bezocht ter validatie van de vragenlijst en om extra informatie te 
bekomen over bijkomende management-parameters zoals stalinfrastructuur en -klimaat. 
Associaties tussen parasitisme en mogelijke risicofactoren werden onderzocht door middel 
van logistische regressie. Van de 1800 bedrijven stuurden er 680 (38%) een complete 
vragenlijst terug en tijdens 66 bedrijfsbezoeken werd data verzameld van 238 stallen. Uit de 
enquêteresultaten kwam een hoge bedrijfsprevalentie van schurft naar voor (74%; 95% CI 
(70.7 – 77.3) en de helft van de veehouders gaf aan dat het probleem moeilijk tot niet te 
controleren was. Nochtans werd slechts in 14% van de stallen een hoge ‘scratch index’ 
gemeten en bij de meeste bemonsterde dieren (80%) bedroeg het aangetaste 
lichaamsoppervlak minder dan 10%. Dit toont aan dat klinische symptomen vaak vrij mild 
zijn ondanks de hoge prevalentie en de moeilijk te controleren aard van de infectie. De 
logistische regressie analyse suggereerde dat er op zwaar geïnfecteerde bedrijven ook meer 
behandeld wordt tegen schurft. Op de meeste bedrijven kwam de infectie het ganse jaar door 
voor en de grootste problemen werden vastgesteld op bedrijven waar jaarlijks grote aantallen 
nieuwe dieren aangekocht werden. Bovendien was de ziekte vaker aanwezig wanneer de 
dieren een lage hygiënescore hadden. Deze score was sterk gecorreleerd met de 
omgevingshygiëne, wat aantoont dat de overdracht van mijten vanuit de omgeving naar de 
dieren niet onderschat mag worden. Tegenstrijdige resultaten werden bekomen omtrent het 
effect van mineralen supplementatie en tevens konden temperatuur, lichtintensiteit, relatieve 
vochtigheid in de stallen, ventilatie-systemen, stalinfrastructuur, bezettingsdichtheid en 
mineralen-bloedwaarden niet aangeduid worden als risicofactoren voor schurft. Er kon 
geconcludeerd worden dat het behouden van een goede hygiëne en het zo min mogelijk 
aankopen van nieuwe dieren kunnen helpen bij de controle van Psoroptes schurft op BB 
vleesveebedrijven. 
 
In de praktijk wordt therapiefalen vaak aan de aanwezigheid van acariciden-resistente 
mijten geweten. Uit hoofdstuk 2 bleek echter dat op de meeste bedrijven een incorrect 
behandelingsschema gebruikt wordt om de infectie te controleren, waarbij enkel de klinisch 
aangetaste dieren behandeld worden, pour-on formulaties in plaats van injecteerbare 
producten gebruikt worden of meer dan 10 dagen tussen 2 behandelingen gelaten wordt. Het 
doel van hoofdstuk 3 was dan ook te evalueren of een intensieve behandeling toch in staat 
was om een infectie op bedrijfsniveau volledig te controleren. Daarom werden 2 intensieve 
behandelingsschema’s toegepast op 9 Vlaamse vleesveebedrijven met een persisterend 
schurftprobleem. Op bedrijven 1-7 werden alle dieren 2 maal behandeld (interval 7 à 10 
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dagen) met een injecteerbaar macrocyclisch lactone (ML). Op de 2 laatste bedrijven werd een 
éénmalige injectie toegediend met de ‘long acting’ (LA) formulatie van moxidectine (10%). 
Eén week na behandelen werden huidafkrabsels genomen en bij aanwezigheid van levende 
mijten bij ten minste 1 dier werden alle dieren (bedrijven 1-7) of alle positieve dieren 
(bedrijven 8 en 9) verder behandeld met een injecteerbaar ML. Op alle bedrijven waren de 
dieren klinisch genezen en schijnbaar vrij van mijten na 2 tot 9 behandelingsrondes (2 
injecties met 7-10 dagen interval of 1 LA injectie). Hoewel er na het daaropvolgende 
weideseizoen op de eerste 7 bedrijven opnieuw tekenen van schurft te zien waren, was dit in 
mindere mate en gemakkelijker te controleren.  
 
Naast de omgevingsfactoren die aan bod kwamen in hoofdstuk 2 en 3, kan een 
gastheer-specifieke immuunrespons ook een mogelijke oorzaak zijn van de natuurlijke 
predispositie van BB runderen voor Psoroptes schurft. Daarom werden in hoofdstuk 4 de 
cutane immuunrespons (in vivo) en de cellulaire immuunrespons (na antigen herstimulatie in 
vitro) onderzocht in natuurlijk geïnfesteerde BB dieren. De cytokine productie in de huid en 
de circulerende geherstimuleerde PBMCs vertoonden een gemengd pro-inflammatoire 
Th2/Th17 profiel, met verhoogde transcriptie van IL-4, IL-13, IL-6 en IL-17. De sterke IL-17 
transcriptie in de huid van geïnfecteerde BB was geassocieerd met een influx van eosinofielen 
en andere immuuncellen, wat mogelijks de ergere symptomen bij BB kan verklaren. Hoewel 
er zo goed als geen IFN-γ transcriptie gedetecteerd kon worden in de huid, werd dit cytokine 
duidelijk wel afgeschreven door geherstimuleerde PBMCs van zowel geïnfecteerde als niet-
geïnfecteerde dieren. Dit suggereert een mogelijke rol voor dit pro-inflammatoire cytokine als 
onderdeel van de aangeboren of ‘innate’ immuunrespons. Bij HF runderen werd een 
grotendeels identieke immuunrespons opgemerkt. De grootste verschillen tussen HF en BB 
dieren waren het gebrek aan een cutane IL-17 respons bij geïnfecteerde HF, de lage 
transcriptiewaarden van IFN-γ en de verhoogde transcriptie van IL-10 in de geherstimuleerde 
PBMCs van zowel geïnfecteerde als niet-geïnfecteerde HF dieren. Verder onderzoek naar de 
cellulaire oorsprong en biologische functies van deze cytokines is noodzakelijk om de basis 
van de verschillende ras-afhankelijke gevoeligheid voor P. ovis bloot te leggen. 
 
Tot slot worden in hoofdstuk 5 alle resultaten, enkele nadelen van de gebruikte 
methodologie en potentiële toekomstperspectieven aangehaald. Naast het bevestigen van het 
belang van Psoroptes schurft in België (74% bedrijfsprevalentie), kon deze thesis 
verschillende factoren (‘slechte hygiëne’ en ‘aankoop van hoge aantallen nieuwe dieren’) 
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identificeren die mogelijks een deel van de gevarieerde gevoeligheid ten opzichte van P. ovis 
tussen BB bedrijven kunnen verklaren. Aangezien het aantal onderzochte bedrijven beperkt 
was, zijn gelijkaardig onderzoek op bijkomende bedrijven en experimentele studies nodig om 
te bevestigen dat deze managementfactoren effectief een invloed hebben op de problematiek 
op bedrijfsniveau. Een bijkomende belangrijke parameter was het behandelingsprotocol tegen 
schurftmijten. Therapiefalen komt onder praktijkomstandigheden vaak voor en ook al kan de 
aanwezigheid van acariciden-resistente mijten niet uitgesloten worden, toch kon in deze thesis 
aangetoond worden dat veehouders vaak een incorrect behandelingsschema toepassen op hun 
bedrijf, wat de lage behandelingsefficiëntie mogelijks kan verklaren. Daarom werd in 
samenwerking met Diergezondheidszorg Vlaanderen een sensibiliseringscampagne op punt 
gesteld waarbij de focus op een correcte diagnose en behandeling van Psoroptes schurft ligt 
(www.dgz.be/publicatie/fiche-aanpak-schurft). Bovendien toonde de evaluatie van 2 
intensieve behandelingsprotocols op 9 probleembedrijven aan dat Psoroptes schurft wel 
degelijk kon gecontroleerd worden, hoewel vaak veel behandelingen nodig waren. Aangezien 
een intensieve behandeling tot goede resultaten leidde, kunnen de resultaten van deze studie 
een stimulans zijn voor andere veehouders om een correct behandelingsschema toe te passen 
in de strijd tegen schurft. Ondanks een gelijkaardig management, behandelingsschema incluis, 
kan een schurftprobleem toch sterk verschillen tussen BB bedrijven onderling. Dit impliceert 
dat naast omgevingsfactoren, ook mijt- en gastheer-specifieke aspecten een rol kunnen spelen 
in de gevoeligheid voor schurft. Door het frequent, maar vaak incorrect gebruik van MLs, 
werd ivermectine resistentie reeds vermoed bij Belgische Psoroptes mijten. Dit werd 
bevestigd door preliminaire resultaten van een in vitro test, waarbij de gevoeligheid van 
mijten afkomstig van 13 Belgische bedrijven sterk varieerde en verlaagd was in vergelijking 
met een gevoelig controle-isolaat. Toekomstig onderzoek dient te focussen op de 
optimalisatie van deze in vitro test, op de validatie van de test op een groter aantal bedrijven, 
op het verband tussen in vitro resultaten en in vivo efficaciteitsdata en op het identificeren van 
het moleculair mechanisme van resistentie in de mijten. Wat betreft gastheer gerelateerde 
factoren,  kon deze thesis bevestigen dat BB dieren een verschillende immunologische reactie 
vertoonden in vergelijking met HF vee. Terwijl bij de geïnfecteerde BB een gemengde 
Th2/Th17 cutane respons opgemerkt werd, was IL-17 transcriptie in de huid van geïnfesteerde 
HF afwezig. Verder kon een sterke en waarschijnlijk aangeboren IFN-γ respons gedetecteerd 
worden in de geherstimuleerde PBMCs van geïnfecteerde en niet-geïnfecteerde BB dieren 
terwijl dit niet te zien was bij HF. Om deze resultaten te bevestigen, de onderliggende 
mechanismen te identificeren en de downstream effecten en functies van deze cytokines aan 
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te tonen, is echter meer onderzoek nodig. Sommige nadelen van de gebruikte methodologie 
zouden hierbij ook aangepakt kunnen worden: de mijten-blootstelling zou gestandaardiseerd 
en gekwantificeerd moeten worden en een longitudinale opvolging van de immuunrespons na 
infectie zou gerealiseerd moeten worden door experimentele infecties uit te voeren en/of door 
meer evaluatie tijdstippen bij het in vitro PBMC werk in te lassen. Bovendien dient in 
toekomstig onderzoek aandacht besteed te worden aan de mogelijke genetische basis van de 
verschillende immuunrespons die geobserveerd werd, met het oog op genetische selectie van 
schurft-resistente dieren. 
Deze thesis heeft verschillende potentiële oorzaken van de overgevoeligheid van BB 
rundvee ten opzichte van Psoroptes schurft geïdentificeerd en praktische richtlijnen 
gegenereerd om bedrijfsafhankelijke factoren te beperken. Verder onderzoek is echter nodig 
om de specifieke immuniteit die BB dieren tegenover P. ovis opbouwen verder te specifiëren 
en zo finaal praktische tools, zoals immunotherapie of vaccinatie, te kunnen voorzien voor de 
controle van Psoroptes schurft. 
 
